
<html lang="en"     class="pb-page"  data-request-id="453d5df1-ef99-4292-bea4-060471de2b12"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.9b01513;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Biphenyl Acid Derivatives as APJ Receptor Agonists" /></meta><meta name="dc.Creator" content="Shun  Su" /></meta><meta name="dc.Creator" content="Adam  Clarke" /></meta><meta name="dc.Creator" content="Ying  Han" /></meta><meta name="dc.Creator" content="Hannguang J.  Chao" /></meta><meta name="dc.Creator" content="Jeffrey  Bostwick" /></meta><meta name="dc.Creator" content="William  Schumacher" /></meta><meta name="dc.Creator" content="Tao  Wang" /></meta><meta name="dc.Creator" content="Mujing  Yan" /></meta><meta name="dc.Creator" content="Mei-Yin  Hsu" /></meta><meta name="dc.Creator" content="Eric  Simmons" /></meta><meta name="dc.Creator" content="Chiuwa  Luk" /></meta><meta name="dc.Creator" content="Carrie  Xu" /></meta><meta name="dc.Creator" content="Marta  Dabros" /></meta><meta name="dc.Creator" content="Michael  Galella" /></meta><meta name="dc.Creator" content="Joelle  Onorato" /></meta><meta name="dc.Creator" content="David  Gordon" /></meta><meta name="dc.Creator" content="Ruth  Wexler" /></meta><meta name="dc.Creator" content="Peter S.  Gargalovic" /></meta><meta name="dc.Creator" content="R. Michael  Lawrence" /></meta><meta name="dc.Description" content="The APJ receptor and its endogenous peptidic ligand apelin have been implicated as important modulators of cardiovascular function, and APJ receptor agonists may be beneficial in the treatment of h..." /></meta><meta name="Description" content="The APJ receptor and its endogenous peptidic ligand apelin have been implicated as important modulators of cardiovascular function, and APJ receptor agonists may be beneficial in the treatment of h..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 14, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01513" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01513" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01513" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01513" /></link>
        
    
    

<title>Biphenyl Acid Derivatives as APJ Receptor Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01513" /></meta><meta property="og:title" content="Biphenyl Acid Derivatives as APJ Receptor Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0013.jpeg" /></meta><meta property="og:description" content="The APJ receptor and its endogenous peptidic ligand apelin have been implicated as important modulators of cardiovascular function, and APJ receptor agonists may be beneficial in the treatment of heart failure. In this article, we describe the discovery of a series of biphenyl acid derivatives as potent APJ receptor agonists. Following the identification of initial high-throughput screen lead 2, successive optimization led to the discovery of lead compound 15a. Compound 15a demonstrated comparable in vitro potency to apelin-13, the endogenous peptidic ligand for the APJ receptor. In vivo, compound 15a demonstrated a dose-dependent improvement in the cardiac output in male Sprague Dawley rats with no significant changes in either mean arterial blood pressure or heart rate, consistent with the hemodynamic profile of apelin-13 in an acute pressure volume loop model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01513"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01513">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01513&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01513&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01513&amp;href=/doi/10.1021/acs.jmedchem.9b01513" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10456-10465</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01545" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01078" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Biphenyl Acid Derivatives as APJ Receptor Agonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Shun Su</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shun Su</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#43102b362d6d103603212e306d202c2e"><span class="__cf_email__" data-cfemail="396a514c57176a4c795b544a175a5654">[email protected]</span></a>. Phone: (+1) 609-466-5079.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shun++Su">Shun Su</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8100-9645" title="Orcid link">http://orcid.org/0000-0001-8100-9645</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adam Clarke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam Clarke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Clarke">Adam Clarke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ying Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Han">Ying Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hannguang J. Chao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hannguang J. Chao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hannguang+J.++Chao">Hannguang J. Chao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffrey Bostwick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey Bostwick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey++Bostwick">Jeffrey Bostwick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">William Schumacher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">William Schumacher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=William++Schumacher">William Schumacher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tao Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tao Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Wang">Tao Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mujing Yan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mujing Yan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mujing++Yan">Mujing Yan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mei-Yin Hsu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mei-Yin Hsu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mei-Yin++Hsu">Mei-Yin Hsu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric Simmons</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric Simmons</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Simmons">Eric Simmons</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3854-1561" title="Orcid link">http://orcid.org/0000-0002-3854-1561</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chiuwa Luk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chiuwa Luk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chiuwa++Luk">Chiuwa Luk</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carrie Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carrie Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carrie++Xu">Carrie Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Dabros</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Dabros</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Dabros">Marta Dabros</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Galella</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Galella</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Galella">Michael Galella</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joelle Onorato</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joelle Onorato</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joelle++Onorato">Joelle Onorato</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Gordon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Gordon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Gordon">David Gordon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruth Wexler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruth Wexler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruth++Wexler">Ruth Wexler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter S. Gargalovic</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter S. Gargalovic</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+S.++Gargalovic">Peter S. Gargalovic</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">R. Michael Lawrence</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">R. Michael Lawrence</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Development, Bristol-Myers Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=R.+Michael++Lawrence">R. Michael Lawrence</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01513&amp;href=/doi/10.1021%2Facs.jmedchem.9b01513" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10456–10465</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 14, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 October 2019</li><li><span class="item_label"><b>Published</b> online</span>14 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 November 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01513" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01513</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10456%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShun%2BSu%252C%2BAdam%2BClarke%252C%2BYing%2BHan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D22%26contentID%3Dacs.jmedchem.9b01513%26title%3DBiphenyl%2BAcid%2BDerivatives%2Bas%2BAPJ%2BReceptor%2BAgonists%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10465%26publicationDate%3DNovember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01513"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1098</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01513" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Biphenyl Acid Derivatives as APJ Receptor Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shun&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Clarke&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Hannguang&quot;,&quot;last_name&quot;:&quot;J. Chao&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;Bostwick&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;Schumacher&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Mujing&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Mei-Yin&quot;,&quot;last_name&quot;:&quot;Hsu&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Simmons&quot;},{&quot;first_name&quot;:&quot;Chiuwa&quot;,&quot;last_name&quot;:&quot;Luk&quot;},{&quot;first_name&quot;:&quot;Carrie&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Dabros&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Galella&quot;},{&quot;first_name&quot;:&quot;Joelle&quot;,&quot;last_name&quot;:&quot;Onorato&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Gordon&quot;},{&quot;first_name&quot;:&quot;Ruth&quot;,&quot;last_name&quot;:&quot;Wexler&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;S. Gargalovic&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Michael Lawrence&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;10456-10465&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01513&quot;},&quot;abstract&quot;:&quot;The APJ receptor and its endogenous peptidic ligand apelin have been implicated as important modulators of cardiovascular function, and APJ receptor agonists may be beneficial in the treatment of heart failure. In this article, we describe the discovery of a series of biphenyl acid derivatives as potent APJ receptor agonists. Following the identification of initial high-throughput screen lead 2, successive optimization led to the discovery of lead compound 15a. Compound 15a demonstrated comparable in vitro potency to apelin-13, the endogenous peptidic ligand for the APJ receptor. In vivo, compound 15a demonstrated a dose-dependent improvement in the cardiac output in male Sprague Dawley rats with no significant changes in either mean arterial blood pressure or heart rate, consistent with the hemodynamic profile of apelin-13 in an acute pressure volume loop model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01513&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01513" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01513&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01513" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01513&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01513" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01513&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01513&amp;href=/doi/10.1021/acs.jmedchem.9b01513" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01513" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01513" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01513%26sid%3Dliteratum%253Aachs%26pmid%3D31724863%26genre%3Darticle%26aulast%3DSu%26date%3D2019%26atitle%3DBiphenyl%2BAcid%2BDerivatives%2Bas%2BAPJ%2BReceptor%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D22%26spage%3D10456%26epage%3D10465%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/jmcmar.2019.62.issue-22/20191127/jmcmar.2019.62.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The APJ receptor and its endogenous peptidic ligand apelin have been implicated as important modulators of cardiovascular function, and APJ receptor agonists may be beneficial in the treatment of heart failure. In this article, we describe the discovery of a series of biphenyl acid derivatives as potent APJ receptor agonists. Following the identification of initial high-throughput screen lead <b>2</b>, successive optimization led to the discovery of lead compound <b>15a</b>. Compound <b>15a</b> demonstrated comparable in vitro potency to apelin-13, the endogenous peptidic ligand for the APJ receptor. In vivo, compound <b>15a</b> demonstrated a dose-dependent improvement in the cardiac output in male Sprague Dawley rats with no significant changes in either mean arterial blood pressure or heart rate, consistent with the hemodynamic profile of apelin-13 in an acute pressure volume loop model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heart failure (HF) and related complications have become an increasing concern to the world’s population. In the US alone, HF affects approximately six million people and leads to increased morbidity, premature death, poor quality of life, and significant health-care expenditure.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> HF is a clinical syndrome characterized by inadequate performance of the heart and inability to deliver sufficient blood and oxygen supply to meet the body’s demands. Despite encouraging advances in HF management,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> which focus primarily on inhibition and downregulation of the renin–angiotensin aldosterone system and co-medications including β-blockers, vasodilators, and diuretics, the prognosis remains poor. Patients display 10% mortality at 28 days posthospitalization for HF, and survival rates are approximately 50% within 5 years of diagnosis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> As a result, the development of novel therapeutic agents is necessary to further improve HF therapy.</div><div class="NLM_p">The APJ receptor (APJ-R) was identified in 1993 as a member of the rhodopsin-like G-protein-coupled receptor family.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> APJ-R is most closely related to the angiotensin AT<sub>1</sub> receptor, with 54% homology in the transmembrane domain, but lacks binding affinity for angiotensin II.<a onclick="showRef(event, 'cit5a'); return false;" href="javascript:void(0);" class="ref cit5a">(5a)</a> APJ-R is widely expressed in various tissues, including the heart, kidney, and blood vessels. APJ-R was deorphanized following the discovery of its endogenous peptidic ligand, apelin.<a onclick="showRef(event, 'cit5a'); return false;" href="javascript:void(0);" class="ref cit5a">(5a)</a> Recently, the Elabela peptide was also identified as an endogenous APJ-R ligand.<a onclick="showRef(event, 'cit5b'); return false;" href="javascript:void(0);" class="ref cit5b">(5b)</a> Apelin is produced as a 77 amino acid pre-pro form and is progressively cleaved to smaller peptidic fragments.<a onclick="showRef(event, 'cit6a'); return false;" href="javascript:void(0);" class="ref cit6a">(6a)</a> Among the biologically active apelin peptides, which include apelin-13, -17, and -36, as well as the pyroglutamate form of apelin-13 ((Pyr<sup>1</sup>)apelin-13, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), (Pyr<sup>1</sup>)apelin-13 has been reported as the most stable and most abundant form present in human plasma and cardiac tissue.<a onclick="showRef(event, 'cit6b cit6c'); return false;" href="javascript:void(0);" class="ref cit6b cit6c">(6b,c)</a> Preclinical animal models indicate that APJ receptor agonists can improve cardiac function<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and this notion is also supported by apelin studies in humans. Acute infusion of (Pyr<sup>1</sup>)apelin-13 into healthy volunteers and into patients with HF resulted in improved cardiac output (CO) and increased ejection fraction without significant effects on blood pressure or heart rate.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Therefore, interest in APJ-R agonism as a potential therapeutic target for HF management has been widespread and is evidenced by the development of both peptido-mimetic<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and small-molecule<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> APJ-R agonists. In this paper, the identification and optimization of a series of biphenyl acid (BPA)-based APJ agonists are described.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (Pyr<sup>1</sup>)apelin-13 and HTS hit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an effort to identify small-molecule APJ-R agonists, a high-throughput screen (HTS) of 1.2 million compounds was undertaken using a homogeneous time-resolved fluorescence assay<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> in HEK293 cells stably expressing human APJ-R. Compounds that demonstrated ≥20% inhibition of forskolin-stimulated cAMP (Ymax) and ≤20% efficacy against a parental HEK293 cell line were further evaluated using confirmatory concentration response analysis. Confirmed hits were then screened against the AT<sub>1</sub> receptor to rule out any compounds with AT<sub>1</sub> activity. This led to the identification of a number of small-molecule agonists including bis-amide <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which contained a biphenyl core, a privileged structure for GPCRs,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and exhibited full agonism<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> of APJ-R with an EC<sub>50</sub> of 29 nM.</div><div class="NLM_p">Following the identification of compound <b>2</b>, an efficient synthetic sequence was developed and used to generate diverse BPA bis-amides through a key orthogonally protected biphenyl tricarboxylic ester intermediate <b>7</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Starting with the known bis-ester <b>3</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> ester exchange followed by triflate formation produced intermediate <b>4</b>. Subsequent palladium-mediated borylation followed by Suzuki coupling generated tri-ester <b>7</b>. Each carboxylic ester on <b>7</b> could be cleaved selectively, providing a versatile starting point for array synthesis. For the re-synthesis of <b>2</b>, zinc-mediated reductive trichloroethyl ester cleavage of <b>7</b> and subsequent amide bond formation afforded bis-ester <b>8</b>. tetra-<i>n</i>-Butylammonium fluoride (TBAF)-mediated (trimethylsilyl)ethyl ester deprotection, amide coupling, and removal of the <i>t</i>-butyl group under acidic conditions generated bis-amides <b>9</b> in excellent yields.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Bis-Amides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-(trimethylsilyl)ethanol, NaH, toluene, 0–50 °C, 62%; (b) Tf<sub>2</sub>O, pyridine, DCM, 0 °C, 99%; (c) bis(pinacolato)diborane, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub>, KOAc, 1,4-dioxane, 65 °C, 96%; (d) PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene, H<sub>2</sub>O, 65 °C, 57%; (e) Zn, sat. NH<sub>4</sub>Cl solution, THF, rt, 97%; (f) 3-fluoro-4-methoxyaniline, HATU, DIEA, MeCN, rt, 81%; (g) TBAF, THF, rt, quant.; (h) RNH<sub>2</sub>, HATU, DIEA, DCM, rt; (i) TFA, DCM, rt, 68–95% for two steps.</p></p></figure><div class="NLM_p">One notable potential liability presented by <b>2</b> was the possible release of aniline as a result of amide hydrolysis under metabolic activation. Efforts were focused on replacement of the aniline and identification of analogues with improved potency. Following the synthetic route depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, a series of structurally diverse aliphatic amines were surveyed on amide A of the BPA core (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). From these efforts, we found that the dihydroindene amine could be replaced with 2-phenylethanolamine to generate <b>9a</b> with comparable potency to compound <b>2</b>. Meanwhile, it was also noted that amides with lipophilic substituents afforded better potency compared to polar amides. Thus, the methylated 2-phenylethanolamine was incorporated resulting in <b>9b</b> with an EC<sub>50</sub> of 0.19 nM, a 310-fold potency improvement compared to <b>9a</b>. It was determined that APJ activity resided primarily in the <i>R</i> enantiomer, whereas the <i>S</i> enantiomer <b>9c</b> showed reduced potency. An in vitro biotransformation study of an early analogue related to <b>9b</b> identified the methyl ether as the major site of metabolism.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The methoxy phenyl ethylene amine was replaced with isosteric <i>n</i>-butyl phenyl ethylene amine in an effort to address this liability, providing <b>9d</b> with comparable potency to <b>9b</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Bis-Amide Examples<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0007.gif" alt="" id="GRAPHIC-d7e528-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0008.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean SEM, <i>n</i> = 2 or more determinations.</p></div></div><div></div></div><div class="NLM_p">Following the identification of <b>9d</b>, amide B of the BPA core was extensively surveyed. Array synthesis was executed by alternating the order of ester cleavage. However, a narrow structure–activity relationship (SAR) was observed at this position and all attempts to replace anilines with aliphatic amines were unproductive.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Subsequent efforts to replace the amide led to the identification of benzimidazole analogue <b>11a</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), the synthesis of which is depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. (Trimethylsilyl)ethyl ester deprotection of <b>7</b> followed by amide coupling provided intermediate <b>10</b>. Reductive cleavage of the trichloroethyl ester generated the corresponding carboxylic acid, which was subjected to amide coupling with <i>o</i>-phenylenediamine. The resulting regiosomeric mixture of amides was treated with acetic acid under elevated temperature to effect benzimidazole formation and <i>t</i>-butyl ester cleavage in one pot to generate <b>11</b>. Exploration of the benzimidazole substitution pattern indicated that various substituents at the 5 position were tolerated for potency. Both 5-Cl (<b>11b</b>) and 5-Me (<b>11c</b>) benzimidazole analogues exhibited slightly improved potency and the 5-OMe compound (<b>11d</b>) offered an additional potency boost. In contrast, as demonstrated by <b>11e</b> and <b>11f</b>, substitution with a methyl group at the 7 position and incorporation of N at the 6 position of the phenyl ring led to a significant loss in potency. In addition to benzimidazoles, heterocycles such as phenylimidazole and benzoxazole were also investigated. Whereas phenyl imidazole <b>11g</b> retained nM level potency, the benzoxazole analogue <b>11h</b> resulted in micromolar potency, indicating that the benzimidazole NH may play a pivotal role in the interaction with APJ-R.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Benzimidazole-Substituted BPAs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TBAF, THF, rt, quant.; (b) (<i>R</i>)-1-phenylbutan-1-amine, HATU, DIEA, DCM, rt, 75%; (c) Zn, sat. NH<sub>4</sub>Cl solution, THF, rt, 90%; (d) HATU, DIEA, DCM, rt, then AcOH, 85 °C, 68%–92%.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Benzimidazole SAR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0009.gif" alt="" id="GRAPHIC-d7e622-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0010.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean SEM, n = 2 or more determinations.</p></div></div><div></div></div><div class="NLM_p">Parallel to the exploration of the benzimidazole SAR, the substitution pattern of the D-ring was investigated (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Replacing the 3-Cl with a proton (<b>12a</b>) or methoxy group (<b>12c</b>) led to less potent compounds, whereas the 3-Me (<b>12b</b>) analogue retained potency. A chlorine walk on the D-ring was subsequently executed. Whereas 1-Cl (<b>12d</b>)- and 2-Cl (<b>11e</b>)-substituted analogues showed reduced potency, the 4-Cl analogue (<b>12f</b>) demonstrated improved potency by sevenfold compared to <b>11a</b>. Compound <b>12f</b> was determined to exist as a 1:1 mixture of atropisomers because of the steric encumbrance surrounding the biaryl bond. The corresponding 4-F (<b>12g</b>) and 4-Me analogues (<b>12h</b>) showed comparable potency to <b>12f</b>. The chlorine substitution was selected to be used for subsequent studies as it was considered to offer higher atropisomeric thermal stability compared to the 4-F analogue,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and afforded superior yield for the biaryl formation step compared to the 4-Me analogue. It is worth noting that the Suzuki coupling between boronic ester <b>5</b> and bromide <b>13</b> was challenging and only moderate yields were initially obtained. Extensive screening of reaction conditions afforded <b>14</b> in satisfactory yield (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Tri-Ester <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, xantphos, 1 M K<sub>3</sub>PO<sub>4</sub>, toluene, 70 °C, 65–74%.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. D-Ring SAR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0011.gif" alt="" id="GRAPHIC-d7e721-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">hAPJEC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">3-H</td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">1-Cl</td><td class="colsep0 rowsep0" align="char" char="±">2100 ± 970</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="char" char="±">9.0 ± 2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="±">0.51 ± 0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.013</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean SEM, <i>n</i> = 2 or more determinations.</p></div></div></div><div class="NLM_p">The atropisomeric mixture <b>12f</b> was subjected to chiral supercritical fluid chromatography (SFC) separation and stable atropisomers <b>15a</b> and <b>15b</b> were obtained (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The absolute configurations of <b>15a</b> and <b>15b</b> were confirmed by X-ray crystallography of the individual atropisomers. The <i>S</i>-atropisomer <b>15a</b> was found to be 200-fold more potent than the corresponding <i>R</i>-atropisomer. The dihedral angle of the biphenyl system was nearly perpendicular in the crystalline form. The 15-fold potency boost compared to <b>11a</b> indicated that conformational restriction of the biphenyl ring system imposed a favorable bioactive conformation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 4. <a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0012.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean SEM, <i>n</i> = 2 or more determinations.</p></div></div><div></div></div><div class="NLM_p">The optimized BPA <b>15a</b> demonstrated agonist potency comparable to (Pyr<sup>1</sup>)apelin-13 versus both human and rat APJ-R (0.093 vs 0.047 nM and 0.12 vs 0.062 nM, respectively). It is worth noting that, in contrast to the 3-Cl series (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, compounds <b>11a</b> vs <b>11d</b>), installation of a methoxy group on the benzimidazole (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, <b>15c</b>) failed to provide further potency improvement. It is hypothesized that the reinforced orthogonal orientation of the biphenyl core projected the methoxy group in a less favorable orientation. To understand the binding site of <b>15a</b>, competition studies between <b>15a</b> and [<sup>125</sup>I]-apelin-13, as well as between [<sup>3</sup>H]-<b>15a</b> and apelin-13, were performed (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The nearly quantitative displacement of [<sup>125</sup>I]-apelin-13 by <b>15a</b> and the displacement of [<sup>3</sup>H]-<b>15a</b> by apelin-13 support the assumption that <b>15a</b> occupied the orthosteric site of APJ-R. Compared to <b>15c</b>, <b>15a</b> appeared to exhibit improved solubility at pH 7.4 (0.66 vs 0.18 mg/mL, amorphous) and was advanced to pressure–volume loop analysis (<i>PV</i>-loop)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> in isoflurane-anesthetized male Sprague Dawley (SD) rats to evaluate its acute hemodynamic effect. When dosed via intravenous infusion at 100 μg/min/kg, <b>15a</b> induced a 10% increase in CO with minimal impact on blood pressure (<5% transient blood pressure drop)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and no effect on heart rate,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> which was consistent with the hemodynamic effect of (Pyr<sup>1</sup>)apelin-13 (<b>1</b>) in this model (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Subsequent dose response studies revealed that <b>15a</b> exhibited a dose-dependent increase in CO without a significant effect on HR, consistent with a (Pyr<sup>1</sup>)apelin-13 response in this model.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Radioligand binding experiments; 1 μg of the human APJ-R-expressing HEK293 cell membrane was incubated with increasing concentration of <b>1</b> or <b>15a</b> and 0.1 nM [<sup>125</sup>I]-(Pyr<sup>1</sup>)apelin-13 in a final volume of 200 μL assay buffer containing 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 10 mM MgCl<sub>2</sub>, 2 mM ethylene glycol-bis(2-aminoethylether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid, and 0.1% bovine serum albumin, pH = 7.2. The membrane was separated from free compounds with a 0.3% poly ethyleneimine-soaked UniFilter-96 GF/B plate after incubation at room temperature for 1 h; inhibition binding reaction was carried out at room temperature for 3 h when 1 nM of [<sup>3</sup>H]-<b>15a</b> was used.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat pressure-volume loop analysis of <b>1</b> and <b>15a</b>. Isoflurane-anesthetized male SD rats with a Millar <i>PV</i>-loop catheter in LV and a Millar pressure catheter in the abdominal aorta. After establishing a stable baseline, <b>1</b> [6 μg/kg/min (3.92 nmol/kg/min), <i>n</i> = 7] or <b>15a</b> (10, 100, 1000 μg/kg/min (0.0157, 0.157, 1.57 μmol/kg/min), <i>n</i> = 8/dose) or <i>N</i>,<i>N</i>-Dimethylacetamide vehicle (100 μL/kg/min, <i>n</i> = 10) was infused into the jugular vein for 15 min with continuous monitoring of hemodynamics. Hemodynamics were monitored for an additional 15 min after terminating infusion. Separate rats were prepared to measure exposures in response to the same 15 min infusions of <b>15a</b> (<i>n</i> = 3/dose); washout samples were obtained after stopping the 10 and 1000 μg/kg/min infusions; plasma concentration of <b>15a</b> (μM) after 15 min of infusion: 0.44 ± 0.18 (10 μg/kg/min); 4.4 ± 0.28 (100 μg/kg/min); 82 ± 4.2 (1000 μg/kg/min).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">BPA bis-amide <b>2</b> was identified from HTS screening as an APJ-R agonist. Initial SAR exploration of the bis-amide series led to optimization of the upper amide, which resulted in an 80-fold increase in in vitro potency (<b>9d</b> vs <b>2</b>). The bis-amide series was further advanced by replacing the lower amide with a benzimidazole. Optimization of the benzimidazole C5 and C7 position substitution and subsequent biphenyl core C4 substitution afforded non-interconverting atropisomer <b>12f</b>. Separation of the respective atropisomers led to the identification of <i>S</i> antipode, <b>15a</b>, with in vitro potency consistent with that observed with the endogenous ligand, (Pyr<sup>1</sup>)apelin-13 (<b>1</b>). Compound <b>15a</b> demonstrated significant improvement in CO in male SD rats with no significant changes in either mean arterial blood pressure or heart rate, which was consistent with the effect of <b>1</b> in this acute rat <i>PV</i>-loop model. The studies described herein demonstrate that the BPA chemotype shows promise as a novel scaffold for the development of potent APJ-R agonists for treatment of HF.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Information</h3><div class="NLM_p">All reagents and solvents used, including anhydrous solvents, were of commercial quality. All reactions were carried out under a static atmosphere of nitrogen and stirred magnetically unless otherwise stated. All flash chromatographic separations were performed using an ISCO RediSep on disposable silica gel columns, eluting with hexanes/ethyl acetate or methylene chloride/methanol. For diastereomeric mixtures, the desired compound was obtained via SFC on a PIC solution 200 SFC system using the following method: Chiralpak AD-H, 21 × 250 mm, 5 μm; 22% EtOH/78% CO<sub>2</sub>; 45 mL/min, 150 bar, 40 °C. Final compounds were purified by reverse phase HPLC on a SunFire C18 preparative column using appropriate gradients of acetonitrile/water/0.1% trifluoroacetic acid (TFA) or methanol/water/0.1% TFA as the eluent. Reactions were monitored either by analytical Liquid chromatography–mass spectrometry (LCMS) or by thin-layer chromatography using 0.25 mm E. Merck silica gel plates (60 F254) and were visualized with UV light or by staining with various staining agents. LCMS data were recorded on a Shimadzu LC-10AT equipped with an SIL-10A injector, an SPD-10AV detector, running DISCOVERY VP software, and coupled with a Waters ZQ mass spectrometer running MassLynx, version 3.5, software using the following method: Phenomenex Luna C-18 2.0 mm × 30 mm column eluted with a 2 min linear gradient from 0 to 100% of B and then 1 min at 100% of B wherein A = 10% methanol/90% water/0.1% TFA and B = 90% methanol/10% water/0.1% TFA. The purity of all final compounds tested was determined to be ≥95% using the following orthogonal HPLC conditions: column-1: SunFire C18 3.5 μm, 3.0 × 150 mm; column-2: Xbridge Phenyl 3.5 μm, 3.0 × 150 mm; flow rate 1.0 mL/min, gradient 10–100% 95:5 AcCN/H<sub>2</sub>O (0.05% TFA) in 5:95 AcCN/H<sub>2</sub>O (0.05% TFA) over 12 min and then 100% of 95:5 AcCN/H<sub>2</sub>O (0.05% TFA) over 3 min; wavelength 1 = 220 nm, wavelength 2 = 254 nm (method A); Column: Waters Acquity BEH C18 1.7 μm 2.1 × 50 mm; flow rate 1.1 mL/min, gradient 0–100% 95:5 AcCN/H<sub>2</sub>O (0.1% TFA) in 5:95 AcCN/H<sub>2</sub>O (0.1% TFA) over 3 min and then 100% of 95:5 AcCN/H<sub>2</sub>O (0.1% TFA) over 0.75 min; and flow rate 1.1 mL/min, gradient 0–100% 95:5 AcCN/H<sub>2</sub>O (10 mM ammonium acetate) in 5:95 AcCN/H<sub>2</sub>O (10 mM ammonium acetate) over 3 min and then 100% of 95:5 AcCN/H<sub>2</sub>O (10 mM ammonium acetate) over 0.75 min wavelength = 220 nm (method B). <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on either a Bruker or a JEOL Fourier transform spectrometer operating at frequencies as follows: <sup>1</sup>H NMR, 400 MHz (Bruker or JEOL) or 500 MHz (JEOL); <sup>13</sup>C NMR, 101 MHz (Bruker or JEOL) or 125 MHz (JEOL). Spectra data are reported in the format chemical shift (multiplicity, coupling constants, and number of hydrogens). Chemical shifts are specified in ppm referenced to deuterated solvent peaks. All <sup>13</sup>C NMR spectra were proton decoupled. Most of the final compounds were confirmed for molecular weight using accurate mass LCMS (HRMS). A Thermo Fisher LTQ Orbitrap mass spectrometer in line with a Waters Acquity UPLC allowed collection of molecular ion data with accuracy of <5 ppm. Optical rotations were obtained on a JASCO P1010 Polarimeter.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> 5′-Chloro-4-((2,3-dihydro-1<i>H</i>-inden-5-yl)carbamoyl)-2′-((3-fluoro-4-methoxyphenyl)-carbamoyl)-[1,1′-biphenyl]-2-carboxylic Acid (<b>2</b>)</h4><div class="NLM_p last">Into the reaction vessel was added <b>8</b> (178 mg, 0.297 mmol), tetrahydrofuran (THF; 5 mL), and TBAF (0.89 mL, 1 M/L in THF, 0.89 mmol). The reaction was stirred at rt for 12 h, diluted with EtOAc (20 mL), and washed with 1 N HCl. The aqueous phase was extracted with additional EtOAc (10 mL × 3). The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to provide the corresponding carboxylic acid. <i>m</i>/<i>z</i> obs 499.9 [M + H]<sup>+</sup>. A portion of this crude carboxylic acid (20 mg, 0.04 mmol) was dissolved in dichloromethane (DCM; 2 mL). 2,3-Dihydro-1<i>H</i>-inden-5-amine (16 mg, 0.12 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (DIEA; 0.021 mL, 0.12 mmol), and HATU (16.7 mg, 0.044 mmol) were added subsequently. The reaction was stirred at rt for 12 h, concentrated, and treated with DCM (1 mL) and TFA (0.10 mL). The reaction was stirred at rt for 12 h, concentrated, and subjected to prep-HPLC purification to produce <b>2</b> (17.8 mg, 0.032 mmol, 80% yield). <sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.47 (d, <i>J</i> = 1.8 Hz, 1H), 8.06 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.66 (d, <i>J</i> = 8.2 Hz, 1H), 7.57–7.51 (m, 2H), 7.41 (d, <i>J</i> = 7.9 Hz, 1H), 7.39–7.34 (m, 1H), 7.33–7.26 (m, 2H), 7.18 (d, <i>J</i> = 8.1 Hz, 1H), 7.01–6.91 (m, 2H), 3.80 (s, 3H), 2.90 (dt, <i>J</i> = 14.8, 7.5 Hz, 4H), 2.09 (quin, <i>J</i> = 7.4 Hz, 2H). Purity 99% (method A). HRMS (ESI): calcd for C<sub>31</sub>H<sub>25</sub>ClFN<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 559.1431; found, 559.1411.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 3-<i>tert</i>-Butyl 1-(2-(Trimethylsilyl)ethyl) 4-(((Trifluoromethyl)sulfonyl) oxy)isophthalate (<b>4</b>)</h4><div class="NLM_p last">Into the reaction vessel was added 2-(trimethylsilyl)ethanol (4.30 g, 36.4 mmol) and toluene (50 mL). The reaction was cooled to 0 °C and NaH (1.248 g, 31.2 mmol) was added. After 5 min, the mixture was warmed to rt and stirred for an additional 50 min. Compound <b>3</b> (2.623 g, 10.40 mmol) was then added and the reaction was heated at 50 °C for 30 min. The reaction was cooled to rt, washed with sat NH<sub>4</sub>Cl (containing 31.2 mmol HCl), and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. Silica gel chromatography (0–20% EtOAc in hexanes) afforded the corresponding (trimethylsilyl)ethyl ester (2.18 g, 6.44 mmol, 62% yield) as a colorless oil. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 11.52 (s, 1H), 8.47 (d, <i>J</i> = 2.2 Hz, 1H), 8.08 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 6.98 (d, <i>J</i> = 8.8 Hz, 1H), 4.44–4.38 (m, 2H), 1.63 (s, 9H), 1.15–1.09 (m, 2H), 0.09 (s, 9H). This intermediate (2.18 g, 6.44 mmol) was mixed with DCM (20 mL) and pyridine (2.60 mL, 32.2 mmol). After cooling to 0 °C, Tf<sub>2</sub>O (1.63 mL, 9.66 mmol) was added. The reaction was warmed to rt, stirred at rt for 30 min, cooled to 0 °C, and 30 mL of DCM and 50 mL of water were added. The organic phase was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and subjected to silica gel chromatography purification (0–10% EtOAc in hexanes) to produce <b>4</b> (3.00 g, 6.38 mmol, 99% yield) as a colorless oil. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.60 (d, <i>J</i> = 2.2 Hz, 1H), 8.22 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 7.35 (d, <i>J</i> = 8.5 Hz, 1H), 4.49–4.45 (m, 2H), 1.64 (s, 9H), 1.18–1.13 (m, 2H), 0.11 (s, 9H).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 3-<i>tert</i>-Butyl 1-(2-(Trimethylsilyl)ethyl) 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate (<b>5</b>)</h4><div class="NLM_p last">Into the reaction vessel was added <b>4</b> (2.30 g, 4.89 mmol), 4,4,4′,4′,5,5, 5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (1.34 g, 5.28 mmol), and 1,4-dioxane (30 mL). PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> (0.20 g, 0.244 mmol) and KOAc (1.20 g, 12.2 mmol) were subsequently added and the reaction mixture was degassed by bubbling N<sub>2</sub> for 10 min. The reaction was stirred at 65 °C for 3 h, cooled to rt, diluted with 1:1:0.01 EtOAc/hexane/Et<sub>3</sub>N (50 mL), filtered through SiO<sub>2</sub> (15 g, 200 mL 1:1:0.01 EtOAc/hexane/Et<sub>3</sub>N as eluent), and concentrated to produce <b>5</b> (2.10 g, 4.69 mmol, 96%) as a brown solid. Compound <b>5</b> was used in the next step without further purification. <i>m</i>/<i>z</i> obs 449.4 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.44 (d, <i>J</i> = 0.8 Hz, 1H), 8.12 (dd, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.55 (d, <i>J</i> = 8.0 Hz, 1H), 4.47–4.44 (m, 2H), 1.61 (s, 9H), 1.43 (s, 12H), 1.17–1.14 (m, 2H).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 2-<i>tert</i>-Butyl 2′-(2,2,2-Trichloroethyl) 4-(2-(Trimethylsilyl)ethyl) 5′-Chloro-[1,1′-biphenyl]-2,2′,4-tricarboxylate (<b>7</b>)</h4><div class="NLM_p last">To a reaction vessel containing <b>5</b> (1.55 g, 3.46 mmol) was added <b>6</b> (1.59 g, 4.33 mmol), toluene (42 mL), PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> (0.127 g, 0.173 mmol), and Na<sub>2</sub>CO<sub>3</sub> (2 M, 6.61 mL, 13.2 mmol). The reaction mixture was degassed by bubbling with N<sub>2</sub> for 10 min, stirred at 65 °C for 12 h, cooled to rt, concentrated, and subjected to silica gel chromatography purification (0–10% EtOAc in hexanes) to produce <b>7</b> (1.20 g, 1.97 mmol, 57% yield) as a white solid. <i>m</i>/<i>z</i> obs 606.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.63 (d, <i>J</i> = 1.7 Hz, 1H), 8.16 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 8.13 (d, <i>J</i> = 8.3 Hz, 1H), 7.49 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.25 (d, <i>J</i> = 2.5 Hz, 2H), 4.72 (s, 2H), 4.49–4.45 (m, 2H), 1.26 (s, 9H), 1.19–1.15 (m, 2H), 0.11 (s, 9H).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-(<i>tert</i>-Butyl) 4-(2-(Trimethylsilyl)ethyl) 5′-chloro-2′-((3-fluoro-4-methoxyphenyl)-carbamoyl)-[1,1′-biphenyl]-2,4-dicarboxylate (<b>8</b>)</h4><div class="NLM_p last">Into the reaction vessel was added <b>7</b> (250 mg, 0.411 mmol), THF (5 mL), sat NH<sub>4</sub>Cl solution (2.5 mL), and Zn (134 mg, 2.06 mmol). The reaction was stirred vigorously at rt for 1 h and extracted with EtOAc (10 mL × 3). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. This crude product was dissolved in DCM (10 mL) and filtered to remove insoluble impurities. After concentration, the crude acid was used in the subsequent step without further purification. <i>m</i>/<i>z</i> obs 477.1 [M + H]<sup>+</sup>. The crude acid was dissolved in DCM (6 mL). 3-Fluoro-4-methoxyaniline (116 mg, 0.822 mmol), DIEA (0.215 mL, 1.23 mmol), and HATU (172 mg, 0.452 mmol) were added subsequently. After stirring at rt for 12 h, the mixture was concentrated and subjected to silica gel chromatography purification (0–90% EtOAc in hexanes) to produce <b>8</b> (178 mg, 0.297 mmol, 72% yield). <i>m</i>/<i>z</i> obs 600.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.44 (s, 1H), 8.40 (d, <i>J</i> = 1.7 Hz, 1H), 8.08 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.75 (d, <i>J</i> = 8.3 Hz, 1H), 7.49 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.32 (d, <i>J</i> = 8.0 Hz, 1H), 7.17–7.12 (m, 2H), 6.79–6.75 (m, 2H), 4.48–4.43 (m, 2H), 3.81 (s, 3H), 1.46 (s, 9H), 1.18–1.13 (m, 2H), 0.09 (s, 9H).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (<i>S</i>)-5′-Chloro-2′-((3-fluoro-4-methoxyphenyl)carbamoyl)-4-((2-hydroxy-1-phenylethyl)carbamoyl)-[1,1′-biphenyl]-2-carboxylic Acid (<b>9a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.87 (br d, <i>J</i> = 8.2 Hz, 1H), 8.23 (br s, 1H), 7.85 (br d, <i>J</i> = 7.3 Hz, 1H), 7.63 (d, <i>J</i> = 8.2 Hz, 1H), 7.54 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 7.44–7.36 (m, 3H), 7.31 (t, <i>J</i> = 7.6 Hz, 2H), 7.24–7.19 (m, 1H), 7.18–7.04 (m, 4H), 7.02–6.97 (m, 1H), 5.10–5.02 (m, 1H), 4.94 (t, <i>J</i> = 6.0 Hz, 1H), 3.74 (s, 3H), 3.72–3.67 (m, 1H), 3.66–3.59 (m, 1H). Purity >99% (method A). HRMS (ESI): calcd for C<sub>30</sub>H<sub>25</sub>ClFN<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 563.1380; found, 563.1360.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>S</i>)-5′-Chloro-2′-((3-fluoro-4-methoxyphenyl)carbamoyl)-4-((2-methoxy-1-phenylethyl)-carbamoyl)-[1,1′-biphenyl]-2-carboxylic Acid (<b>9b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.51–8.40 (m, 2H), 7.96–7.91 (m, 1H), 7.63 (dd, <i>J</i> = 8.3, 1.7 Hz, 1H), 7.44 (dd, <i>J</i> = 8.3, 1.1 Hz, 1H), 7.40–7.28 (m, 7H), 7.17–7.08 (m, 2H), 6.89–6.84 (m, 1H), 6.77–6.70 (m, 1H), 5.42–5.36 (m, 1H), 3.84–3.75 (m, 5H), 3.38 (s, 3H). Purity >99% (method A). HRMS (ESI): calcd for C<sub>31</sub>H<sub>27</sub>ClFN<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 577.1536; found, 577.1526.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>R</i>)-5′-Chloro-2′-((3-fluoro-4-methoxyphenyl)carbamoyl)-4-((2-methoxy-1-phenylethyl)carbamoyl)-[1,1′-biphenyl]-2-carboxylic Acid (<b>9c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.41 (d, <i>J</i> = 1.7 Hz, 1H), 8.00 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.65 (d, <i>J</i> = 8.2 Hz, 1H), 7.52 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.44–7.31 (m, 5H), 7.31–7.23 (m, 3H), 6.99–6.91 (m, 2H), 5.34 (dd, <i>J</i> = 8.6, 5.0 Hz, 1H), 3.80 (s, 3H), 3.76 (dd, <i>J</i> = 10.1, 8.6 Hz, 1H), 3.67 (dd, <i>J</i> = 10.2, 5.0 Hz, 1H), 3.39 (s, 3H). Purity >99% (method B). HRMS (ESI): calcd for C<sub>31</sub>H<sub>27</sub>ClFN<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 577.1536; found, 577.1523.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>R</i>)-5′-Chloro-2′-((3-fluoro-4-methoxyphenyl)carbamoyl)-4-((1-phenylbutyl)carbamoyl)-[1,1′-biphenyl]-2-carboxylic Acid (<b>9d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.95 (d, <i>J</i> = 8.3 Hz, 1H), 8.32 (d, <i>J</i> = 1.1 Hz, 1H), 7.99–7.95 (m, 1H), 7.66 (d, <i>J</i> = 8.3 Hz, 1H), 7.57 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.45–7.37 (m, 3H), 7.34–7.25 (m, 4H), 7.24–7.19 (m, 1H), 7.16 (br d, <i>J</i> = 8.5 Hz, 1H), 7.03 (t, <i>J</i> = 9.4 Hz, 1H), 5.03 (td, <i>J</i> = 8.7, 6.2 Hz, 1H), 3.76 (s, 3H), 1.92–1.83 (m, 1H), 1.76–1.67 (m, 1H), 1.44–1.35 (m, 1H), 1.33–1.24 (m, 1H), 0.90 (t, <i>J</i> = 7.3 Hz, 3H). Purity 99% (method B). <i>m</i>/<i>z</i> obs 575.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-2-<i>tert</i>-Butyl 2′-(2,2,2-Trichloroethyl) 5′-Chloro-4-((1-phenylbutyl) carbamoyl)-[1,1′-biphenyl]-2,2′-dicarboxylate (<b>10</b>)</h4><div class="NLM_p last">Into the reaction vessel was added <b>7</b> (600 mg, 0.986 mmol), THF (9.86 mL), and TBAF (4.93 mL, 4.93 mmol). The reaction was stirred at rt for 30 min, quenched with sat NH<sub>4</sub>Cl (20 mL), and extracted with EtOAc (25 mL × 3). The combined organic phase was dried over sodium sulfate, filtered, and concentrated to yield the corresponding acid. Into the reaction vessel containing the crude acid was added (<i>R</i>)-1-phenylbutan-1-amine (147 mg, 0.986 mmol), DIEA (0.517 mL, 2.96 mmol), DCM (10 mL), and HATU (487 mg, 1.28 mmol). The reaction was stirred at rt for 12 h and concentrated. Silica gel chromatography (0–20% EtOAc in hexanes) produced <b>10</b> (475 mg, 0.743 mmol, 75% yield) as a white solid. <i>m</i>/<i>z</i> obs 637.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.31 (d, <i>J</i> = 9.4 Hz, 1H), 8.12 (d, <i>J</i> = 8.5 Hz, 1H), 8.05–7.97 (m, 1H), 7.52–7.48 (m, 1H), 7.38 (d, <i>J</i> = 5.0 Hz, 4H), 7.26–7.22 (m, 3H), 6.45 (br d, <i>J</i> = 6.1 Hz, 1H), 5.31 (s, 2H), 5.20 (q, <i>J</i> = 7.4 Hz, 1H), 4.74–4.69 (m, 2H), 1.99–1.87 (m, 2H), 1.46–1.41 (m, 2H), 1.21 (s, 9H), 0.98 (t, <i>J</i> = 7.3 Hz, 3H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-5′-chloro-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>11a</b>)</h4><div class="NLM_p last">Into the reaction vessel was added <b>10</b> (475 mg, 0.743 mmol), THF (7.43 mL), sat NH<sub>4</sub>Cl solution (3 mL), and Zn (243 mg, 3.71 mmol). The reaction was stirred vigorously at rt for 1 h and extracted with EtOAc (20 mL × 3). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to produce crude carboxylic acid as a white solid (339 mg, 0.667 mmol, 90% yield), which was used in the subsequent step without further purification. <i>m</i>/<i>z</i> obs 508.1 [M + H]<sup>+</sup>. Into the reaction vessel was added crude carboxylic acid (18 mg, 0.035 mmol), 4-methoxy-benzene-1,2-diamine (9.79 mg, 0.071 mmol), DIEA (0.031 mL, 0.177 mmol), DCM (1 mL), and HATU (20.2 mg, 0.053 mmol). The reaction was stirred at rt for 12 h, concentrated, and dissolved in AcOH (1 mL)/water (0.1 mL). After stirring at 85 °C for 12 h, the reaction was cooled to rt, concentrated, and subjected to preparative HPLC purification to produce <b>11a</b> (16.3 mg, 0.024 mmol, 69% yield). <sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.30 (s, 1H), 7.93 (br d, <i>J</i> = 7.5 Hz, 1H), 7.85 (d, <i>J</i> = 8.4 Hz, 1H), 7.70 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 7.58 (dd, <i>J</i> = 6.1, 3.2 Hz, 2H), 7.53 (d, <i>J</i> = 2.0 Hz, 1H), 7.46–7.40 (m, 2H), 7.39–7.35 (m, 3H), 7.34–7.29 (m, 2H), 7.26–7.21 (m, 1H), 5.07 (dd, <i>J</i> = 8.8, 6.5 Hz, 1H), 1.93–1.86 (m, 1H), 1.85–1.79 (m, 1H), 1.48–1.39 (m, 1H), 1.38–1.31 (m, 1H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H). Purity 95% (method B). HRMS (ESI): calcd for C<sub>31</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 524.1735; found, 524.1722.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 5′-Chloro-2′-(5-chloro-1<i>H</i>-1,3-benzodiazol-2-yl)-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>11b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.33 (d, <i>J</i> = 1.7 Hz, 1H), 7.98 (br d, <i>J</i> = 7.9 Hz, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.69 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.58 (d, <i>J</i> = 1.5 Hz, 1H), 7.55–7.51 (m, 2H), 7.43–7.36 (m, 4H), 7.34–7.29 (m, 2H), 7.26–7.21 (m, 1H), 5.08 (dd, <i>J</i> = 8.9, 6.6 Hz, 1H), 1.96–1.88 (m, 1H), 1.86–1.78 (m, 1H), 1.49–1.40 (m, 1H), 1.39–1.30 (m, 1H), 0.97 (t, <i>J</i> = 7.4 Hz, 3H). Purity 96% (method B). HRMS (ESI): calcd for C<sub>31</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 558.1346; found, 558.1333.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5′-Chloro-2′-(5-methyl-1<i>H</i>-1,3-benzodiazol-2-yl)-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>11c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.32 (br d, <i>J</i> = 2.4 Hz, 1H), 7.99 (br t, <i>J</i> = 6.0 Hz, 1H), 7.85 (d, <i>J</i> = 8.4 Hz, 1H), 7.73 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.57 (d, <i>J</i> = 2.1 Hz, 1H), 7.50 (d, <i>J</i> = 8.5 Hz, 1H), 7.46–7.39 (m, 2H), 7.39–7.30 (m, 5H), 7.26–7.20 (m, 1H), 5.08 (dd, <i>J</i> = 8.9, 6.6 Hz, 1H), 2.48 (s, 3H), 1.94–1.88 (m, 1H), 1.85–1.78 (m, 1H), 1.48–1.40 (m, 1H), 1.39–1.32 (m, 1H), 0.97 (t, <i>J</i> = 7.4 Hz, 3H). Purity 96% (method B). HRMS (ESI): calcd for C<sub>32</sub>H<sub>29</sub>ClN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 538.1892; found, 538.1879.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 5′-Chloro-2′-(5-methoxy-1<i>H</i>-1,3-benzodiazol-2-yl)-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>11d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.97 (br d, <i>J</i> = 8.3 Hz, 1H), 8.37 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.08–8.01 (m, 1H), 7.85 (d, <i>J</i> = 8.3 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 7.59 (s, 1H), 7.53 (d, <i>J</i> = 9.1 Hz, 1H), 7.49 (t, <i>J</i> = 7.6 Hz, 1H), 7.40–7.36 (m, 2H), 7.32 (t, <i>J</i> = 7.6 Hz, 2H), 7.27–7.20 (m, 1H), 7.16 (dd, <i>J</i> = 9.1, 2.2 Hz, 1H), 7.08 (d, <i>J</i> = 2.2 Hz, 1H), 5.12–5.05 (m, 1H), 3.85 (s, 3H), 1.95–1.88 (m, 1H), 1.86–1.79 (m, 1H), 1.49–1.40 (m, 1H), 1.39–1.31 (m, 1H), 0.97 (t, <i>J</i> = 7.4 Hz, 3H). Purity 100% (method A). HRMS (ESI): calcd for C<sub>32</sub>H<sub>29</sub>ClN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 554.1841; found, 554.1827.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5′-Chloro-2′-(4-methyl-1<i>H</i>-1,3-benzodiazol-2-yl)-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>11e</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.27 (s, 1H), 7.98 (br d, <i>J</i> = 7.2 Hz, 1H), 7.87 (d, <i>J</i> = 8.4 Hz, 1H), 7.74 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.60 (d, <i>J</i> = 2.0 Hz, 1H), 7.44 (d, <i>J</i> = 8.1 Hz, 1H), 7.40–7.34 (m, 4H), 7.31 (t, <i>J</i> = 7.6 Hz, 3H), 7.27–7.21 (m, 1H), 5.07 (dd, <i>J</i> = 8.8, 6.5 Hz, 1H), 2.53 (s, 3H), 1.93–1.87 (m, 1H), 1.85–1.78 (m, 1H), 1.48–1.40 (m, 1H), 1.37–1.30 (m, 1H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H). Purity > 95% (method B). HRMS (ESI): calcd for C<sub>32</sub>H<sub>29</sub>ClN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 538.1892; found, 538.1877.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5′-Chloro-2′-{1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-yl}-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>11f</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 9.02 (s, 1H), 8.43 (d, <i>J</i> = 6.6 Hz, 1H), 8.34 (dd, <i>J</i> = 11.6, 1.7 Hz, 1H), 8.02–7.95 (m, 2H), 7.92 (d, <i>J</i> = 8.2 Hz, 1H), 7.67 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 7.48 (d, <i>J</i> = 2.1 Hz, 1H), 7.43–7.37 (m, 3H), 7.33 (br t, <i>J</i> = 6.9 Hz, 2H), 7.27–7.20 (m, 1H), 5.13–5.08 (m, 1H), 1.98–1.90 (m, 1H), 1.88–1.79 (m, 1H), 1.53–1.43 (m, 1H), 1.42–1.32 (m, 1H), 0.99 (t, <i>J</i> = 7.2 Hz, 3H). Purity > 99% (method B). HRMS (ESI): calcd for C<sub>30</sub>H<sub>26</sub>ClN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 525.1688; found, 525.1679.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5′-Chloro-2′-(5-phenyl-1<i>H</i>-imidazol-2-yl)-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>11g</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.96 (br d, <i>J</i> = 8.3 Hz, 1H), 8.39 (br d, <i>J</i> = 1.4 Hz, 1H), 8.09 (br t, <i>J</i> = 7.3 Hz, 1H), 7.79 (d, <i>J</i> = 8.3 Hz, 1H), 7.73–7.69 (m, 2H), 7.62–7.55 (m, 3H), 7.50 (br d, <i>J</i> = 8.3 Hz, 1H), 7.45 (br s, 3H), 7.41–7.36 (m, 2H), 7.32 (t, <i>J</i> = 7.6 Hz, 2H), 7.26–7.21 (m, 1H), 5.15–5.07 (m, 1H), 1.97–1.89 (m, 1H), 1.87–1.80 (m, 1H), 1.50–1.41 (m, 1H), 1.41–1.33 (m, 1H), 0.97 (t, <i>J</i> = 7.3 Hz, 3H). Purity 98% (method B). <i>m</i>/<i>z</i> obs 550.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>R</i>)-2′-(Benzo[<i>d</i>]oxazol-2-yl)-5′-chloro-4-((1-phenylbutyl)carbamoyl)-[1,1′-biphenyl]-2-carboxylic Acid (<b>11h</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.45 (d, <i>J</i> = 1.7 Hz, 1H), 8.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.98 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.60 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 7.59–7.56 (m, 1H), 7.47–7.40 (m, 3H), 7.39–7.35 (m, 3H), 7.33–7.25 (m, 4H), 5.15 (dd, <i>J</i> = 8.9, 6.4 Hz, 1H), 2.03–1.95 (m, 1H), 1.92–1.84 (m, 1H), 1.57–1.47 (m, 1H), 1.47–1.39 (m, 1H), 1.02 (t, <i>J</i> = 7.4 Hz, 3H). Purity 100% (method A). HRMS (ESI): calcd for C<sub>31</sub>H<sub>26</sub>ClN<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 525.1576; found, 525.1562.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>12a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.29 (s, 1H), 7.96 (br d, <i>J</i> = 7.8 Hz, 1H), 7.88 (dd, <i>J</i> = 7.6, 1.1 Hz, 1H), 7.82–7.77 (m, 1H), 7.74–7.69 (m, 1H), 7.64 (dd, <i>J</i> = 6.3, 3.2 Hz, 2H), 7.56–7.49 (m, 3H), 7.41 (d, <i>J</i> = 7.9 Hz, 1H), 7.39–7.35 (m, 2H), 7.34–7.29 (m, 2H), 7.26–7.20 (m, 1H), 5.08 (dd, <i>J</i> = 8.8, 6.5 Hz, 1H), 1.96–1.87 (m, 1H), 1.86–1.78 (m, 1H), 1.49–1.40 (m, 1H), 1.39–1.31 (m, 1H), 0.97 (t, <i>J</i> = 7.3 Hz, 3H); purity 97% (method B). HRMS (ESI): calcd for C<sub>31</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 490.2125; found, 490.2113.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-5′-methyl-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>12b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.96 (d, <i>J</i> = 8.3 Hz, 1H), 8.27 (d, <i>J</i> = 1.9 Hz, 1H), 8.00 (dd, <i>J</i> = 8.0, 1.4 Hz, 1H), 7.79 (d, <i>J</i> = 7.7 Hz, 1H), 7.55 (dd, <i>J</i> = 6.1, 3.0 Hz, 2H), 7.48 (d, <i>J</i> = 7.7 Hz, 1H), 7.41–7.37 (m, 2H), 7.35–7.29 (m, 5H), 7.25–7.19 (m, 2H), 5.07–4.98 (m, 1H), 2.45 (s, 3H), 1.92–1.82 (m, 1H), 1.76–1.67 (m, 1H), 1.43–1.33 (m, 1H), 1.31–1.23 (m, 1H), 0.90 (t, <i>J</i> = 7.3 Hz, 3H). Purity 96% (method B). HRMS (ESI): calcd for C<sub>32</sub>H<sub>30</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 504.2282; found, 504.2271.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-5′-methoxy-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>12c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.26 (s, 1H), 7.92 (br d, <i>J</i> = 7.8 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 1H), 7.67–7.59 (m, 2H), 7.53–7.48 (m, 2H), 7.40–7.32 (m, 5H), 7.28–7.23 (m, 2H), 7.06 (d, <i>J</i> = 2.4 Hz, 1H), 5.10 (dd, <i>J</i> = 8.9, 6.4 Hz, 1H), 3.95 (s, 3H), 1.98–1.89 (m, 1H), 1.87–1.78 (m, 1H), 1.50–1.42 (m, 1H), 1.40–1.33 (m, 1H), 0.99 (t, <i>J</i> = 7.4 Hz, 3H). Purity 96% (method B). HRMS (ESI): calcd for C<sub>32</sub>H<sub>30</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 520.2231; found, 520.2224.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>R</i>)-2′-(1<i>H</i>-Benzo[<i>d</i>]imidazole-2-yl)-3′-chloro-4-((1-phenylbutyl)carbamoyl)-[1,1′-biphenyl]-2-carboxylic Acid (<b>12d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.85 (br d, <i>J</i> = 8.3 Hz, 1H), 8.17 (d, <i>J</i> = 1.4 Hz, 1H), 7.83–7.77 (m, 1H), 7.68 (d, <i>J</i> = 8.0 Hz, 1H), 7.63–7.54 (m, 1H), 7.48–7.42 (m, 2H), 7.35–7.26 (m, 5H), 7.24–7.19 (m, 2H), 7.15–7.11 (m, 2H), 5.00–4.88 (m, 1H), 1.85–1.75 (m, 1H), 1.71–1.62 (m, 1H), 1.39–1.26 (m, 1H), 1.24–1.18 (m, 1H), 0.86 (t, <i>J</i> = 7.4 Hz, 3H). Purity 100% (method B). <i>m</i>/<i>z</i> obs 524.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-4′-chloro-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>12e</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.32 (s, 1H), 7.99 (br d, <i>J</i> = 7.2 Hz, 1H), 7.95 (d, <i>J</i> = 2.1 Hz, 1H), 7.79 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.65–7.60 (m, 2H), 7.53–7.48 (m, 3H), 7.44 (d, <i>J</i> = 7.9 Hz, 1H), 7.38–7.34 (m, 2H), 7.34–7.28 (m, 2H), 7.25–7.21 (m, 1H), 5.07 (dd, <i>J</i> = 8.9, 6.6 Hz, 1H), 1.95–1.87 (m, 1H), 1.85–1.78 (m, 1H), 1.48–1.39 (m, 1H), 1.38–1.29 (m, 1H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H). Purity 96% (method B). HRMS (ESI): calcd for C<sub>31</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 524.1735; found, 524.1724.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-6′-chloro-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>12f</b>)</h4><div class="NLM_p last">Into the reaction vessel was added <b>SI14</b> (301 mg, 0.577 mmol), THF (10 mL), water (5 mL), and LiOH·H<sub>2</sub>O (121 mg, 2.88 mmol). The reaction was stirred at rt for 1 day, diluted with EtOAc (30 mL), and washed with 20 mL of sat NH<sub>4</sub>Cl containing 2.88 mmol HCl. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to produce crude 2′-(<i>tert</i>-butoxycarbonyl)-6-chloro-4′-(((<i>R</i>)-1-phenylbutyl)carbamoyl)-[1,1′-biphenyl]-2-carboxylic acid (293 mg, 0.577 mmol, 100% yield), which was used for the next step without further purification. Into the reaction vessel was added the crude carboxylic acid (293 mg, 0.577 mmol), benzene-1,2-diamine (125 mg, 1.154 mmol), DIEA (0.302 mL, 1.730 mmol), DCM (5 mL), and HATU (285 mg, 0.750 mmol). The reaction was stirred at rt for 12h, concentrated, and dissolved in AcOH (4.5 mL)/water (0.5 mL). After stirring at 85 °C for 12 h, the reaction was cooled to rt and concentrated. Preparative HPLC purification of the resulting residue produced <b>12f</b> (300 mg, 0.471 mmol, 82% yield). <sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.34 (dd, <i>J</i> = 3.5, 1.8 Hz, 1H), 7.84–7.80 (m, 1H), 7.77 (d, <i>J</i> = 7.6 Hz, 1H), 7.74 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 7.63–7.58 (m, 1H), 7.53–7.48 (m, 2H), 7.37–7.33 (m, 2H), 7.33–7.27 (m, 4H), 7.25–7.20 (m, 1H), 7.17 (d, <i>J</i> = 7.9 Hz, 1H), 5.08–5.02 (m, 1H), 1.93–1.84 (m, 1H), 1.83–1.75 (m, 1H), 1.48–1.39 (m, 1H), 1.36–1.32 (m, 1H), 0.98–0.93 (m, 3H). Purity >95% (method B). <i>m</i>/<i>z</i> obs 524.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-6′-fluoro-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>12g</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.47 (d, <i>J</i> = 1.8 Hz, 0.5H), 8.45 (d, <i>J</i> = 1.8 Hz, 0.5H), 7.93–7.88 (m, 1H), 7.76–7.71 (m, 2H), 7.64–7.60 (m, 2H), 7.57–7.52 (m, 1H), 7.51–7.46 (m, 2H), 7.38–7.34 (m, 2H), 7.33–7.29 (m, 3H), 7.26–7.20 (m, 1H), 5.10–5.04 (m, 1H), 1.93–1.86 (m, 1H), 1.84–1.77 (m, 1H), 1.48–1.40 (m, 1H), 1.38–1.31 (m, 1H), 0.99–0.93 (m, 3H). Purity 97% (method B). HRMS (ESI): calcd for C<sub>31</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 508.2031; found, 508.2026.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-6′-methyl-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>12h</b>)</h4><div class="NLM_p"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.34 (dd, <i>J</i> = 6.0, 1.8 Hz, 1H), 7.93 (ddd, <i>J</i> = 7.9, 5.9, 1.9 Hz, 1H), 7.68 (dd, <i>J</i> = 10.5, 7.5 Hz, 2H), 7.64–7.57 (m, 3H), 7.50 (ddd, <i>J</i> = 6.2, 3.2, 1.1 Hz, 2H), 7.37–7.29 (m, 5H), 7.25–7.20 (m, 1H), 5.10–5.04 (m, 1H), 2.10 (s, 3H), 1.93–1.85 (m, 1H), 1.84–1.77 (m, 1H), 1.46–1.38 (m, 1H), 1.36–1.29 (m, 1H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H). Purity >95% (method B). HRMS (ESI): calcd for C<sub>32</sub>H<sub>30</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 504.2282; found, 504.2272.</div><div class="NLM_p last">Preparation of <b>15a</b> and <b>15b</b> via chiral SFC purification: <b>12f</b> was subjected to the chiral SFC purification condition below to afford optically pure compounds <b>15a</b> (second eluting peak) and <b>15b</b> (first eluting peak)—instrument: PIC solution 200 SFC; column: Chiralpak AD-H, 21 × 250 mm, 5 μm; mobile phase: 22% EtOH/78% CO<sub>2</sub>; flow conditions: 45 mL/min, 150 bar, 40 °C; detector wavelength: 220 nm; injection details: 0.5 mL of ∼27 mg/mL in EtOH/MeCN. <b>15a</b>, RT = 8.37 min; <b>15b</b>, RT = 6.28 min.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-6′-chloro-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>15a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.43 (d, <i>J</i> = 1.8 Hz, 1H), 7.92 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.84 (td, <i>J</i> = 8.5, 1.1 Hz, 2H), 7.69–7.65 (m, 1H), 7.63–7.58 (m, 2H), 7.49–7.46 (m, 2H), 7.36–7.28 (m, 5H), 7.24–7.20 (m, 1H), 5.05 (dd, <i>J</i> = 8.9, 6.6 Hz, 1H), 1.92–1.85 (m, 1H), 1.84–1.75 (m, 1H), 1.47–1.38 (m, 1H), 1.37–1.30 (m, 1H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, methanol-<i>d</i><sub>4</sub>): δ 167.6, 167.0, 148.7, 143.0, 140.3, 139.2, 135.5, 134.2, 132.9, 132.4, 132.3, 131.1, 130.3, 129.4, 129.3, 128.6, 128.1, 126.8, 126.3, 126.0, 125.9, 113.9, 54.1, 37.8, 19.5, 12.6. Purity: >99% (chiral analytical chromatographic condition: Berger analytical SFC; Chiralpak AD-H, 4.6 × 250 mm, 5 μm; 20% EtOH/80% CO<sub>2</sub>; 2 mL/min, 150 bar, 40 °C; injection details: 5 μL of 1 mg/mL in ACN); HRMS (ESI): calcd for C<sub>31</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 524.1735; found, 524.1727. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −38.4° (<i>C</i> = 0.5, MeOH). Full crystallographic data for compound <b>15a</b> have been deposited to the Cambridge Crystallographic Data Center (CCDC reference no. CCDC 1918519) and can be obtained free of charge via the internet at <a href="http://www.ccdc.cam.ac.uk" class="extLink">http://www.ccdc.cam.ac.uk</a>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-2′-(1<i>H</i>-1,3-Benzodiazol-2-yl)-6′-chloro-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>15b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.30 (d, <i>J</i> = 1.7 Hz, 1H), 7.78 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.75 (dd, <i>J</i> = 7.6, 1.1 Hz, 1H), 7.69 (dd, <i>J</i> = 8.2, 1.1 Hz, 1H), 7.59–7.54 (m, 1H), 7.49–7.44 (m, 2H), 7.37–7.33 (m, 2H), 7.32–7.28 (m, 2H), 7.26–7.19 (m, 3H), 7.11 (d, <i>J</i> = 7.9 Hz, 1H), 5.05 (dd, <i>J</i> = 8.9, 6.5 Hz, 1H), 1.92–1.83 (m, 1H), 1.82–1.74 (m, 1H), 1.48–1.38 (m, 1H), 1.36–1.28 (m, 1H), 0.95 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, methanol-<i>d</i><sub>4</sub>): δ 169.9, 167.4, 150.6, 143.1, 139.8, 139.7, 136.5, 134.9, 134.5, 134.0, 131.1, 130.6, 130.2, 129.3, 129.0, 128.3, 128.1, 128.1, 126.7, 126.3, 123.3, 114.4, 53.9, 37.9, 19.5, 12.7. Purity: >99% (chiral analytical chromatographic condition: Berger analytical SFC; Chiralpak AD-H, 4.6 × 250 mm, 5 μm; 20% EtOH/80% CO<sub>2</sub>; 2 mL/min, 150 bar, 40 °C; injection details—5 μL of 1 mg/mL in ACN); HRMS (ESI): calcd for C<sub>31</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 524.1735; found, 524.1725. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +43.3° (<i>C</i> = 0.43, MeOH). Full crystallographic data for compound <b>15b</b> have been deposited to the Cambridge Crystallographic Data Center (CCDC reference no. CCDC 1918520) and can be obtained free of charge via the internet at <a href="http://www.ccdc.cam.ac.uk" class="extLink">http://www.ccdc.cam.ac.uk</a>.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>S</i>)-2′-Chloro-6′-(5-methoxy-1<i>H</i>-1,3-benzodiazol-2-yl)-4-{[(1<i>R</i>)-1-phenylbutyl]carbamoyl}-[1,1′-biphenyl]-2-carboxylic Acid (<b>15c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.97 (br d, <i>J</i> = 8.0 Hz, 1H), 8.47 (d, <i>J</i> = 1.9 Hz, 1H), 7.95 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.88 (dd, <i>J</i> = 8.3, 1.1 Hz, 1H), 7.83 (dd, <i>J</i> = 7.7, 1.1 Hz, 1H), 7.74–7.66 (m, 1H), 7.52 (d, <i>J</i> = 9.4 Hz, 1H), 7.37–7.34 (m, 2H), 7.33–7.29 (m, 3H), 7.25–7.20 (m, 1H), 7.15 (dd, <i>J</i> = 9.1, 2.5 Hz, 1H), 7.07 (d, <i>J</i> = 2.2 Hz, 1H), 5.10–5.03 (m, 1H), 3.84 (s, 3H), 1.95–1.86 (m, 1H), 1.85–1.77 (m, 1H), 1.49–1.39 (m, 1H), 1.39–1.30 (m, 1H), 0.96 (t, <i>J</i> = 7.3 Hz, 3H). Purity 95% (method A). HRMS (ESI): calcd for C<sub>32</sub>H<sub>29</sub>ClN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 554.1841; found, 554.1828.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01513" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10548" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10548" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01513" class="ext-link">10.1021/acs.jmedchem.9b01513</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplementary synthetic schemes, experimental protocols, synthesis of <b>12a–h</b>, synthesis of <b>15a</b> via intermediate <b>14</b>, assay condition, summary of <i>PV</i>-loop study, biotransformation study on the analogue of <b>9b</b>, details on HTP screening, and NMR spectra and HPLC traces (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_001.pdf" class="ext-link">PDF</a>).</p></li><li><p class="inline">Molecular formula strings for the final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_001.pdf">jm9b01513_si_001.pdf (2.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_002.csv">jm9b01513_si_002.csv (2.52 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01513" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shun Su</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8100-9645" title="Orcid link">http://orcid.org/0000-0001-8100-9645</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#82d1eaf7ecacd1f7c2e0eff1ace1edef"><span class="__cf_email__" data-cfemail="adfec5d8c383fed8edcfc0de83cec2c0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Clarke</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Han</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span>; 
    <span>Present Address:
                        GreenBioChem LLC, 410 Sackett Point Road, Bldg 20 North Haven, CT 06473</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hannguang J. Chao</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey Bostwick</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William Schumacher</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Wang</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mujing Yan</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei-Yin Hsu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Simmons</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3854-1561" title="Orcid link">http://orcid.org/0000-0002-3854-1561</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiuwa Luk</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carrie Xu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Dabros</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Galella</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joelle Onorato</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Gordon</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruth Wexler</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter S. Gargalovic</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Michael Lawrence</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers
Squibb, Co., P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Atsu Apedo for support on chiral separation, Gerry G. Everlof for support on solubility determination, Robert Langish and Linping Wang for support with HRMS, and Dr. Yi Hsiao for support on high-throughput reaction screening. We thank Dr. Heather Finlay, Dr. Scott Shaw, and Vladimir Ladziata for their assistance in manuscript preparation.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">HF</td><td class="NLM_def"><p class="first last">heart failure</p></td></tr><tr><td class="NLM_term">CO</td><td class="NLM_def"><p class="first last">cardiac output</p></td></tr><tr><td class="NLM_term"><i>PV</i>-loop</td><td class="NLM_def"><p class="first last">pressure–volume loop</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">BPA</td><td class="NLM_def"><p class="first last">biphenyl acid</p></td></tr><tr><td class="NLM_term">APJ-R</td><td class="NLM_def"><p class="first last">APJ receptor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 19 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yancy, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozkurt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drazner, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonarow, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraci, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januzzi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masoudi, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riegel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W. H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkoff, B. L.</span></span> <span> </span><span class="NLM_article-title">2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">e240</span>– <span class="NLM_lpage">e327</span>, <span class="refDoi"> DOI: 10.1161/cir.0b013e31829e8776</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2Fcir.0b013e31829e8776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=23741058" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2013&pages=e240-e327&author=C.+W.+Yancyauthor=M.+Jessupauthor=B.+Bozkurtauthor=J.+Butlerauthor=D.+E.+Caseyauthor=M.+H.+Draznerauthor=G.+C.+Fonarowauthor=S.+A.+Geraciauthor=T.+Horwichauthor=J.+L.+Januzziauthor=M.+R.+Johnsonauthor=E.+K.+Kasperauthor=W.+C.+Levyauthor=F.+A.+Masoudiauthor=P.+E.+McBrideauthor=J.+J.+V.+McMurrayauthor=J.+E.+Mitchellauthor=P.+N.+Petersonauthor=B.+Riegelauthor=F.+Samauthor=L.+W.+Stevensonauthor=W.+H.+W.+Tangauthor=E.+J.+Tsaiauthor=B.+L.+Wilkoff&title=2013+ACCF%2FAHA+Guideline+for+the+Management+of+Heart+Failure%3A+A+Report+of+the+American+College+of+Cardiology+Foundation%2FAmerican+Heart+Association+Task+Force+on+Practice+Guidelines&doi=10.1161%2Fcir.0b013e31829e8776"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1161%2Fcir.0b013e31829e8776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fcir.0b013e31829e8776%26sid%3Dliteratum%253Aachs%26aulast%3DYancy%26aufirst%3DC.%2BW.%26aulast%3DJessup%26aufirst%3DM.%26aulast%3DBozkurt%26aufirst%3DB.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DCasey%26aufirst%3DD.%2BE.%26aulast%3DDrazner%26aufirst%3DM.%2BH.%26aulast%3DFonarow%26aufirst%3DG.%2BC.%26aulast%3DGeraci%26aufirst%3DS.%2BA.%26aulast%3DHorwich%26aufirst%3DT.%26aulast%3DJanuzzi%26aufirst%3DJ.%2BL.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DKasper%26aufirst%3DE.%2BK.%26aulast%3DLevy%26aufirst%3DW.%2BC.%26aulast%3DMasoudi%26aufirst%3DF.%2BA.%26aulast%3DMcBride%26aufirst%3DP.%2BE.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%2BV.%26aulast%3DMitchell%26aufirst%3DJ.%2BE.%26aulast%3DPeterson%26aufirst%3DP.%2BN.%26aulast%3DRiegel%26aufirst%3DB.%26aulast%3DSam%26aufirst%3DF.%26aulast%3DStevenson%26aufirst%3DL.%2BW.%26aulast%3DTang%26aufirst%3DW.%2BH.%2BW.%26aulast%3DTsai%26aufirst%3DE.%2BJ.%26aulast%3DWilkoff%26aufirst%3DB.%2BL.%26atitle%3D2013%2520ACCF%252FAHA%2520Guideline%2520for%2520the%2520Management%2520of%2520Heart%2520Failure%253A%2520A%2520Report%2520of%2520the%2520American%2520College%2520of%2520Cardiology%2520Foundation%252FAmerican%2520Heart%2520Association%2520Task%2520Force%2520on%2520Practice%2520Guidelines%26jtitle%3DCirculation%26date%3D2013%26volume%3D128%26spage%3De240%26epage%3De327%26doi%3D10.1161%2Fcir.0b013e31829e8776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roger, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd-Jones, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravata, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailpern, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heit, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissela, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittner, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackland, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makuc, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchar, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozaffarian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mussolino, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paynter, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotoodehnia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turan, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virani, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. B.</span></span> <span> </span><span class="NLM_article-title">Heart Disease and Stroke Statistics: 2012 Update</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">e2</span>– <span class="NLM_lpage">e220</span>, <span class="refDoi"> DOI: 10.1161/CIR.0b013e31823ac046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2FCIR.0b013e31823ac046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=22179539" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=e2-e220&author=V.+L.+Rogerauthor=A.+S.+Goauthor=D.+M.+Lloyd-Jonesauthor=E.+J.+Benjaminauthor=J.+D.+Berryauthor=W.+B.+Bordenauthor=D.+M.+Bravataauthor=S.+Daiauthor=E.+S.+Fordauthor=C.+S.+Foxauthor=H.+J.+Fullertonauthor=C.+Gillespieauthor=S.+M.+Hailpernauthor=J.+A.+Heitauthor=V.+J.+Howardauthor=B.+M.+Kisselaauthor=S.+J.+Kittnerauthor=D.+T.+Lacklandauthor=J.+H.+Lichtmanauthor=L.+D.+Lisabethauthor=D.+M.+Makucauthor=G.+M.+Marcusauthor=A.+Marelliauthor=D.+B.+Matcharauthor=C.+S.+Moyauthor=D.+Mozaffarianauthor=M.+E.+Mussolinoauthor=G.+Nicholauthor=N.+P.+Paynterauthor=E.+Z.+Solimanauthor=P.+D.+Sorlieauthor=N.+Sotoodehniaauthor=T.+N.+Turanauthor=S.+S.+Viraniauthor=N.+D.+Wongauthor=D.+Wooauthor=M.+B.+Turner&title=Heart+Disease+and+Stroke+Statistics%3A+2012+Update&doi=10.1161%2FCIR.0b013e31823ac046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1161%2FCIR.0b013e31823ac046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIR.0b013e31823ac046%26sid%3Dliteratum%253Aachs%26aulast%3DRoger%26aufirst%3DV.%2BL.%26aulast%3DGo%26aufirst%3DA.%2BS.%26aulast%3DLloyd-Jones%26aufirst%3DD.%2BM.%26aulast%3DBenjamin%26aufirst%3DE.%2BJ.%26aulast%3DBerry%26aufirst%3DJ.%2BD.%26aulast%3DBorden%26aufirst%3DW.%2BB.%26aulast%3DBravata%26aufirst%3DD.%2BM.%26aulast%3DDai%26aufirst%3DS.%26aulast%3DFord%26aufirst%3DE.%2BS.%26aulast%3DFox%26aufirst%3DC.%2BS.%26aulast%3DFullerton%26aufirst%3DH.%2BJ.%26aulast%3DGillespie%26aufirst%3DC.%26aulast%3DHailpern%26aufirst%3DS.%2BM.%26aulast%3DHeit%26aufirst%3DJ.%2BA.%26aulast%3DHoward%26aufirst%3DV.%2BJ.%26aulast%3DKissela%26aufirst%3DB.%2BM.%26aulast%3DKittner%26aufirst%3DS.%2BJ.%26aulast%3DLackland%26aufirst%3DD.%2BT.%26aulast%3DLichtman%26aufirst%3DJ.%2BH.%26aulast%3DLisabeth%26aufirst%3DL.%2BD.%26aulast%3DMakuc%26aufirst%3DD.%2BM.%26aulast%3DMarcus%26aufirst%3DG.%2BM.%26aulast%3DMarelli%26aufirst%3DA.%26aulast%3DMatchar%26aufirst%3DD.%2BB.%26aulast%3DMoy%26aufirst%3DC.%2BS.%26aulast%3DMozaffarian%26aufirst%3DD.%26aulast%3DMussolino%26aufirst%3DM.%2BE.%26aulast%3DNichol%26aufirst%3DG.%26aulast%3DPaynter%26aufirst%3DN.%2BP.%26aulast%3DSoliman%26aufirst%3DE.%2BZ.%26aulast%3DSorlie%26aufirst%3DP.%2BD.%26aulast%3DSotoodehnia%26aufirst%3DN.%26aulast%3DTuran%26aufirst%3DT.%2BN.%26aulast%3DVirani%26aufirst%3DS.%2BS.%26aulast%3DWong%26aufirst%3DN.%2BD.%26aulast%3DWoo%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DM.%2BB.%26atitle%3DHeart%2520Disease%2520and%2520Stroke%2520Statistics%253A%25202012%2520Update%26jtitle%3DCirculation%26date%3D2012%26volume%3D125%26spage%3De2%26epage%3De220%26doi%3D10.1161%2FCIR.0b013e31823ac046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Muiesan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agabiti
Rosei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertacchini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stassaldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvetti, M.</span></span> <span> </span><span class="NLM_article-title">Current Pharmacological Therapies in Heart Failure Patients</span>. <i>High Blood Pressure Cardiovasc. Prev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1007/s40292-017-0194-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1007%2Fs40292-017-0194-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=28349441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt1eltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=107-114&author=M.+L.+Muiesanauthor=A.+Painiauthor=C.+Agabiti%0ARoseiauthor=F.+Bertacchiniauthor=D.+Stassaldiauthor=M.+Salvetti&title=Current+Pharmacological+Therapies+in+Heart+Failure+Patients&doi=10.1007%2Fs40292-017-0194-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Current Pharmacological Therapies in Heart Failure Patients</span></div><div class="casAuthors">Muiesan, Maria Lorenza; Paini, Anna; Agabiti Rosei, Claudia; Bertacchini, Fabio; Stassaldi, Deborah; Salvetti, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">High Blood Pressure & Cardiovascular Prevention</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-114</span>CODEN:
                <span class="NLM_cas:coden">HBPCCX</span>;
        ISSN:<span class="NLM_cas:issn">1120-9879</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Heart failure (HF) is a major problem of public health.  More than 23 million patients worldwide are affected by heart failure.  Despite incidence and prevalence of heart failure may vary according to real world or randomized trials database, advancing age is a major determinant of heart failure.  Heart failure is also characterized by an elevated rate of morbidity and mortality and represents one of the leading causes of hospitalization.  A major consequence of heart failure is the frequent hospital admissions and related costs.  Guidelines have clearly indicated evidence-based treatments in patients with heart failure, and the adherence to these indications has translated in an improvement of patient's prognosis.  Nevertheless, the use of recommended treatments at the recommended dosages is still lower than expected.  In the last year in Europe new guidelines on the diagnosis and treatment of heart failure and in USA an update on pharmacol. treatment of heart failure were published, pointing the attention on the use of new available pharmacol. and non-pharmacol. treatments.  HF syndrome reflects the interaction between hemodynamic dysregulation (alterations in myocardial preload, afterload, and contractility and a neurohormonal disarray those results in the development of symptoms and in the progression of the disease.  Current treatment approaches target both hemodynamic alterations and the neurohumoral elements to slow disease progression as well as to improve symptoms and outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCAvxpveOE2bVg90H21EOLACvtfcHk0lhfozU0nfn-tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt1eltbg%253D&md5=8483a453e80d1dca0d950cef05fe47eb</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1007%2Fs40292-017-0194-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40292-017-0194-3%26sid%3Dliteratum%253Aachs%26aulast%3DMuiesan%26aufirst%3DM.%2BL.%26aulast%3DPaini%26aufirst%3DA.%26aulast%3DAgabiti%2BRosei%26aufirst%3DC.%26aulast%3DBertacchini%26aufirst%3DF.%26aulast%3DStassaldi%26aufirst%3DD.%26aulast%3DSalvetti%26aufirst%3DM.%26atitle%3DCurrent%2520Pharmacological%2520Therapies%2520in%2520Heart%2520Failure%2520Patients%26jtitle%3DHigh%2520Blood%2520Pressure%2520Cardiovasc.%2520Prev.%26date%3D2017%26volume%3D24%26spage%3D107%26epage%3D114%26doi%3D10.1007%2Fs40292-017-0194-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jessup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brozena, S.</span></span> <span> </span><span class="NLM_article-title">Heart Failure</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2018</span>, <span class="refDoi"> DOI: 10.1056/nejmra021498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1056%2Fnejmra021498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=12748317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A280%3ADC%252BD3s3is12nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=2007-2018&author=M.+Jessupauthor=S.+Brozena&title=Heart+Failure&doi=10.1056%2Fnejmra021498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Heart failure</span></div><div class="casAuthors">Jessup Mariell; Brozena Susan</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2007-18</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvZ4lEH0HKskBuFdjgVNKSfW6udTcc2eYOKZic-lFpOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3is12nsg%253D%253D&md5=981c81c01f5c46d885bdcc3e53428586</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2Fnejmra021498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmra021498%26sid%3Dliteratum%253Aachs%26aulast%3DJessup%26aufirst%3DM.%26aulast%3DBrozena%26aufirst%3DS.%26atitle%3DHeart%2520Failure%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D2007%26epage%3D2018%26doi%3D10.1056%2Fnejmra021498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roger, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redfield, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellermann-Homan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yawn, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, S. J.</span></span> <span> </span><span class="NLM_article-title">Trends in Heart Failure Incidence and Survival in a Community-based Population</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1001/jama.292.3.344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1001%2Fjama.292.3.344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=15265849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFaju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2004&pages=344-350&author=V.+L.+Rogerauthor=S.+A.+Westonauthor=M.+M.+Redfieldauthor=J.+P.+Hellermann-Homanauthor=J.+Killianauthor=B.+P.+Yawnauthor=S.+J.+Jacobsen&title=Trends+in+Heart+Failure+Incidence+and+Survival+in+a+Community-based+Population&doi=10.1001%2Fjama.292.3.344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in heart failure incidence and survival in a community-based population</span></div><div class="casAuthors">Roger, Veronique L.; Weston, Susan A.; Redfield, Margaret M.; Hellermann-Homan, Jens P.; Killian, Jill; Yawn, Barbara P.; Jacobsen, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-350</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Context: The epidemic of heart failure has yet to be fully investigated, and data on incidence, survival, and sex-specific temporal trends in community-based populations are limited.  Objective: To test the hypothesis that the incidence of heart failure has declined and survival after heart failure diagnosis has improved over time but that secular trends have diverged by sex.  Design, Setting, and Participants: Population-based cohort study using the resources of the Rochester Epidemiol. Project conducted in Olmsted County, Minnesota.  Patients were 4537 Olmsted County residents (57% women; mean [SD] age, 74 [14] years) with a diagnosis of heart failure between 1979 and 2000.  Framingham criteria and clin. criteria were used to validate the diagnosis.  Main Outcome Measures: Incidence of heart failure and survival after heart failure diagnosis.  Results: The incidence of heart failure was higher among men (378/100000 persons; 95% confidence interval [Cl], 361-395 for men; 289/100000 persons; 95% Cl, 277-300 for women) and did not change over time among men or women.  After a mean follow-up of 4.2 yr (range, 0-23.8 yr), 3347 deaths occurred, including 1930 among women and 1417 among men.  Survival after heart failure diagnosis was worse among men than women (relative risk, 1.33; 95% Cl, 1.24-1.43) but overall improved over time (5-yr age-adjusted survival, 43 % in 1979-1984 vs 52 % in 1996-2000, P<.001).  However, men and younger persons experienced larger survival gains, contrasting with less or no improvement for women and elderly persons.  Conclusion: In this community-based cohort, the incidence of heart failure has not declined during 2 decades, but survival after onset of heart failure has increased over-all, with less improvement among women and elderly persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO6I2PZwR6h7Vg90H21EOLACvtfcHk0lhyRhowEUxeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFaju7k%253D&md5=44407f9bedb9db27ddb39013ad273226</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1001%2Fjama.292.3.344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.292.3.344%26sid%3Dliteratum%253Aachs%26aulast%3DRoger%26aufirst%3DV.%2BL.%26aulast%3DWeston%26aufirst%3DS.%2BA.%26aulast%3DRedfield%26aufirst%3DM.%2BM.%26aulast%3DHellermann-Homan%26aufirst%3DJ.%2BP.%26aulast%3DKillian%26aufirst%3DJ.%26aulast%3DYawn%26aufirst%3DB.%2BP.%26aulast%3DJacobsen%26aufirst%3DS.%2BJ.%26atitle%3DTrends%2520in%2520Heart%2520Failure%2520Incidence%2520and%2520Survival%2520in%2520a%2520Community-based%2520Population%26jtitle%3DJAMA%26date%3D2004%26volume%3D292%26spage%3D344%26epage%3D350%26doi%3D10.1001%2Fjama.292.3.344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petronis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span> <span> </span><span class="NLM_article-title">A Human Gene that Shows Identity with the Gene Encoding the Angiotensin Receptor is Located on Chromosome 11</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/0378-1119(93)90495-o</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2F0378-1119%2893%2990495-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=8294032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFGnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1993&pages=355-360&author=B.+F.+O%E2%80%99Dowdauthor=M.+Heiberauthor=A.+Chanauthor=H.+H.+Hengauthor=L.+C.+Tsuiauthor=J.+L.+Kennedyauthor=X.+Siauthor=A.+Petronisauthor=S.+R.+Georgeauthor=T.+Nguyen&title=A+Human+Gene+that+Shows+Identity+with+the+Gene+Encoding+the+Angiotensin+Receptor+is+Located+on+Chromosome+11&doi=10.1016%2F0378-1119%2893%2990495-o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11</span></div><div class="casAuthors">O'Dowd, Brian F.; Heiber, Michael; Chan, Audrey; Heng, Henry H. Q.; Tsui, Lap Chee; Kennedy, James L.; Shi, Xiaomei; Petronis, Arturas; George, Susan R.; Nguyen Tuan</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">355-60</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    </div><div class="casAbstract">The authors report the cloning of a gene, intron-less in its coding region, which the authors have named APJ.  This gene was cloned using the polymerase chain reaction (PCR), with a set of primers designed on the basis of the conservation that members of G protein-coupled receptors (GPCR) have in their transmembrane (TM) regions.  The putative receptor protein, APJ, shares closest identity to the angiotensin receptor (AT1) ranging from 40 to 50% in the hydrophobic TM regions of these receptors.  The transcripts for this gene were detected in many regions of the brain.  PCR anal. of somatic cell lines found APJ-related sequences to be only present on chromosome 11, and high-resoln. mapping by fluorescence in situ hybridization (FISH) sub-localized APJ on band q12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqp2kdIKETdbVg90H21EOLACvtfcHk0lgk5e3S9No6LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFGnsL0%253D&md5=4beb37696cbf0f919df6c1d22088e719</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0378-1119%2893%2990495-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-1119%252893%252990495-O%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DB.%2BF.%26aulast%3DHeiber%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DHeng%26aufirst%3DH.%2BH.%26aulast%3DTsui%26aufirst%3DL.%2BC.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26aulast%3DSi%26aufirst%3DX.%26aulast%3DPetronis%26aufirst%3DA.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DNguyen%26aufirst%3DT.%26atitle%3DA%2520Human%2520Gene%2520that%2520Shows%2520Identity%2520with%2520the%2520Gene%2520Encoding%2520the%2520Angiotensin%2520Receptor%2520is%2520Located%2520on%2520Chromosome%252011%26jtitle%3DGene%26date%3D1993%26volume%3D136%26spage%3D355%26epage%3D360%26doi%3D10.1016%2F0378-1119%2893%2990495-o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tatemoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, M.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukusumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujino, M.</span></span> <span> </span><span class="NLM_article-title">Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>251</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1998.9489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1006%2Fbbrc.1998.9489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=9792798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADyaK1cXmvF2msbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1998&pages=471-476&author=K.+Tatemotoauthor=M.+Hosoyaauthor=Y.+Habataauthor=R.+Fujiiauthor=T.+Kakegawaauthor=M.-X.+Zouauthor=Y.+Kawamataauthor=S.+Fukusumiauthor=S.+Hinumaauthor=C.+Kitadaauthor=T.+Kurokawaauthor=H.+Ondaauthor=M.+Fujino&title=Isolation+and+Characterization+of+a+Novel+Endogenous+Peptide+Ligand+for+the+Human+APJ+Receptor&doi=10.1006%2Fbbrc.1998.9489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor</span></div><div class="casAuthors">Tatemoto, Kazuhiko; Hosoya, Masaki; Habata, Yugo; Fujii, Ryo; Kakegawa, Tadao; Zou, Min-Xu; Kawamata, Yuji; Fukusumi, Shoji; Hinuma, Shuji; Kitada, Chieko; Kurokawa, Tsutomu; Onda, Haruo; Fujino, Masahiko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">In the search for an endogenous ligand of the orphan G protein-coupled receptor APJ, the presence of the ligand in various tissue exts. was examd. by measuring the increase in extracellular acidification rate of the cells expressing the APJ receptor as a specific signal induced by the interaction of the receptor and ligand.  By monitoring this activity, the authors isolated an APJ receptor ligand, designated apelin, from bovine stomach exts.  The structures of bovine and human apelin preproproteins were deduced from the sequences of the corresponding cDNAs.  The preproproteins consisted of 77 amino acid residues, and the apelin sequence was encoded in the C-terminal regions.  Synthetic peptides derived from the C-terminal amino acid sequence of bovine preproapelin were capable of specifically promoting the acidification rate in the cells expressing the APJ receptor in a range from 10-7 to 10-10 M, indicating that apelin is an endogenous ligand for the APJ receptor.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfZFYcVKcQs7Vg90H21EOLACvtfcHk0lgk5e3S9No6LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvF2msbY%253D&md5=54a069e5884731979abfdc1738ba6d44</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.9489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.9489%26sid%3Dliteratum%253Aachs%26aulast%3DTatemoto%26aufirst%3DK.%26aulast%3DHosoya%26aufirst%3DM.%26aulast%3DHabata%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DR.%26aulast%3DKakegawa%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DM.-X.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DFukusumi%26aufirst%3DS.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DKitada%26aufirst%3DC.%26aulast%3DKurokawa%26aufirst%3DT.%26aulast%3DOnda%26aufirst%3DH.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520a%2520Novel%2520Endogenous%2520Peptide%2520Ligand%2520for%2520the%2520Human%2520APJ%2520Receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1998%26volume%3D251%26spage%3D471%26epage%3D476%26doi%3D10.1006%2Fbbrc.1998.9489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kuba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, T.</span></span> <span> </span><span class="NLM_article-title">Apelin and Elabela/Toddler; Double Ligands for APJ/Apelin Receptor in Heart Development, Physiology, and Pathology</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2018.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.peptides.2018.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=29684595" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2018&pages=62-70&author=K.+Kubaauthor=T.+Satoauthor=Y.+Imaiauthor=T.+Yamaguchi&title=Apelin+and+Elabela%2FToddler%3B+Double+Ligands+for+APJ%2FApelin+Receptor+in+Heart+Development%2C+Physiology%2C+and+Pathology&doi=10.1016%2Fj.peptides.2018.04.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2018.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2018.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKuba%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26atitle%3DApelin%2520and%2520Elabela%252FToddler%253B%2520Double%2520Ligands%2520for%2520APJ%252FApelin%2520Receptor%2520in%2520Heart%2520Development%252C%2520Physiology%252C%2520and%2520Pathology%26jtitle%3DPeptides%26date%3D2018%26volume%3D111%26spage%3D62%26epage%3D70%26doi%3D10.1016%2Fj.peptides.2018.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Japp, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span> <span> </span><span class="NLM_article-title">The Apelin–APJ System in Heart Failure: Pathophysiologic Relevance and Therapeutic Potential</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1882</span>– <span class="NLM_lpage">1892</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2007.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bcp.2007.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=18272138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFOmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=1882-1892&author=A.+G.+Jappauthor=D.+E.+Newby&title=The+Apelin%E2%80%93APJ+System+in+Heart+Failure%3A+Pathophysiologic+Relevance+and+Therapeutic+Potential&doi=10.1016%2Fj.bcp.2007.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">The apelin-APJ system in heart failure</span></div><div class="casAuthors">Japp, Alan G.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1882-1892</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Apelin is the endogenous ligand for the previously orphaned G protein-coupled receptor, APJ.  This novel peptidic signalling pathway is widely represented in the heart and vasculature, and is emerging as an important regulator of cardiovascular homeostasis.  In preclin. models, apelin causes nitric oxide-dependent vasodilatation, reduces ventricular preload and afterload, and increases cardiac contractility in rats with normal and failing hearts.  Apelin-APJ signalling also attenuates ischemic myocardial injury and maintains cardiac performance in aging and chronic pressure overload.  Downregulation of apelin and APJ expression coincides with declining cardiac performance raising the possibility that diminished apelin-APJ activity may have pathophysiol. implications.  At present, data from human studies is limited but changes in apelin and APJ expression in patients with chronic heart failure parallel those seen in preclin. models.  Detailed clin. investigation is now required to establish the role of apelin in human cardiovascular physiol. and pathophysiol., and to det. the therapeutic potential of augmenting apelin signalling in patients with heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAka0TeezMa7Vg90H21EOLACvtfcHk0lgk5e3S9No6LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFOmsr4%253D&md5=63c1bf3e8feb31a6b78098b1b5336bf3</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DThe%2520Apelin%25E2%2580%2593APJ%2520System%2520in%2520Heart%2520Failure%253A%2520Pathophysiologic%2520Relevance%2520and%2520Therapeutic%2520Potential%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D1882%26epage%3D1892%26doi%3D10.1016%2Fj.bcp.2007.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winborn, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrie, K. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervieu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolaky, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrity, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darker, J. G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological and Immunohistochemical Characterization of the APJ Receptor and its Endogenous Ligand Apelin</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1162</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.01587.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1046%2Fj.1471-4159.2003.01587.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=12603839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1ejtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=1162-1172&author=A.+D.+Medhurstauthor=C.+A.+Jenningsauthor=M.+J.+Robbinsauthor=R.+P.+Davisauthor=C.+Ellisauthor=K.+Y.+Winbornauthor=K.+W.+M.+Lawrieauthor=G.+Hervieuauthor=G.+Rileyauthor=J.+E.+Bolakyauthor=N.+C.+Herrityauthor=P.+Murdockauthor=J.+G.+Darker&title=Pharmacological+and+Immunohistochemical+Characterization+of+the+APJ+Receptor+and+its+Endogenous+Ligand+Apelin&doi=10.1046%2Fj.1471-4159.2003.01587.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin</span></div><div class="casAuthors">Medhurst, Andrew D.; Jennings, Carol A.; Robbins, Melanie J.; Davis, Robert P.; Ellis, Catherine; Winborn, Kim Y.; Lawrie, Kenneth W. M.; Hervieu, Guillaume; Riley, Graham; Bolaky, Jane E.; Herrity, Nicole C.; Murdock, Paul; Darker, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1162-1172</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Apelin peptides have recently been identified to be the endogenous ligands for the G protein-coupled receptor APJ.  However, little is known about the physiol. roles of this ligand-receptor pairing.  In the present study the authors investigated the pharmacol. of several apelin analogs at the human recombinant APJ receptor using radioligand binding and functional assays.  This has led to the identification of key residues in the apelin peptide required for functional potency and binding affinity through structure-activity studies.  In particular, the authors have identified that replacement of leucine in position 5, or arginine in position 2 and 4 of the C-terminal apelin peptide, apelin-13, resulted in significant changes in pharmacol.  The authors also investigated the detailed localization of pre-proapelin and APJ receptor mRNA in a wide range of human, rat and mouse tissues using quant. RT-PCR, and carried out a detailed immunohistochem. study of the distribution of the APJ receptor in rat brain and spinal cord.  Interestingly, the APJ receptor was not only co-localized in white matter with GFAP in the spinal cord, but was also clearly localized on neurons in the brain, suggesting that this receptor and its peptide may be involved in a wide range of biol. process yet to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99tyPHrKfxLVg90H21EOLACvtfcHk0ljsOq4e1Hum2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1ejtb8%253D&md5=4a83eb10e5612872943c2a327659ab6d</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.01587.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.01587.x%26sid%3Dliteratum%253Aachs%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DJennings%26aufirst%3DC.%2BA.%26aulast%3DRobbins%26aufirst%3DM.%2BJ.%26aulast%3DDavis%26aufirst%3DR.%2BP.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DWinborn%26aufirst%3DK.%2BY.%26aulast%3DLawrie%26aufirst%3DK.%2BW.%2BM.%26aulast%3DHervieu%26aufirst%3DG.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DBolaky%26aufirst%3DJ.%2BE.%26aulast%3DHerrity%26aufirst%3DN.%2BC.%26aulast%3DMurdock%26aufirst%3DP.%26aulast%3DDarker%26aufirst%3DJ.%2BG.%26atitle%3DPharmacological%2520and%2520Immunohistochemical%2520Characterization%2520of%2520the%2520APJ%2520Receptor%2520and%2520its%2520Endogenous%2520Ligand%2520Apelin%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D84%26spage%3D1162%26epage%3D1172%26doi%3D10.1046%2Fj.1471-4159.2003.01587.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgs, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, J. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamyl Apelin-13 Identified as the Major Apelin Isoform in Human Plasma</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>442</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2013.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.ab.2013.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=23872001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=442&publication_year=2013&pages=1-9&author=E.+Y.+Zhenauthor=R.+E.+Higgsauthor=J.+A.+Gutierrez&title=Pyroglutamyl+Apelin-13+Identified+as+the+Major+Apelin+Isoform+in+Human+Plasma&doi=10.1016%2Fj.ab.2013.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma</span></div><div class="casAuthors">Zhen, Eugene Y.; Higgs, Richard E.; Gutierrez, Jesus A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">442</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apelin is emerging as an important hormone regulator of cardiovascular homeostasis and an important biomarker for heart failure.  Apelin concns. have historically been measured by immunoassays; however, reported apelin concns. measured in healthy volunteers show a large disparity from a few picograms per mL (pg/mL) to several nanograms per mL (ng/mL).  Apelin exists in several isoforms ranging in size from 12 to 36 residues, and immunoassays generally cannot distinguish the specific forms present.  In this study, an optimized method for enriching apelin peptides with cation-exchange beads followed with mass spectrometry anal. is presented.  Apelin peptides are labile in plasma at physiol. conditions; however, by lowering the plasma pH to 4.5, the recovery of apelin peptides can be increased significantly.  Through optimizing the cation-exchange extn. process, the authors improved the lower limit of detection for most of the apelin peptides monitored to a few pg/mL.  Using the improved method, the authors detected pyroglutamyl apelin-13 [(pyr)apelin-13] as the major apelin isoform present in plasma from several healthy volunteers at concns. ranging from 7.7 to 23.3 pg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9q8cU6NvKV7Vg90H21EOLACvtfcHk0ljsOq4e1Hum2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntbzN&md5=32a7a24e4194c99ee6285be5408089dd</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2013.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2013.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DE.%2BY.%26aulast%3DHiggs%26aufirst%3DR.%2BE.%26aulast%3DGutierrez%26aufirst%3DJ.%2BA.%26atitle%3DPyroglutamyl%2520Apelin-13%2520Identified%2520as%2520the%2520Major%2520Apelin%2520Isoform%2520in%2520Human%2520Plasma%26jtitle%3DAnal.%2520Biochem.%26date%3D2013%26volume%3D442%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.ab.2013.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitkin, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, A. P.</span></span> <span> </span><span class="NLM_article-title">[Pyr<sup>1</sup>]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart: Vasoactive Mechanisms and Inotropic Action in Disease</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">598</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1161/hypertensionaha.109.134619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2FHYPERTENSIONAHA.109.134619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=19597036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsleksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=598-604&author=J.+J.+Maguireauthor=M.+J.+Kleinzauthor=S.+L.+Pitkinauthor=A.+P.+Davenport&title=%5BPyr1%5DApelin-13+Identified+as+the+Predominant+Apelin+Isoform+in+the+Human+Heart%3A+Vasoactive+Mechanisms+and+Inotropic+Action+in+Disease&doi=10.1161%2Fhypertensionaha.109.134619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">[Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart</span></div><div class="casAuthors">Maguire, Janet J.; Kleinz, Matthias J.; Pitkin, Sarah L.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">598-604</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Apelin receptors, present on vascular smooth muscle cells, endothelium, and cardiomyocytes, are activated by the family of apelin peptides to elicit cardiovascular effects in exptl. animals, but functional activity in humans has not been studied in detail.  The authors detected low levels of apelin immunoreactivity in plasma of volunteers consistent with an autocrine/paracrine action and detected apelin immunoreactivity in the supernatant from human cultured endothelial cells.  The authors found that [Pyr1]apelin-13 was the predominant isoform in cardiac tissue from patients with coronary artery disease.  The authors tested the hypothesis that apelins have vascular and cardiac actions in human tissues in vitro and compared responses to [Pyr1]apelin-13, apelin-13, and apelin-36.  In endothelium-intact mammary artery, all 3 of the apelins induced concn.-dependent vasodilatation with comparable potency (EC50: 0.6 to 1.6 nM; max. response: 40% to 50%).  Vasodilatation was abolished after endothelial removal or preincubation with indomethacin but was unaffected by preincubation with NG-nitro-l-arginine Me ester, indicating involvement of prostanoids but not NO in dilatation by apelins in this patient group.  Apelins were potent constrictors of endothelium-denuded saphenous vein (EC50: 0.6 to 1.6 nM; max. response: 17% to 26%) and mammary artery ([Pyr1]apelin-13; EC50: 0.2 nM; max. response: 29%).  In paced atrial strips, all 3 of the peptides increased the force of contraction with subnanomolar potencies (EC50: 40 to 125 pM).  For the first time, the authors demonstrate that the 3 principal forms of apelin have comparable potency and efficacy in human cardiovascular tissues.  Apelins are potent endothelium-dependent vasodilators acting via a prostanoid-dependent mechanism; however, removal of the endothelium revealed direct vasoconstrictor actions in both the artery and vein.  Furthermore, in human cardiac tissue, the apelin peptides are among the most potent endogenous pos. inotropic agents yet reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0rlY7c6SsibVg90H21EOLACvtfcHk0ljsOq4e1Hum2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsleksL4%253D&md5=bf568a68931b0815502522cc785df8ca</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.109.134619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.109.134619%26sid%3Dliteratum%253Aachs%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DKleinz%26aufirst%3DM.%2BJ.%26aulast%3DPitkin%26aufirst%3DS.%2BL.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3D%255BPyr1%255DApelin-13%2520Identified%2520as%2520the%2520Predominant%2520Apelin%2520Isoform%2520in%2520the%2520Human%2520Heart%253A%2520Vasoactive%2520Mechanisms%2520and%2520Inotropic%2520Action%2520in%2520Disease%26jtitle%3DHypertension%26date%3D2009%26volume%3D54%26spage%3D598%26epage%3D604%26doi%3D10.1161%2Fhypertensionaha.109.134619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szokodi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Földes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voutilainen-Myllylä, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikkarainen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piuhola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rysä, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tóth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruskoaho, H.</span></span> <span> </span><span class="NLM_article-title">Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1161/01.res.0000033522.37861.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2F01.RES.0000033522.37861.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=12215493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2002&pages=434-440&author=I.+Szokodiauthor=P.+Taviauthor=G.+F%C3%B6ldesauthor=S.+Voutilainen-Myllyl%C3%A4author=M.+Ilvesauthor=H.+Tokolaauthor=S.+Pikkarainenauthor=J.+Piuholaauthor=J.+Rys%C3%A4author=M.+T%C3%B3thauthor=H.+Ruskoaho&title=Apelin%2C+the+Novel+Endogenous+Ligand+of+the+Orphan+Receptor+APJ%2C+Regulates+Cardiac+Contractility&doi=10.1161%2F01.res.0000033522.37861.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility</span></div><div class="casAuthors">Szokodi, Istvan; Tavi, Pasi; Foeldes, Gabor; Voutilainen-Myllylae, Sari; Ilves, Mika; Tokola, Heikki; Pikkarainen, Sampsa; Piuhola, Jarkko; Rysae, Jaana; Toth, Miklos; Ruskoaho, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The orphan receptor APJ and its recently identified endogenous ligand, apelin, exhibit high levels of mRNA expression in the heart.  However, the functional importance of apelin in the cardiovascular system is not known.  In isolated perfused rat hearts, infusion of apelin (0.01 to 10 nmol/L) induced a dose-dependent pos. inotropic effect (EC50: 33.1±1.5 pmol/L).  Moreover, preload-induced increase in dP/dtmax was significantly augmented (P<0.05) in the presence of apelin.  Inhibition of phospholipase C (PLC) with U-73122 and suppression of protein kinase C (PKC) with staurosporine and GF-109203X markedly attenuated the apelin-induced inotropic effect (P<0.001).  In addn., zoniporide, a selective inhibitor of Na+-H+ exchange (NHE) isoform-1, and KB-R7943, a potent inhibitor of the reverse mode Na+-Ca2+ exchange (NCX), significantly suppressed the response to apelin (P<0.001).  Perforated patch-clamp recordings showed that apelin did not modulate L-type Ca2+ current or voltage-activated K+ currents in isolated adult rat ventricular myocytes.  Apelin mRNA was markedly downregulated in cultured neonatal rat ventricular myocytes subjected to mech. stretch and in vivo in two models of chronic ventricular pressure overload.  The present study provides the first evidence for the physiol. significance of apelin in the heart.  Our results show that apelin is one of the most potent endogenous pos. inotropic substances yet identified and that the inotropic response to apelin may involve activation of PLC, PKC, and sarcolemmal NHE and NCX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAJihT3bR9_bVg90H21EOLACvtfcHk0ljqjRhjCmf20g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVKktL0%253D&md5=78b3fb521970692595debb7c819f0e3b</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000033522.37861.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000033522.37861.69%26sid%3Dliteratum%253Aachs%26aulast%3DSzokodi%26aufirst%3DI.%26aulast%3DTavi%26aufirst%3DP.%26aulast%3DF%25C3%25B6ldes%26aufirst%3DG.%26aulast%3DVoutilainen-Myllyl%25C3%25A4%26aufirst%3DS.%26aulast%3DIlves%26aufirst%3DM.%26aulast%3DTokola%26aufirst%3DH.%26aulast%3DPikkarainen%26aufirst%3DS.%26aulast%3DPiuhola%26aufirst%3DJ.%26aulast%3DRys%25C3%25A4%26aufirst%3DJ.%26aulast%3DT%25C3%25B3th%26aufirst%3DM.%26aulast%3DRuskoaho%26aufirst%3DH.%26atitle%3DApelin%252C%2520the%2520Novel%2520Endogenous%2520Ligand%2520of%2520the%2520Orphan%2520Receptor%2520APJ%252C%2520Regulates%2520Cardiac%2520Contractility%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D91%26spage%3D434%26epage%3D440%26doi%3D10.1161%2F01.res.0000033522.37861.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finsterbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffarelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichhorn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greve, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quertermous, T.</span></span> <span> </span><span class="NLM_article-title">The Endogenous Peptide Apelin Potently Improves Cardiac Contractility and Reduces Cardiac Loading <i>in vivo</i></span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1016/j.cardiores.2004.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.cardiores.2004.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=15621035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFCqt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=73-82&author=E.+Ashleyauthor=J.+Powersauthor=M.+Chenauthor=R.+Kunduauthor=T.+Finsterbachauthor=A.+Caffarelliauthor=A.+Dengauthor=J.+Eichhornauthor=R.+Mahajanauthor=R.+Agrawalauthor=J.+Greveauthor=R.+Robbinsauthor=A.+J.+Pattersonauthor=D.+Bernsteinauthor=T.+Quertermous&title=The+Endogenous+Peptide+Apelin+Potently+Improves+Cardiac+Contractility+and+Reduces+Cardiac+Loading+in+vivo&doi=10.1016%2Fj.cardiores.2004.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo</span></div><div class="casAuthors">Ashley, Euan A.; Powers, Jennifer; Chen, Mary; Kundu, Ramendra; Finsterbach, Tom; Caffarelli, Anthony; Deng, Alicia; Eichhorn, Jens; Mahajan, Raina; Agrawal, Rani; Greve, Joan; Robbins, Robert; Patterson, Andrew J.; Bernstein, Daniel; Quertermous, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-82</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endogenous peptide apelin is differentially regulated in cardiovascular disease but the nature of its role in cardiac function remains unclear.  The authors investigated the functional relevance of this peptide using eCG and respiration gated magnetic resonance imaging, conductance catheter pressure-vol. hemodynamic measurements, and echocardiog. in vivo.  In addn., the authors carried out histol. and immunohistochem. to assess cardiac hypertrophy and to localize apelin and APJ in the adult and embryonic mouse heart.  The i.p. injection of apelin (300 μg/kg) resulted in a decrease in left ventricular end diastolic area (pre: 0.122; post: 0.104 cm2) and an increase in heart rate (pre: 537; post: 559 beats per min).  Hemodynamic measurements revealed a marked increase in ventricular elastance (pre: 3.7; post: 6.5 mm Hg/RVU) and preload recruitable stroke work (pre: 27.4; post: 51.8) with little change in diastolic parameters following acute infusion of apelin.  Chronic infusion (2 mg/kg/day) resulted in significant increases in the velocity of circumferential shortening (baseline: 5.36; 14 days: 6.85 circ/s) and cardiac output (baseline: 0.142; 14 days: 0.25 l/min) as detd. by 15 MHz echocardiog.  Post-mortem cor. heart wts. were not different between apelin and saline groups and histol. revealed no evidence of cellular hypertrophy in the apelin group.  Immunohistochem. studies revealed APJ staining of myocardial cells in all regions of the adult mouse heart.  Antibody staining, as well as quant. real time polymerase chain reaction identified expression of both APJ and apelin in embryonic myocardium as early as embryonic day 13.5.  Thus, apelin reduces left ventricular preload and afterload and increases contractile reserve without evidence of hypertrophy.  These results assoc. apelin with a pos. hemodynamic profile and suggest it as an attractive target for pharmacotherapy in the setting of heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkEP8xIMrQ2LVg90H21EOLACvtfcHk0ljqjRhjCmf20g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFCqt7vM&md5=07088f2a5bc3ed114b26c2876bfd9a51</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.cardiores.2004.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardiores.2004.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DKundu%26aufirst%3DR.%26aulast%3DFinsterbach%26aufirst%3DT.%26aulast%3DCaffarelli%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DA.%26aulast%3DEichhorn%26aufirst%3DJ.%26aulast%3DMahajan%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DR.%26aulast%3DGreve%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DA.%2BJ.%26aulast%3DBernstein%26aufirst%3DD.%26aulast%3DQuertermous%26aufirst%3DT.%26atitle%3DThe%2520Endogenous%2520Peptide%2520Apelin%2520Potently%2520Improves%2520Cardiac%2520Contractility%2520and%2520Reduces%2520Cardiac%2520Loading%2520in%2520vivo%26jtitle%3DCardiovasc.%2520Res.%26date%3D2005%26volume%3D65%26spage%3D73%26epage%3D82%26doi%3D10.1016%2Fj.cardiores.2004.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koguchi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishimitsu, T.</span></span> <span> </span><span class="NLM_article-title">Cardioprotective Effect of Apelin-13 on Cardiac Performance and Remodeling in End-stage Heart Failure</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1253/circj.cj-11-0689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1253%2Fcircj.cj-11-0689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2jt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2012&pages=137-144&author=W.+Koguchiauthor=N.+Kobayashiauthor=H.+Takeshimaauthor=M.+Ishikawaauthor=F.+Sugiyamaauthor=T.+Ishimitsu&title=Cardioprotective+Effect+of+Apelin-13+on+Cardiac+Performance+and+Remodeling+in+End-stage+Heart+Failure&doi=10.1253%2Fcircj.cj-11-0689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure</span></div><div class="casAuthors">Koguchi, Wataru; Kobayashi, Naohiko; Takeshima, Hiroshi; Ishikawa, Mayuko; Sugiyama, Fumihiro; Ishimitsu, Toshihiko</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">CJIOBY</span>;
        ISSN:<span class="NLM_cas:issn">1346-9843</span>.
    
            (<span class="NLM_cas:orgname">Japanese Circulation Society</span>)
        </div><div class="casAbstract">Background: Apelin and its cognate G protein-coupled receptor, APJ, constitute a signaling pathway with a pos. inotropic effect on cardiac function.  Recently, we and other investigators demonstrated that a redn. in myocardial apelin/APJ expression might play a crit. role in exptl. models of end-stage heart failure (HF).  Therefore, we evaluated whether exogenous apelin infusion restores apelin/APJ expression and improves cardiac function in the failing heart of Dahl salt-sensitive hypertensive (DS) rats.  Methods and Results: High salt-loaded DS rats were treated with vehicle and pyroglutamylated apelin-13 (Pyr-AP13; 200μg · kg-1 · day-1, IP) from the age of 11 to 18 wk.  Decreased end-systolic elastance and percent fractional shortening in failing rats was significantly ameliorated by Pyr-AP13.  Pyr-AP13 effectively inhibited vascular lesion formation and suppressed expression of inflammation factors such as tumor necrosis factor-α and interleukin-1β protein.  Downregulation of apelin and APJ expression, and phosphorylation of endothelial nitric oxide synthase at Ser1177 and Akt at Ser473 in failing rats was significantly increased by Pyr-AP13.  Upregulation of NAD(P)H oxidase p22phox, p47phox and gp91phox in DS rats was significantly suppressed by Pyr-AP13.  Conclusions: Exogenous apelin-13 may ameliorate cardiac dysfunction and remodeling and restore apelin/APJ expression in DS rats with end-stage HF.  Thus, apelin-13 may have significant therapeutic potential for end-stage HF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRZ6P_1OR7bVg90H21EOLACvtfcHk0ljqjRhjCmf20g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2jt7w%253D&md5=ee9dc78fa905dc8d92d74afd39b4d883</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1253%2Fcircj.cj-11-0689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1253%252Fcircj.cj-11-0689%26sid%3Dliteratum%253Aachs%26aulast%3DKoguchi%26aufirst%3DW.%26aulast%3DKobayashi%26aufirst%3DN.%26aulast%3DTakeshima%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DSugiyama%26aufirst%3DF.%26aulast%3DIshimitsu%26aufirst%3DT.%26atitle%3DCardioprotective%2520Effect%2520of%2520Apelin-13%2520on%2520Cardiac%2520Performance%2520and%2520Remodeling%2520in%2520End-stage%2520Heart%2520Failure%26jtitle%3DCirculation%26date%3D2012%26volume%3D76%26spage%3D137%26epage%3D144%26doi%3D10.1253%2Fcircj.cj-11-0689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Japp, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruden, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amer, D. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudie, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Megson, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flapan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span> <span> </span><span class="NLM_article-title">Vascular Effects of Apelin <i>in vivo</i> in Man</span>. <i>J. Am. Coll. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1016/j.jacc.2008.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.jacc.2008.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=18772060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyjsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=908-913&author=A.+G.+Jappauthor=N.+L.+Crudenauthor=D.+A.+B.+Amerauthor=V.+K.+Y.+Liauthor=E.+B.+Goudieauthor=N.+R.+Johnstonauthor=S.+Sharmaauthor=I.+Neilsonauthor=D.+J.+Webbauthor=I.+L.+Megsonauthor=A.+D.+Flapanauthor=D.+E.+Newby&title=Vascular+Effects+of+Apelin+in+vivo+in+Man&doi=10.1016%2Fj.jacc.2008.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Effects of Apelin In Vivo in Man</span></div><div class="casAuthors">Japp, Alan G.; Cruden, Nicholas L.; Amer, David A. B.; Li, Vivienne K. Y.; Goudie, Ewan B.; Johnston, Neil R.; Sharma, Sushma; Neilson, Ilene; Webb, David J.; Megson, Ian L.; Flapan, Andrew D.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">908-913</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This study was designed to establish the direct vascular effects of apelin in vivo in man.  Apelin is the endogenous ligand for the previously orphaned G-protein-coupled receptor, APJ.  This novel pathway is widely expressed in the cardiovascular system and is emerging as an important mediator of cardiovascular homeostasis.  In pre-clin. models, apelin causes venous and arterial vasodilation.  Vascular effects of apelin were assessed in 24 healthy volunteers.  Dorsal hand vein diam. was measured by the Aellig technique during local i.v. infusions (0.1 to 3 nmol/min) of apelin-36, (Pyr1)apelin-13, and sodium nitroprusside (0.6 nmol/min).  Forearm blood flow was measured by venous occlusion plethysmog. during intrabrachial infusions of apelin-36 and (Pyr1)apelin-13 (0.1 to 30 nmol/min) and subsequently in the presence or absence of a "nitric oxide clamp" (nitric oxide synthase inhibitor, L-N G-monomethylarginine [8 μmol/min], coinfused with nitric oxide donor, sodium nitroprusside [90 to 900 ng/min]), or a single oral dose of aspirin (600 mg) or matched placebo.  Although sodium nitroprusside caused venodilation (p < 0.0001), apelin-36 and (Pyr1)apelin-13 had no effect on dorsal hand vein diam. (p = 0.2).  Both apelin isoforms caused reproducible vasodilation in forearm resistance vessels (p < 0.0001).  (Pyr1)apelin-13-mediated vasodilation was attenuated by the nitric oxide clamp (p = 0.004) but unaffected by aspirin (p = 0.7).  Although having no apparent effect on venous tone, apelin causes nitric oxide-dependent arterial vasodilation in vivo in man.  The apelin-APJ system merits further clin. investigation to det. its role in cardiovascular homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFV91OuN1h07Vg90H21EOLACvtfcHk0lj0s-ARBDu7WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyjsbnE&md5=77645b8ab8034837a4f6c3f02868f4ab</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2008.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2008.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DAmer%26aufirst%3DD.%2BA.%2BB.%26aulast%3DLi%26aufirst%3DV.%2BK.%2BY.%26aulast%3DGoudie%26aufirst%3DE.%2BB.%26aulast%3DJohnston%26aufirst%3DN.%2BR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DNeilson%26aufirst%3DI.%26aulast%3DWebb%26aufirst%3DD.%2BJ.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26aulast%3DFlapan%26aufirst%3DA.%2BD.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DVascular%2520Effects%2520of%2520Apelin%2520in%2520vivo%2520in%2520Man%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2008%26volume%3D52%26spage%3D908%26epage%3D913%26doi%3D10.1016%2Fj.jacc.2008.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Japp, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruden, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemeren, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denvir, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Megson, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flapan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span> <span> </span><span class="NLM_article-title">Acute Cardiovascular Effects of Apelin in Humans Potential Role in Patients with Chronic Heart Failure</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">1818</span>– <span class="NLM_lpage">1827</span>, <span class="refDoi"> DOI: 10.1161/circulationaha.109.911339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2Fcirculationaha.109.911339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=20385929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2010&pages=1818-1827&author=A.+G.+Jappauthor=N.+L.+Crudenauthor=G.+Barnesauthor=N.+van+Gemerenauthor=J.+Mathewsauthor=J.+Adamsonauthor=N.+R.+Johnstonauthor=M.+A.+Denvirauthor=I.+L.+Megsonauthor=A.+D.+Flapanauthor=D.+E.+Newby&title=Acute+Cardiovascular+Effects+of+Apelin+in+Humans+Potential+Role+in+Patients+with+Chronic+Heart+Failure&doi=10.1161%2Fcirculationaha.109.911339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Acute Cardiovascular Effects of Apelin in Humans: Potential Role in Patients With Chronic Heart Failure</span></div><div class="casAuthors">Japp, A. G.; Cruden, N. L.; Barnes, G.; van Gemeren, N.; Mathews, J.; Adamson, J.; Johnston, N. R.; Denvir, M. A.; Megson, I. L.; Flapan, A. D.; Newby, D. E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1818-1827</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND: Apelin, the endogenous ligand for the novel G protein-coupled receptor APJ, has major cardiovascular effects in preclin. models.  The study objectives were to establish the effects of acute apelin administration on peripheral, cardiac, and systemic hemodynamic variables in healthy volunteers and patients with heart failure.  METHODS AND RESULTS: Eighteen patients with New York Heart Assocn. class II to III chronic heart failure, 6 patients undergoing diagnostic coronary angiog., and 26 healthy volunteers participated in a series of randomized, double-blind, placebo-controlled studies.  Measurements of forearm blood flow, coronary blood flow, left ventricular pressure, and cardiac output were made by venous occlusion plethysmog., Doppler flow wire and quant. coronary angiog., pressure wire, and thoracic bioimpedance, resp.  Intrabrachial infusions of (Pyr)apelin-13, acetylcholine, and sodium nitroprusside caused forearm vasodilatation in patients and control subjects (all P < 0.0001).  Vasodilatation to acetylcholine (P = 0.01) but not apelin (P = 0.3) or sodium nitroprusside (P = 0.9) was attenuated in patients with heart failure.  Intracoronary bolus of apelin-36 increased coronary blood flow and the max. rate of rise in left ventricular pressure and reduced peak and end-diastolic left ventricular pressures (all P < 0.05).  Systemic infusions of (Pyr)apelin-13 (30 to 300 nmol/min) increased cardiac index and lowered mean arterial pressure and peripheral vascular resistance in patients and healthy control subjects (all P<0.01) but increased heart rate only in control subjects (P < 0.01).  CONCLUSIONS: Acute apelin administration in humans causes peripheral and coronary vasodilatation and increases cardiac output.  APJ agonism represents a novel potential therapeutic target for patients with heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiqCbkcSGzQ7Vg90H21EOLACvtfcHk0lj0s-ARBDu7WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVOls7k%253D&md5=35dd169c74c36b03d9c82c1215401467</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1161%2Fcirculationaha.109.911339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fcirculationaha.109.911339%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DBarnes%26aufirst%3DG.%26aulast%3Dvan%2BGemeren%26aufirst%3DN.%26aulast%3DMathews%26aufirst%3DJ.%26aulast%3DAdamson%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DN.%2BR.%26aulast%3DDenvir%26aufirst%3DM.%2BA.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26aulast%3DFlapan%26aufirst%3DA.%2BD.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DAcute%2520Cardiovascular%2520Effects%2520of%2520Apelin%2520in%2520Humans%2520Potential%2520Role%2520in%2520Patients%2520with%2520Chronic%2520Heart%2520Failure%26jtitle%3DCirculation%26date%3D2010%26volume%3D121%26spage%3D1818%26epage%3D1827%26doi%3D10.1161%2Fcirculationaha.109.911339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veitch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruden, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Japp, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span> <span> </span><span class="NLM_article-title">Sustained Cardiovascular Actions of APJ Agonism During Renin-angiotensin System Activation and in Patients with Heart Failure</span>. <i>Circ.: Heart Failure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1161/circheartfailure.111.000077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2FCIRCHEARTFAILURE.111.000077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=23519586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSntbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=482-491&author=G.+D.+Barnesauthor=S.+Alamauthor=G.+Carterauthor=C.+M.+Pedersenauthor=K.+M.+Leeauthor=T.+J.+Hubbardauthor=S.+Veitchauthor=H.+Jeongauthor=A.+Whiteauthor=N.+L.+Crudenauthor=L.+Husonauthor=A.+G.+Jappauthor=D.+E.+Newby&title=Sustained+Cardiovascular+Actions+of+APJ+Agonism+During+Renin-angiotensin+System+Activation+and+in+Patients+with+Heart+Failure&doi=10.1161%2Fcircheartfailure.111.000077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained Cardiovascular Actions of APJ Agonism During Renin-Angiotensin System Activation and in Patients With Heart Failure</span></div><div class="casAuthors">Barnes, Gareth D.; Alam, Shirjel; Carter, Gordon; Pedersen, Christian M.; Lee, Kristina M.; Hubbard, Thomas J.; Veitch, Scott; Jeong, Herim; White, Audrey; Cruden, Nicholas L.; Huson, Les; Japp, Alan G.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation: Heart Failure</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">CHFICM</span>;
        ISSN:<span class="NLM_cas:issn">1941-3289</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: To assess cardiovascular actions of APJ agonism during prolonged (Pyr)apelin-13 infusion and renin-angiotensin system activation.  METHODS AND RESULTS-: Forty-eight volunteers and 12 patients with chronic stable heart failure attended a series of randomized placebo-controlled studies.  Forearm blood flow, cardiac index, left ventricular dimensions, and mean arterial pressure were measured using bilateral venous occlusion plethysmog., bioimpedance cardiog., transthoracic echocardiog., and sphygmomanometry, resp., during brief local (0.3-3.0 nmol/min) and systemic (30-300 nmol/min) or prolonged systemic (30 nmol/min) (Pyr)apelin-13 infusions in the presence or absence of renin-angiotensin system activation with sodium depletion or angiotensin II coinfusion.  During sodium depletion and angiotensin II coinfusion, (Pyr)apelin-13-induced vasodilatation was preserved (P<0.02 for both).  Systemic i.v. (Pyr)apelin-13 infusion increased cardiac index, whereas reducing mean arterial pressure and peripheral vascular resistance index (P<0.001 for all) irresp. of sodium depletion or angiotensin II (0.5 ng/kg per min) coinfusion (P>0.05 for all).  Prolonged 6-h (Pyr)apelin-13 infusion caused a sustained increase in cardiac index with increased left ventricular ejection fraction in patients with chronic heart failure (ANOVA; P<0.001 for all).  CONCLUSIONS-: APJ agonism has sustained cardiovascular effects that are preserved in the presence of renin-angiotensin system activation or heart failure.  APJ agonism may hold major promise to complement current optimal medical therapy in patients with chronic heart failure.  Clin. TRIAL REGISTRATION-: URL: http://www.clinicaltrials.gov.  Unique identifiers: NCT00901719, NCT00901888, NCT01049646, NCT01179061.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWOAUpCsQtubVg90H21EOLACvtfcHk0li3PkYtwB2bfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSntbvM&md5=7aa0219a8f5a363c3092b1b6a0631ed2</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1161%2FCIRCHEARTFAILURE.111.000077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCHEARTFAILURE.111.000077%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DG.%2BD.%26aulast%3DAlam%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DG.%26aulast%3DPedersen%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DK.%2BM.%26aulast%3DHubbard%26aufirst%3DT.%2BJ.%26aulast%3DVeitch%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DHuson%26aufirst%3DL.%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DSustained%2520Cardiovascular%2520Actions%2520of%2520APJ%2520Agonism%2520During%2520Renin-angiotensin%2520System%2520Activation%2520and%2520in%2520Patients%2520with%2520Heart%2520Failure%26jtitle%3DCirc.%253A%2520Heart%2520Failure%26date%3D2013%26volume%3D6%26spage%3D482%26epage%3D491%26doi%3D10.1161%2Fcircheartfailure.111.000077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudej, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akita, G. Y.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular Effects of a PEGylated Apelin</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2012.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.peptides.2012.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=22986020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GqurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=181-188&author=Z.+Q.+Jiaauthor=L.+Houauthor=A.+Legerauthor=I.+Wuauthor=A.+B.+Kudejauthor=J.+Stefanoauthor=C.+Jiangauthor=C.+Q.+Panauthor=G.+Y.+Akita&title=Cardiovascular+Effects+of+a+PEGylated+Apelin&doi=10.1016%2Fj.peptides.2012.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular effects of a PEGylated apelin</span></div><div class="casAuthors">Jia, Z. Q.; Hou, L.; Leger, A.; Wu, I.; Kudej, A. B.; Stefano, J.; Jiang, C.; Pan, C. Q.; Akita, G. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-188</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several studies have documented cardiovascular effects of apelin, including enhanced inotropy and vasodilation.  However, these cardiovascular effects are short lived due to the predicted short circulating half-life of the apelin peptide.  To address this limitation of apelin, we pursued N-terminal PEGylation of apelin and examd. the cardiovascular effects of the PEGylated apelin.  A 40 kDa PEG conjugated apelin-36 (PEG-apelin-36) was successfully produced with N-terminal conjugation, high purity (>98%) and min. redn. of APJ receptor binding affinity.  Using an adenylate cyclase inhibition assay, comparable in vitro bioactivity was obsd. between the PEG-apelin-36 and unmodified apelin-36.  In vivo evaluation of the PEG-apelin-36 was performed in normal rats and rats with myocardial infarction (MI).  Cardiac function was assessed via echocardiog. before, during a 20 min IV infusion and up to 100 min post peptide infusion.  Similar increases in cardiac ejection fraction (EF) were obsd. during the infusion of PEG-apelin-36 and apelin-36 in normal rats.  However, animals that received PEG-apelin-36 maintained significantly increased EF over the 100 min post infusion monitoring period compared to the animals that received unmodified apelin-36.  Interestingly, EF increases obsd. with PEG-apelin-36 and apelin-36 were greater in the MI rats.  PEG-apelin-36 had a prolonged circulating life compared to apelin-36 in rats.  There were no changes in aortic blood pressure when PEG-apelin-36 or apelin-36 was administered.  To our knowledge this is the first report of apelin PEGylation and documentation of its cardiovascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHeGbLwfiE0rVg90H21EOLACvtfcHk0li3PkYtwB2bfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GqurnI&md5=f46c15bd9764951ab36614c183304f0c</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2012.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2012.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.%2BQ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DLeger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DI.%26aulast%3DKudej%26aufirst%3DA.%2BB.%26aulast%3DStefano%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DC.%2BQ.%26aulast%3DAkita%26aufirst%3DG.%2BY.%26atitle%3DCardiovascular%2520Effects%2520of%2520a%2520PEGylated%2520Apelin%26jtitle%3DPeptides%26date%3D2012%26volume%3D38%26spage%3D181%26epage%3D188%26doi%3D10.1016%2Fj.peptides.2012.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Macaluso, N. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span> <span> </span><span class="NLM_article-title">Exploring the “RPRL” Motif of Apelin-13 through Molecular Simulation and Biological Evaluation of Cyclic Peptide Analogues</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1002%2Fcmdc.201000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=20486151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptl2jur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1247-1253&author=N.+J.+M.+Macalusoauthor=R.+C.+Glen&title=Exploring+the+%E2%80%9CRPRL%E2%80%9D+Motif+of+Apelin-13+through+Molecular+Simulation+and+Biological+Evaluation+of+Cyclic+Peptide+Analogues&doi=10.1002%2Fcmdc.201000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the RPRL' Motif of Apelin-13 through Molecular Simulation and Biological Evaluation of Cyclic Peptide Analogues</span></div><div class="casAuthors">Macaluso, N. J. Maximilian; Glen, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1247-1253</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Structural and binding-affinity studies on N-terminal fragments of apelin-13, either linear or cyclic, have not been performed.  Without exptl.-derived coordinates of apelin bound to the active APJ receptor, how can we know that a β-turn at the RPRL sequence is indeed important for ligand recognition in APJ receptor binding To address this question, we designed four novel cyclic peptide analogs of apelin-13 from the first nine residues of the natural sequence.  This result reveals the importance of conformation, namely the β-turn at the RPRL sequence, in apelin receptor ligand recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0cuIWzSe9SrVg90H21EOLACvtfcHk0li3PkYtwB2bfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptl2jur4%253D&md5=a57328da2633e223b154dcb8461141ec</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000061%26sid%3Dliteratum%253Aachs%26aulast%3DMacaluso%26aufirst%3DN.%2BJ.%2BM.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DExploring%2520the%2520%25E2%2580%259CRPRL%25E2%2580%259D%2520Motif%2520of%2520Apelin-13%2520through%2520Molecular%2520Simulation%2520and%2520Biological%2520Evaluation%2520of%2520Cyclic%2520Peptide%2520Analogues%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1247%26epage%3D1253%26doi%3D10.1002%2Fcmdc.201000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Murza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karadereye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, É.</span></span> <span> </span><span class="NLM_article-title">Elucidation of the Structure-activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma Stability</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1002%2Fcmdc.201100492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=22170700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=318-325&author=A.+Murzaauthor=A.+Parentauthor=E.+Besserer-Offroyauthor=H.+Tremblayauthor=F.+Karadereyeauthor=N.+Beaudetauthor=R.+Leducauthor=P.+Sarretauthor=%C3%89.+Marsault&title=Elucidation+of+the+Structure-activity+Relationships+of+Apelin%3A+Influence+of+Unnatural+Amino+Acids+on+Binding%2C+Signaling%2C+and+Plasma+Stability&doi=10.1002%2Fcmdc.201100492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of the Structure-Activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma Stability</span></div><div class="casAuthors">Murza, Alexandre; Parent, Alexandre; Besserer-Offroy, Elie; Tremblay, Hugo; Karadereye, Felix; Beaudet, Nicolas; Leduc, Richard; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-325</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of the APJ receptor, a member of the G-protein-coupled receptor family.  The apelin-APJ complex has been detected in many tissues and is emerging as a promising target for several pathophysiol. conditions.  There is currently little information on the structure-activity relationship (SAR) of the apelin hormone.  In an effort to better delineate SAR, we synthesized analogs of apelin-13 modified at selected positions with unnatural amino acids, with a particular emphasis on the C-terminal portion.  Analogs were then tested in binding and functional assays by evaluating Gi/o-mediated decreases in cAMP levels and by assessing β-arrestin2 recruitment to the APJ receptor.  The plasma stability of new compds. was also assessed.  Several analogs were found to possess increased binding and higher stability than the parent peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb17rjHTl2IrVg90H21EOLACvtfcHk0li3PkYtwB2bfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgur%252FL&md5=01202090f34b4a1933a0a3045cdf5763</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100492%26sid%3Dliteratum%253Aachs%26aulast%3DMurza%26aufirst%3DA.%26aulast%3DParent%26aufirst%3DA.%26aulast%3DBesserer-Offroy%26aufirst%3DE.%26aulast%3DTremblay%26aufirst%3DH.%26aulast%3DKaradereye%26aufirst%3DF.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3D%25C3%2589.%26atitle%3DElucidation%2520of%2520the%2520Structure-activity%2520Relationships%2520of%2520Apelin%253A%2520Influence%2520of%2520Unnatural%2520Amino%2520Acids%2520on%2520Binding%252C%2520Signaling%252C%2520and%2520Plasma%2520Stability%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D318%26epage%3D325%26doi%3D10.1002%2Fcmdc.201100492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhungana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span></span> <span> </span><span class="NLM_article-title">Identifying Structural Determinants of Potency for Analogs of Apelin-13: Integration of C-terminal Truncation with Structure-activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2992</span>– <span class="NLM_lpage">2997</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bmc.2014.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=24755525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2992-2997&author=Y.+Zhangauthor=R.+Maitraauthor=D.+L.+Harrisauthor=S.+Dhunganaauthor=R.+Snyderauthor=S.+P.+Runyon&title=Identifying+Structural+Determinants+of+Potency+for+Analogs+of+Apelin-13%3A+Integration+of+C-terminal+Truncation+with+Structure-activity&doi=10.1016%2Fj.bmc.2014.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure-activity</span></div><div class="casAuthors">Zhang, Yanyan; Maitra, Rangan; Harris, Danni L.; Dhungana, Suraj; Snyder, Rodney; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2992-2997</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apelin peptides function as endogenous ligands of the APJ receptor and have been implicated in a no. of important biol. processes.  While several apelinergic peptides have been reported, apelin-13 (Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe) remains the most commonly studied and reported ligand of APJ.  This study examines the effect of C-terminal peptide truncations and comprehensive structure-activity relationship (SAR) for a series of analogs based on apelin-13 to develop more potent and stable analogs.  C-terminal truncation studies identified apelin-13 (N-acetyl 2-11) amide as a potent agonist (EC50 = 4.4 nM).  Comprehensive SAR studies also detd. that Arg 2, Leu 5, Lys 8, Met 11, were key positions for detg. agonist potency, whereas the hydrophobic vol. of Lys-8 was a specific determinate of activity.  Plasma stability studies on the truncated 10-mer peptide (EC50 = 33 nM) indicated the primary sites of cleavage occurred between Nle 3 and Leu 4 and also between Ala 5 and Ala-6.  These new ligands represent the shortest known apelin peptides with good functional potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvVQ3Bxd0D_bVg90H21EOLACvtfcHk0ljX0nlw6PIvnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCmurg%253D&md5=6f04420714d191792dd27d43796d886d</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DD.%2BL.%26aulast%3DDhungana%26aufirst%3DS.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DIdentifying%2520Structural%2520Determinants%2520of%2520Potency%2520for%2520Analogs%2520of%2520Apelin-13%253A%2520Integration%2520of%2520C-terminal%2520Truncation%2520with%2520Structure-activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2992%26epage%3D2997%26doi%3D10.1016%2Fj.bmc.2014.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Iturriox, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvear-Perez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mota, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabire, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Jouan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabane, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerbier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdeaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maigret, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galzi, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llorens-Cortes, C.</span></span> <span> </span><span class="NLM_article-title">Identification and Pharmacological Properties of E339-3D6, the First Nonpeptidic Apelin Receptor Agonist</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1506</span>– <span class="NLM_lpage">1516</span>, <span class="refDoi"> DOI: 10.1096/fj.09-140715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1096%2Ffj.09-140715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=20040517" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=1506-1516&author=X.+Iturrioxauthor=R.+Alvear-Perezauthor=N.+De+Motaauthor=C.+Franchetauthor=F.+Guillierauthor=V.+Lerouxauthor=H.+Dabireauthor=M.+Le+Jouanauthor=H.+Chabaneauthor=R.+Gerbierauthor=D.+Bonnetauthor=A.+Berdeauxauthor=B.+Maigretauthor=J.-L.+Galziauthor=M.+Hibertauthor=C.+Llorens-Cortes&title=Identification+and+Pharmacological+Properties+of+E339-3D6%2C+the+First+Nonpeptidic+Apelin+Receptor+Agonist&doi=10.1096%2Ffj.09-140715"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1096%2Ffj.09-140715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.09-140715%26sid%3Dliteratum%253Aachs%26aulast%3DIturriox%26aufirst%3DX.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DFranchet%26aufirst%3DC.%26aulast%3DGuillier%26aufirst%3DF.%26aulast%3DLeroux%26aufirst%3DV.%26aulast%3DDabire%26aufirst%3DH.%26aulast%3DLe%2BJouan%26aufirst%3DM.%26aulast%3DChabane%26aufirst%3DH.%26aulast%3DGerbier%26aufirst%3DR.%26aulast%3DBonnet%26aufirst%3DD.%26aulast%3DBerdeaux%26aufirst%3DA.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DGalzi%26aufirst%3DJ.-L.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520Pharmacological%2520Properties%2520of%2520E339-3D6%252C%2520the%2520First%2520Nonpeptidic%2520Apelin%2520Receptor%2520Agonist%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D1506%26epage%3D1516%26doi%3D10.1096%2Ffj.09-140715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, P.</span>; <span class="NLM_string-name">Maloney, P. R.</span>; <span class="NLM_string-name">Hedrick, M.</span>; <span class="NLM_string-name">Gosalia, P.</span>; <span class="NLM_string-name">Milewski, M.</span>; <span class="NLM_string-name">Li, L.</span>; <span class="NLM_string-name">Roth, G. R.</span>; <span class="NLM_string-name">Sergienko, E.</span>; <span class="NLM_string-name">Suyama, E.</span>; <span class="NLM_string-name">Sugarman, E.</span>; <span class="NLM_string-name">Nguyen, K.</span>; <span class="NLM_string-name">Mehta, A.</span>; <span class="NLM_string-name">Vasile, S.</span>; <span class="NLM_string-name">Su, Y.</span>; <span class="NLM_string-name">Shi, S.</span>; <span class="NLM_string-name">Stonich, D.</span>; <span class="NLM_string-name">Nguyen, H.</span>; <span class="NLM_string-name">Zeng, F.-Y.</span>; <span class="NLM_string-name">Novo, A. M.</span>; <span class="NLM_string-name">Vicchiarelli, M.</span>; <span class="NLM_string-name">Diwan, J.</span>; <span class="NLM_string-name">Chung, T. D. Y.</span>; <span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Smith, L. H.</span></span> <i>Functional Agonists of the Apelin (APJ) Receptor</i>. Sanford Burnham Center for Chemical Genomics Probe Report. <span class="NLM_year">2011</span>; <a href="http://www.ncbi.nlm.nih.gov/books/NBK98921/" class="extLink">http://www.ncbi.nlm.nih.gov/books/NBK98921/</a> (accessed Oct 28, <span class="NLM_year">2019</span>);</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+Khan&author=P.+R.+Maloney&author=M.+Hedrick&author=P.+Gosalia&author=M.+Milewski&author=L.+Li&author=G.+R.+Roth&author=E.+Sergienko&author=E.+Suyama&author=E.+Sugarman&author=K.+Nguyen&author=A.+Mehta&author=S.+Vasile&author=Y.+Su&author=S.+Shi&author=D.+Stonich&author=H.+Nguyen&author=F.-Y.+Zeng&author=A.+M.+Novo&author=M.+Vicchiarelli&author=J.+Diwan&author=T.+D.+Y.+Chung&author=A.+B.+Pinkerton&author=L.+H.+Smith&title=Functional+Agonists+of+the+Apelin+%28APJ%29+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DP.%26jtitle%3DFunctional%2520Agonists%2520of%2520the%2520Apelin%2520%2528APJ%2529%2520Receptor%26date%3D2011%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hachtel, S.</span>; <span class="NLM_string-name">Wohlfart, P.</span>; <span class="NLM_string-name">Weston, J.</span>; <span class="NLM_string-name">Mueller, M.</span>; <span class="NLM_string-name">Defossa, E.</span>; <span class="NLM_string-name">Mertsch, K.</span>; <span class="NLM_string-name">Weng, J.-H.</span>; <span class="NLM_string-name">Binnie, R. A.</span>; <span class="NLM_string-name">Abdul-Latif, F.</span>; <span class="NLM_string-name">Bock, W. J.</span>; <span class="NLM_string-name">Walser, A.</span></span> <span> </span><span class="NLM_article-title">Benzoimidazole-carboxylic Acid Amide Derivatives as APJ Receptor Modulators</span>. PCT Int. Appl. <span class="NLM_patent">WO2014044738A1</span>, <span class="NLM_year">2014</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Hachtel&author=P.+Wohlfart&author=J.+Weston&author=M.+Mueller&author=E.+Defossa&author=K.+Mertsch&author=J.-H.+Weng&author=R.+A.+Binnie&author=F.+Abdul-Latif&author=W.+J.+Bock&author=A.+Walser&title=Benzoimidazole-carboxylic+Acid+Amide+Derivatives+as+APJ+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHachtel%26aufirst%3DS.%26atitle%3DBenzoimidazole-carboxylic%2520Acid%2520Amide%2520Derivatives%2520as%2520APJ%2520Receptor%2520Modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Smith, L. H.</span></span> <span> </span><span class="NLM_article-title">Agonists of the Apelin Receptor and Methods of Use</span>. <span class="NLM_patent">WO2015184011A2</span>, <span class="NLM_year">2015</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+B.+Pinkerton&author=L.+H.+Smith&title=Agonists+of+the+Apelin+Receptor+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26atitle%3DAgonists%2520of%2520the%2520Apelin%2520Receptor%2520and%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span>; <span class="NLM_string-name">Maitra, R.</span>; <span class="NLM_string-name">Narayanan, S.</span>; <span class="NLM_string-name">Thomas, J. B.</span></span> <span> </span><span class="NLM_article-title">Preparation of Imidazolecarboxylic Acid Amino Acid and Peptide Amides as Apelin Receptor Agonists and Uses thereof</span>. <span class="NLM_patent">WO2015188073A1</span>, <span class="NLM_year">2015</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+P.+Runyon&author=R.+Maitra&author=S.+Narayanan&author=J.+B.+Thomas&title=Preparation+of+Imidazolecarboxylic+Acid+Amino+Acid+and+Peptide+Amides+as+Apelin+Receptor+Agonists+and+Uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DPreparation%2520of%2520Imidazolecarboxylic%2520Acid%2520Amino%2520Acid%2520and%2520Peptide%2520Amides%2520as%2520Apelin%2520Receptor%2520Agonists%2520and%2520Uses%2520thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortoff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasukuttan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Small Molecule Agonist Scaffold for the APJ Receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3758</span>– <span class="NLM_lpage">3770</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bmc.2016.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=27369451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOntLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3758-3770&author=S.+Narayananauthor=R.+Maitraauthor=J.+R.+Deschampsauthor=K.+Bortoffauthor=J.+B.+Thomasauthor=Y.+Zhangauthor=K.+Warnerauthor=V.+Vasukuttanauthor=A.+Deckerauthor=S.+P.+Runyon&title=Discovery+of+a+Novel+Small+Molecule+Agonist+Scaffold+for+the+APJ+Receptor&doi=10.1016%2Fj.bmc.2016.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10fR"><div class="casContent"><span class="casTitleNuber">10f</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel small molecule agonist scaffold for the APJ receptor</span></div><div class="casAuthors">Narayanan, Sanju; Maitra, Rangan; Deschamps, Jeffery R.; Bortoff, Katherine; Thomas, James B.; Zhang, Yanyan; Warner, Keith; Vasukuttan, Vineetha; Decker, Ann; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3758-3770</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The apelinergic system includes a series of endogenous peptides apelin, ELABELA/TODDLER and their 7-transmembrane G-protein coupled apelin receptor (APJ, AGTRL-1, APLNR).  The APJ receptor is an attractive therapeutic target because of its involvement in cardiovascular diseases and potentially other disorders including liver fibrosis, obesity, diabetes, and neuroprotection.  To date, pharmacol. characterization of the APJ receptor has been limited due to the lack of small mol. functional agonists or antagonists.  Through focused screening we identified a drug-like small mol. agonist hit 1 with a functional EC50 value of 21.5 ± 5 μM and binding affinity (Ki) of 5.2 ± 0.5 μM.  Initial structure-activity studies afforded compd. 22 having a 27-fold enhancement in potency and the first sub-micromolar full agonist with an EC50 value of 800 ± 0.1 nM and Ki of 1.3 ± 0.3 μM.  Preliminary SAR, synthetic methodol., and in vitro pharmacol. characterization indicate this scaffold will serve as a favorable starting point for further refinement of APJ potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol6Pre0xFpRbVg90H21EOLACvtfcHk0lhpKBAZBjbKMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOntLnK&md5=5732daf586e08076db669b2e9aca1602</span></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DBortoff%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWarner%26aufirst%3DK.%26aulast%3DVasukuttan%26aufirst%3DV.%26aulast%3DDecker%26aufirst%3DA.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Small%2520Molecule%2520Agonist%2520Scaffold%2520for%2520the%2520APJ%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3758%26epage%3D3770%26doi%3D10.1016%2Fj.bmc.2016.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Read, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuc, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, A. P.</span></span> <span> </span><span class="NLM_article-title">Cardiac Action of the First G protein Biased Small Molecule Apelin Agonist</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2016.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bcp.2016.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=27475715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1GhtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=63-72&author=C.+Readauthor=C.+M.+Fitzpatrickauthor=P.+Yangauthor=R.+E.+Kucauthor=J.+J.+Maguireauthor=R.+C.+Glenauthor=R.+E.+Fosterauthor=A.+P.+Davenport&title=Cardiac+Action+of+the+First+G+protein+Biased+Small+Molecule+Apelin+Agonist&doi=10.1016%2Fj.bcp.2016.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10gR"><div class="casContent"><span class="casTitleNuber">10g</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac action of the first G protein biased small molecule apelin agonist</span></div><div class="casAuthors">Read, Cai; Fitzpatrick, Christopher M.; Yang, Peiran; Kuc, Rhoda E.; Maguire, Janet J.; Glen, Robert C.; Foster, Richard E.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apelin peptide analogs displaying bias towards G protein signalling pathways have beneficial cardiovascular actions compared with the native peptide in humans in vivo.  Our aim was to det. whether small mol. agonists could retain G protein bias.  We have identified a biased small mol., CMF-019 (I), and characterised it in vitro and in vivo.  In competition radioligand binding expts. in heart homogenates, CMF-019 bound to the human, rat and mouse apelin receptor with high affinity (pKi = 8.58 ± 0.04, 8.49 ± 0.04 and 8.71 ± 0.06 resp.).  In cell-based functional assays, whereas, CMF-019 showed similar potency for the Gαi pathway to the endogenous agonist [Pyr1]apelin-13 (pD2 = 10.00 ± 0.13 vs 9.34 ± 0.15), in β-arrestin and internalisation assays it was less potent (pD2 = 6.65 ± 0.15 vs 8.65 ± 0.10 and pD2 = 6.16 ± 0.21 vs 9.28 ± 0.10 resp.).  Anal. of these data demonstrated a bias of ∼400 for the Gαi over the β-arrestin pathway and ∼6000 over receptor internalisation.  CMF-019 was tested for in vivo activity using i.v. injections into anesthetized male Sprague-Dawley rats fitted with a pressure-vol. catheter in the left ventricle.  CMF-019 caused a significant increase in cardiac contractility of 606 ± 112 mmHg/s (p < 0.001) at 500 nmol.  CMF-019 is the first biased small mol. identified at the apelin receptor and increases cardiac contractility in vivo.  We have demonstrated that Gαi over β-arrestin/internalisation bias can be retained in a non-peptide analog and predict that such bias will have the therapeutic benefit following chronic use.  CMF-019 is suitable as a tool compd. and provides the basis for design of biased agonists with improved pharmacokinetics for treatment of cardiovascular conditions such as pulmonary arterial hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqmJ0WndHEdLVg90H21EOLACvtfcHk0lhpKBAZBjbKMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1GhtbnJ&md5=0a2ba0ccb57382ceda2e0d27ff46c61e</span></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2016.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2016.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DRead%26aufirst%3DC.%26aulast%3DFitzpatrick%26aufirst%3DC.%2BM.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DKuc%26aufirst%3DR.%2BE.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DFoster%26aufirst%3DR.%2BE.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DCardiac%2520Action%2520of%2520the%2520First%2520G%2520protein%2520Biased%2520Small%2520Molecule%2520Apelin%2520Agonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2016%26volume%3D116%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.bcp.2016.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span>; <span class="NLM_string-name">Kim, S.-H.</span>; <span class="NLM_string-name">Lawrence, R. M.</span>; <span class="NLM_string-name">Myers, M. C.</span>; <span class="NLM_string-name">Chao, H. J.</span>; <span class="NLM_string-name">Phillips, M.</span>; <span class="NLM_string-name">Jiang, J.</span></span> <span> </span><span class="NLM_article-title">Preparation of 4-Hydroxy-3-(heteroaryl)pyridine-2-one APJ Agonists for Use in the Treatment of Cardiovascular Disorders</span>. <span class="NLM_patent">WO2016196771A1</span>, <span class="NLM_year">2016</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+A.+Johnson&author=S.-H.+Kim&author=R.+M.+Lawrence&author=M.+C.+Myers&author=H.+J.+Chao&author=M.+Phillips&author=J.+Jiang&title=Preparation+of+4-Hydroxy-3-%28heteroaryl%29pyridine-2-one+APJ+Agonists+for+Use+in+the+Treatment+of+Cardiovascular+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DPreparation%2520of%25204-Hydroxy-3-%2528heteroaryl%2529pyridine-2-one%2520APJ%2520Agonists%2520for%2520Use%2520in%2520the%2520Treatment%2520of%2520Cardiovascular%2520Disorders%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Holder, J. R.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Miranda, L. P.</span>; <span class="NLM_string-name">Aral, J.</span>; <span class="NLM_string-name">Doherty, E. M.</span>; <span class="NLM_string-name">Nixey, T.</span></span> <span> </span><span class="NLM_article-title">APJ Receptor Agonists and Uses thereof</span>. U.S. Patent <span class="NLM_patent">20,160,067,347 A1</span>, <span class="NLM_year">2016</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+R.+Holder&author=G.+Swaminath&author=L.+P.+Miranda&author=J.+Aral&author=E.+M.+Doherty&author=T.+Nixey&title=APJ+Receptor+Agonists+and+Uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolder%26aufirst%3DJ.%2BR.%26atitle%3DAPJ%2520Receptor%2520Agonists%2520and%2520Uses%2520thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span>; <span class="NLM_string-name">Maitra, R.</span>; <span class="NLM_string-name">Narayanan, S.</span>; <span class="NLM_string-name">Thomas, J. B.</span>; <span class="NLM_string-name">Rehder, K. S.</span>; <span class="NLM_string-name">Olepu, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted Pyrazoles as Improved Apelin Receptor (APJ) Agonists and Uses thereof</span>. <span class="NLM_patent">WO2017100558A1</span>, <span class="NLM_year">2017</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+P.+Runyon&author=R.+Maitra&author=S.+Narayanan&author=J.+B.+Thomas&author=K.+S.+Rehder&author=S.+Olepu&title=Preparation+of+Substituted+Pyrazoles+as+Improved+Apelin+Receptor+%28APJ%29+Agonists+and+Uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DPreparation%2520of%2520Substituted%2520Pyrazoles%2520as%2520Improved%2520Apelin%2520Receptor%2520%2528APJ%2529%2520Agonists%2520and%2520Uses%2520thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Connors, R. V.</span>; <span class="NLM_string-name">Debenedetto, M. V.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Fu, Z.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Hedley, S. J.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Judd, T. C.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Olson, S. H.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Yeh, W.-C.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Triazole Compounds as Agonists of the APJ Receptor</span>. <span class="NLM_patent">WO2017192485A1</span>, <span class="NLM_year">2017</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=X.+Chen&author=Y.+Chen&author=A.+C.+Cheng&author=R.+V.+Connors&author=M.+V.+Debenedetto&author=P.+J.+Dransfield&author=Z.+Fu&author=J.+S.+Harvey&author=J.+A.+Heath&author=S.+J.+Hedley&author=J.+Houze&author=T.+C.+Judd&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=N.+Nishimura&author=S.+H.+Olson&author=V.+Pattaropong&author=G.+Swaminath&author=X.+Wang&author=W.-C.+Yeh&title=Heterocyclic+Triazole+Compounds+as+Agonists+of+the+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26atitle%3DHeterocyclic%2520Triazole%2520Compounds%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Connors, R. V.</span>; <span class="NLM_string-name">Deignan, J.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Fu, Z.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Horne, D. B.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Kaller, M. R.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">McGee, L. R.</span>; <span class="NLM_string-name">Medina, J. C.</span>; <span class="NLM_string-name">Mihalic, J. T.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Olson, S. H.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Yang, K.</span>; <span class="NLM_string-name">Yeh, W.-C.</span>; <span class="NLM_string-name">Debenedetto, M. V.</span>; <span class="NLM_string-name">Farrell, R. P.</span>; <span class="NLM_string-name">Hedley, S. J.</span>; <span class="NLM_string-name">Judd, T. C.</span>; <span class="NLM_string-name">Kayser, F.</span></span> <span> </span><span class="NLM_article-title">Triazoles as Agonists of the APJ Receptor and their Preparation</span>. <span class="NLM_patent">WO2016187308A1</span>, <span class="NLM_year">2016</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+Chen&author=X.+Chen&author=Y.+Chen&author=A.+C.+Cheng&author=R.+V.+Connors&author=J.+Deignan&author=P.+J.+Dransfield&author=X.+Du&author=Z.+Fu&author=J.+A.+Heath&author=D.+B.+Horne&author=J.+Houze&author=M.+R.+Kaller&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=L.+R.+McGee&author=J.+C.+Medina&author=J.+T.+Mihalic&author=N.+Nishimura&author=S.+H.+Olson&author=V.+Pattaropong&author=G.+Swaminath&author=X.+Wang&author=K.+Yang&author=W.-C.+Yeh&author=M.+V.+Debenedetto&author=R.+P.+Farrell&author=S.+J.+Hedley&author=T.+C.+Judd&author=F.+Kayser&title=Triazoles+as+Agonists+of+the+APJ+Receptor+and+their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26atitle%3DTriazoles%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%2520and%2520their%2520Preparation%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span>; <span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Connors, R. V.</span>; <span class="NLM_string-name">Deignan, J.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Fu, Z.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Heumann, L. V.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Kayser, F.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Medina, J. C.</span>; <span class="NLM_string-name">Mihalic, J. T.</span>; <span class="NLM_string-name">Olson, S. H.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Wanska, M.</span>; <span class="NLM_string-name">Yeh, W.-C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Furanyl Triazoles as Agonists of the APJ Receptor</span>. <span class="NLM_patent">WO2018097944A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Brown&author=N.+Chen&author=X.+Chen&author=Y.+Chen&author=A.+C.+Cheng&author=R.+V.+Connors&author=J.+Deignan&author=P.+J.+Dransfield&author=X.+Du&author=Z.+Fu&author=J.+S.+Harvey&author=J.+A.+Heath&author=L.+V.+Heumann&author=J.+Houze&author=F.+Kayser&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=J.+C.+Medina&author=J.+T.+Mihalic&author=S.+H.+Olson&author=V.+Pattaropong&author=G.+Swaminath&author=X.+Wang&author=M.+Wanska&author=W.-C.+Yeh&title=Preparation+of+Furanyl+Triazoles+as+Agonists+of+the+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Furanyl%2520Triazoles%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Connors, R. V.</span>; <span class="NLM_string-name">Deignan, J.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Fu, Z.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Heumann, L. V.</span>; <span class="NLM_string-name">Horne, D. B.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Kaller, M. R.</span>; <span class="NLM_string-name">Kayser, F.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Medina, J. C.</span>; <span class="NLM_string-name">Mihalic, J. T.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Olson, S. H.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Wanska, M.</span>; <span class="NLM_string-name">Yang, K.</span>; <span class="NLM_string-name">Yeh, W.-C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Heteroaryl Triazoles as Agonists of the APJ Receptor</span>. <span class="NLM_patent">WO2018097945A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=N.+Chen&author=X.+Chen&author=Y.+Chen&author=A.+C.+Cheng&author=R.+V.+Connors&author=J.+Deignan&author=P.+J.+Dransfield&author=X.+Du&author=Z.+Fu&author=J.+S.+Harvey&author=J.+A.+Heath&author=L.+V.+Heumann&author=D.+B.+Horne&author=J.+Houze&author=M.+R.+Kaller&author=F.+Kayser&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=J.+C.+Medina&author=J.+T.+Mihalic&author=N.+Nishimura&author=S.+H.+Olson&author=V.+Pattaropong&author=G.+Swaminath&author=X.+Wang&author=M.+Wanska&author=K.+Yang&author=W.-C.+Yeh&title=Preparation+of+Heteroaryl+Triazoles+as+Agonists+of+the+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26atitle%3DPreparation%2520of%2520Heteroaryl%2520Triazoles%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Debenedetto, M. V.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Yeh, W.-C.</span>; <span class="NLM_string-name">Kreiman, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Triazole Phenyl Compounds as Agonists of APJ Receptor</span>. <span class="NLM_patent">WO2018093579A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=N.+Chen&author=Y.+Chen&author=M.+V.+Debenedetto&author=P.+J.+Dransfield&author=J.+S.+Harvey&author=J.+A.+Heath&author=J.+Houze&author=A.+Y.+Khakoo&author=S.-J.+Lai&author=Z.+Ma&author=N.+Nishimura&author=V.+Pattaropong&author=G.+Swaminath&author=W.-C.+Yeh&author=C.+Kreiman&title=Preparation+of+Triazole+Phenyl+Compounds+as+Agonists+of+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26atitle%3DPreparation%2520of%2520Triazole%2520Phenyl%2520Compounds%2520as%2520Agonists%2520of%2520APJ%2520Receptor%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Debenedetto, M. V.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Kreiman, C.</span>; <span class="NLM_string-name">Moebius, D. C.</span>; <span class="NLM_string-name">Sharma, A.</span></span> <span> </span><span class="NLM_article-title">Preparation of Triazole Pyridyl Compounds as Agonists of the APJ Receptor</span>. <span class="NLM_patent">WO2018093580A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Y.+Chen&author=A.+C.+Cheng&author=M.+V.+Debenedetto&author=P.+J.+Dransfield&author=J.+S.+Harvey&author=J.+Houze&author=A.+Y.+Khakoo&author=S.-J.+Lai&author=Z.+Ma&author=V.+Pattaropong&author=G.+Swaminath&author=C.+Kreiman&author=D.+C.+Moebius&author=A.+Sharma&title=Preparation+of+Triazole+Pyridyl+Compounds+as+Agonists+of+the+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520Triazole%2520Pyridyl%2520Compounds%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">DeBenedetto, M. V.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Yeh, W.-C.</span>; <span class="NLM_string-name">Ramsden, P. D.</span>; <span class="NLM_string-name">Sharma, A.</span></span> <span> </span><span class="NLM_article-title">Alkyl Substituted Triazole Compounds as Agonists of the APJ Receptor and their Preparation</span>. <span class="NLM_patent">WO2018093576A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Y.+Chen&author=M.+V.+DeBenedetto&author=P.+J.+Dransfield&author=J.+S.+Harvey&author=J.+Houze&author=A.+Y.+Khakoo&author=S.-J.+Lai&author=Z.+Ma&author=N.+Nishimura&author=V.+Pattaropong&author=G.+Swaminath&author=W.-C.+Yeh&author=P.+D.+Ramsden&author=A.+Sharma&title=Alkyl+Substituted+Triazole+Compounds+as+Agonists+of+the+APJ+Receptor+and+their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DAlkyl%2520Substituted%2520Triazole%2520Compounds%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%2520and%2520their%2520Preparation%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Yeh, W.-C.</span>; <span class="NLM_string-name">Ramsden, P. D.</span></span> <span> </span><span class="NLM_article-title">Cycloalkyl Substituted Triazole Compounds as Agonists of the APJ Receptor and Their Preparation</span>. <span class="NLM_patent">WO2018093577A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Y.+Chen&author=P.+J.+Dransfield&author=J.+S.+Harvey&author=J.+A.+Heath&author=J.+Houze&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=N.+Nishimura&author=V.+Pattaropong&author=G.+Swaminath&author=W.-C.+Yeh&author=P.+D.+Ramsden&title=Cycloalkyl+Substituted+Triazole+Compounds+as+Agonists+of+the+APJ+Receptor+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10r&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DCycloalkyl%2520Substituted%2520Triazole%2520Compounds%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%2520and%2520Their%2520Preparation%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span>; <span class="NLM_string-name">Maitra, R.</span>; <span class="NLM_string-name">Narayanan, S.</span>; <span class="NLM_string-name">Rehder, K. S.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Apelin Receptor (APJ) Agonists and Uses thereof</span>. <span class="NLM_patent">WO2018071526A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+P.+Runyon&author=R.+Maitra&author=S.+Narayanan&author=K.+S.+Rehder&title=Heterocyclic+Apelin+Receptor+%28APJ%29+Agonists+and+Uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DHeterocyclic%2520Apelin%2520Receptor%2520%2528APJ%2529%2520Agonists%2520and%2520Uses%2520thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10t"><span><span class="NLM_label">(t) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trifonov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palczewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshin, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruzman, A.</span></span> <span> </span><span class="NLM_article-title">An Expedient Synthesis of CMF-019: (S)-5-Methyl-3-{1-(pentan-3-yl)-2- (thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic Acid, a Potent Apelin Receptor (APJ) Agonist</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.2174/1573406414666180412154952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10t&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.2174%2F1573406414666180412154952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10t&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=29651942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10t&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOrtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=688-694&author=L.+Trifonovauthor=M.+Afriauthor=K.+Palczewskiauthor=E.+E.+Korshinauthor=A.+Gruzman&title=An+Expedient+Synthesis+of+CMF-019%3A+%28S%29-5-Methyl-3-%7B1-%28pentan-3-yl%29-2-+%28thiophen-2-ylmethyl%29-1H-benzo%5Bd%5Dimidazole-5-carboxamido%7Dhexanoic+Acid%2C+a+Potent+Apelin+Receptor+%28APJ%29+Agonist&doi=10.2174%2F1573406414666180412154952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10tR"><div class="casContent"><span class="casTitleNuber">10t</span><div class="casTitle"><span class="NLM_cas:atitle">An Expedient Synthesis of CMF-019: (S)-5-Methyl-3-{1-(pentan-3-yl)-2-(thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic Acid, a Potent Apelin Receptor (APJ) Agonist</span></div><div class="casAuthors">Trifonov, Lena; Afri, Michal; Palczewski, Krzysztof; Korshin, Edward E.; Gruzman, Arie</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">688-694</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Here, a detailed prepn. of (S)-5-methyl-3-{1-(pentan-3-yl)-2-(thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic acid (CMF-019) (I) through a modified and improved synthetic pathway was described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoomZkzMgjze7Vg90H21EOLACvtfcHk0liVmC9H4UwSrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOrtLbO&md5=3cb74ff0832e87edd877a443c5805bf8</span></div><a href="/servlet/linkout?suffix=cit10t&amp;dbid=16384&amp;doi=10.2174%2F1573406414666180412154952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573406414666180412154952%26sid%3Dliteratum%253Aachs%26aulast%3DTrifonov%26aufirst%3DL.%26aulast%3DAfri%26aufirst%3DM.%26aulast%3DPalczewski%26aufirst%3DK.%26aulast%3DKorshin%26aufirst%3DE.%2BE.%26aulast%3DGruzman%26aufirst%3DA.%26atitle%3DAn%2520Expedient%2520Synthesis%2520of%2520CMF-019%253A%2520%2528S%2529-5-Methyl-3-%257B1-%2528pentan-3-yl%2529-2-%2520%2528thiophen-2-ylmethyl%2529-1H-benzo%255Bd%255Dimidazole-5-carboxamido%257Dhexanoic%2520Acid%252C%2520a%2520Potent%2520Apelin%2520Receptor%2520%2528APJ%2529%2520Agonist%26jtitle%3DMed.%2520Chem.%26date%3D2018%26volume%3D14%26spage%3D688%26epage%3D694%26doi%3D10.2174%2F1573406414666180412154952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Card, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapik, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, B.</span></span> <span> </span><span class="NLM_article-title">HTRF: A Technology Tailored for Drug Discovery—A Review of Theoretical Aspects and Recent Applications</span>. <i>Curr. Chem. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.2174/1875397300903010022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.2174%2F1875397300903010022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=20161833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=22-32&author=F.+Degorceauthor=A.+Cardauthor=S.+Sohauthor=E.+Trinquetauthor=G.+P.+Knapikauthor=B.+Xie&title=HTRF%3A+A+Technology+Tailored+for+Drug+Discovery%E2%80%94A+Review+of+Theoretical+Aspects+and+Recent+Applications&doi=10.2174%2F1875397300903010022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications</span></div><div class="casAuthors">Degorce, Francois; Card, Amy; Soh, Sharon; Trinquet, Eric; Knapik, Glenn P.; Xie, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HTRF (Homogeneous Time Resolved Fluorescence) is the most frequently used generic assay technol. to measure analytes in a homogenous format, which is the ideal platform used for drug target studies in high-throughput screening (HTS).  This technol. combines fluorescence resonance energy transfer technol. (FRET) with time-resolved measurement (TR).  In TR-FRET assays, a signal is generated through fluorescent resonance energy transfer between a donor and an acceptor mol. when in close proximity to each other.  Buffer and media interference is dramatically reduced by dual-wavelength detection, and the final signal is proportional to the extent of product formation.  The HTRF assay is usually sensitive and robust that can be miniaturized into the 384 and 1536-well plate formats.  This assay technol. has been applied to many antibody-based assays including GPCR signaling (cAMP and IP-One), kinases, cytokines and biomarkers, bioprocess (antibody and protein prodn.), as well as the assays for protein-protein, protein-peptide, and protein-DNA/RNA interactions.  Since its introduction to the drug-screening world over ten years ago, researchers have used HTRF to expedite the study of GPCRs, kinases, new biomarkers, protein-protein interactions, and other targets of interest.  HTRF has also been utilized as an alternative method for bioprocess monitoring.  The first-generation HTRF technol., which uses Europium cryptate as a fluorescence donor to monitor reactions between biomols., was extended in 2008 through the introduction of a second-generation donor, Terbium cryptate (Tb), enhancing screening performance.  Terbium cryptate possesses different photophys. properties compared to Europium, including increased quantum yield and a higher molar extinction coeff.  In addn. to being compatible with the same acceptor fluorophors used with Europium, it can serve as a donor fluorophore to green-emitting fluors because it has multiple emission peaks including one at 490 nm.  Moreover, all Terbium HTRF assays can be read on the same HTRF-compatible instruments as Europium HTRF assays.  Overall, HTRF is a highly sensitive, robust technol. for the detection of mol. interactions in vitro and is widely used for primary and secondary screening phases of drug development.  This review addresses the general principles of HTRF and its current applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKDP8Vd8k247Vg90H21EOLACvtfcHk0liVmC9H4UwSrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D&md5=9590149ceeed17ce424522ef85aa32f9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1875397300903010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397300903010022%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DF.%26aulast%3DCard%26aufirst%3DA.%26aulast%3DSoh%26aufirst%3DS.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DKnapik%26aufirst%3DG.%2BP.%26aulast%3DXie%26aufirst%3DB.%26atitle%3DHTRF%253A%2520A%2520Technology%2520Tailored%2520for%2520Drug%2520Discovery%25E2%2580%2594A%2520Review%2520of%2520Theoretical%2520Aspects%2520and%2520Recent%2520Applications%26jtitle%3DCurr.%2520Chem.%2520Genomics%26date%3D2009%26volume%3D3%26spage%3D22%26epage%3D32%26doi%3D10.2174%2F1875397300903010022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bondensgaard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ankersen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thøgersen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulff, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bywater, R. P.</span></span> <span> </span><span class="NLM_article-title">Recognition of Privileged Structures by G-Protein Coupled Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1021/jm0309452</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0309452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFyjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=888-899&author=K.+Bondensgaardauthor=M.+Ankersenauthor=H.+Th%C3%B8gersenauthor=B.+S.+Hansenauthor=B.+S.+Wulffauthor=R.+P.+Bywater&title=Recognition+of+Privileged+Structures+by+G-Protein+Coupled+Receptors&doi=10.1021%2Fjm0309452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recognition of Privileged Structures by G-Protein Coupled Receptors</span></div><div class="casAuthors">Bondensgaard, Kent; Ankersen, Michael; Thogersen, Henning; Hansen, Birgit S.; Wulff, Birgitte S.; Bywater, Robert P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">888-899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Privileged structures are ligand substructures that are widely used to generate high-affinity ligands for more than one type of receptor.  To explain this, we surmised that there must be some common feature in the target proteins.  For a set of class A GPCRs, we found a good correlation between conservation patterns of residues in the ligand binding pocket and the privileged structure fragments in class A GPCR ligands.  A major part of interior surface of the common ligand binding pocket of class A receptors, identified in many GPCRs, is lined with variable residues that are responsible for selectivity in ligand recognition, while other regions, typically located deeper into the binding pocket, are more conserved and retain a predominantly hydrophobic and arom. character.  The latter is reflected in the chem. nature of most GPCR privileged structures and is proposed to be the common feature that is recognized by the privileged structures.  Further, we find that this subpocket is conserved even in distant orthologs within the class A family.  Three pairs of ligands recognizing widely different receptor types were docked into receptor models of their target receptors utilizing available structure- activity relationships and mutagenesis data.  For each pair of ligands, the ligand-receptor complexes reveal that the nature of the privileged structure binding pocket is conserved between the two complexes, in support of our hypothesis.  Only part of the privileged structures can be accommodated within the conserved subpocket.  Some contacts are established between the privileged structure and the nonconserved parts of the binding pocket.  This implies that any one particular privileged structure can target only a subset of receptors, those complementary to the full privileged structure.  Our hypothesis leads to a valuable novelty in that ligand libraries can be designed without any foreknowledge of the structure of the endogenous ligand, which in turn means that even orphan receptors can in principle now be addressed as potential drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodmGlCbtYqNLVg90H21EOLACvtfcHk0lhmt5Sxew7ivg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFyjsg%253D%253D&md5=9640167e22644d2a79e2577bb2542ab8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm0309452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309452%26sid%3Dliteratum%253Aachs%26aulast%3DBondensgaard%26aufirst%3DK.%26aulast%3DAnkersen%26aufirst%3DM.%26aulast%3DTh%25C3%25B8gersen%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DB.%2BS.%26aulast%3DWulff%26aufirst%3DB.%2BS.%26aulast%3DBywater%26aufirst%3DR.%2BP.%26atitle%3DRecognition%2520of%2520Privileged%2520Structures%2520by%2520G-Protein%2520Coupled%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D888%26epage%3D899%26doi%3D10.1021%2Fjm0309452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Compared to the activation by (Pyr<sup>1</sup>)apelin-13 (<b>1</b>) which was set at 100%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niimi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigenaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai-Moritani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, S.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Activity of Selective and Orally Available TF/FVIIa Complex Inhibitors Containing Non-amidine P1 Ligands</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bmc.2006.09.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=17064913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=160-173&author=M.+Miuraauthor=N.+Sekiauthor=T.+Koikeauthor=T.+Ishiharaauthor=T.+Niimiauthor=F.+Hirayamaauthor=T.+Shigenagaauthor=Y.+Sakai-Moritaniauthor=A.+Tagawaauthor=T.+Kawasakiauthor=S.+Sakamotoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamoto&title=Design%2C+Synthesis+and+Biological+Activity+of+Selective+and+Orally+Available+TF%2FFVIIa+Complex+Inhibitors+Containing+Non-amidine+P1+Ligands&doi=10.1016%2Fj.bmc.2006.09.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands</span></div><div class="casAuthors">Miura, Masanori; Seki, Norio; Koike, Takanori; Ishihara, Tsukasa; Niimi, Tatsuya; Hirayama, Fukushi; Shigenaga, Takeshi; Sakai-Moritani, Yumiko; Tagawa, Ayako; Kawasaki, Tomihisa; Sakamoto, Shuichi; Okada, Minoru; Ohta, Mitsuaki; Tsukamoto, Shin-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">160-173</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We found the novel selective and orally available non-amidine TF/FVIIa complex inhibitor 21e (I), 4-({[(1S)-(aminocarbonyl)-3-methylbutyl]amino}carbonyl)-2'-({[4- (aminomethyl)phenyl]amino}carbonyl)-4'-(methylamino)biphenyl-2-carboxylic acid.  The derivs. were synthesized by conversions of the iso-Bu moiety and the introduction of alkylamino groups to 4'-position of the central Ph ring of compds. 2a and 2b reported previously.  Some compds. show increased in vitro anti-TF/FVIIa and PT prolongation activities.  Among them, compd. 21e reached and sustained micromolar plasma concn. levels of up to 2 h after oral administration in mice.  Moreover, compd. 21e did not prolong the bleeding time even at the highest dose level in cynomolgus monkeys, while PT was prolonged 3.7-fold increases at this dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeyYBTGFY_DbVg90H21EOLACvtfcHk0lhmt5Sxew7ivg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrbM&md5=5349b8f0727b66611a9fb43f04aa0365</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.071%26sid%3Dliteratum%253Aachs%26aulast%3DMiura%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DNiimi%26aufirst%3DT.%26aulast%3DHirayama%26aufirst%3DF.%26aulast%3DShigenaga%26aufirst%3DT.%26aulast%3DSakai-Moritani%26aufirst%3DY.%26aulast%3DTagawa%26aufirst%3DA.%26aulast%3DKawasaki%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Activity%2520of%2520Selective%2520and%2520Orally%2520Available%2520TF%252FFVIIa%2520Complex%2520Inhibitors%2520Containing%2520Non-amidine%2520P1%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D160%26epage%3D173%26doi%3D10.1016%2Fj.bmc.2006.09.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_001.pdf" class="ext-link">Supporting Information</a> for detail.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Unpublished results.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span> <span> </span><span class="NLM_article-title">Atropisomerism, Biphenyls, and Fluorine: A Comparison of Rotational Barriers and Twist Angles</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1002/cbic.200300906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1002%2Fcbic.200300906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=15122636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFeqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=644-649&author=F.+Leroux&title=Atropisomerism%2C+Biphenyls%2C+and+Fluorine%3A+A+Comparison+of+Rotational+Barriers+and+Twist+Angles&doi=10.1002%2Fcbic.200300906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomerism, biphenyls, and fluorine: A comparison of rotational barriers and twist angles</span></div><div class="casAuthors">Leroux, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">644-649</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLmDoMA_ANbVg90H21EOLACvtfcHk0lhmt5Sxew7ivg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFeqtLY%253D&md5=5112533a436c00b58807fb23f8c169d3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200300906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200300906%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux%26aufirst%3DF.%26atitle%3DAtropisomerism%252C%2520Biphenyls%252C%2520and%2520Fluorine%253A%2520A%2520Comparison%2520of%2520Rotational%2520Barriers%2520and%2520Twist%2520Angles%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D644%26epage%3D649%26doi%3D10.1002%2Fcbic.200300906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span> <span> </span><span class="NLM_article-title">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7005</span>– <span class="NLM_lpage">7022</span>, <span class="refDoi"> DOI: 10.1021/jm200584g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200584g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7005-7022&author=S.+R.+LaPlanteauthor=L.+D.+Faderauthor=K.+R.+Fandrickauthor=D.+R.+Fandrickauthor=O.+Huckeauthor=R.+Kemperauthor=S.+P.+F.+Millerauthor=P.+J.+Edwards&title=Assessing+Atropisomer+Axial+Chirality+in+Drug+Discovery+and+Development&doi=10.1021%2Fjm200584g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span></div><div class="casAuthors">LaPlante, Steven R.; Fader, Lee D.; Fandrick, Keith R.; Fandrick, Daniel R.; Hucke, Oliver; Kemper, Ray; Miller, Stephen P. F.; Edwards, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7005-7022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ8uS-SDx68bVg90H21EOLACvtfcHk0ljdqp8ztvnpeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN&md5=6b44135b3871d2460fba4b3246b899e3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm200584g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200584g%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DFandrick%26aufirst%3DK.%2BR.%26aulast%3DFandrick%26aufirst%3DD.%2BR.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DKemper%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DS.%2BP.%2BF.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26atitle%3DAssessing%2520Atropisomer%2520Axial%2520Chirality%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7005%26epage%3D7022%26doi%3D10.1021%2Fjm200584g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bátkai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span> <span> </span><span class="NLM_article-title">Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1422</span>– <span class="NLM_lpage">1434</span>, <span class="refDoi"> DOI: 10.1038/nprot.2008.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1038%2Fnprot.2008.138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=18772869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1422-1434&author=P.+Pacherauthor=T.+Nagayamaauthor=P.+Mukhopadhyayauthor=S.+B%C3%A1tkaiauthor=D.+A.+Kass&title=Measurement+of+cardiac+function+using+pressure-volume+conductance+catheter+technique+in+mice+and+rats&doi=10.1038%2Fnprot.2008.138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats</span></div><div class="casAuthors">Pacher, Pal; Nagayama, Takahiro; Mukhopadhyay, Partha; Batkai, Sandor; Kass, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1422-1434</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ventricular pressure-vol. relationships have become well established as the most rigorous and comprehensive ways to assess intact heart function.  Thanks to advances in miniature sensor technol., this approach has been successfully translated to small rodents, allowing for detailed characterization of cardiovascular function in genetically engineered mice, testing effects of pharmacotherapies and studying disease conditions.  This method is unique for providing measures of left ventricular (LV) performance that are more specific to the heart and less affected by vascular loading conditions.  Here we present descriptions and movies for procedures employing this method (anesthesia, intubation and surgical techniques, calibrations).  We also provide examples of hemodynamics measurements obtained from normal mice/rats, and from animals with cardiac hypertrophy/heart failure, and describe values for various useful load-dependent and load-independent indexes of LV function obtained using different types of anesthesia.  The completion of the protocol takes 1-4 h (depending on the exptl. design/end points).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcTELjk9tJALVg90H21EOLACvtfcHk0ljdqp8ztvnpeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsL7M&md5=c45c214702bd92ba67e38bfaa564ad54</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.138%26sid%3Dliteratum%253Aachs%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DMeasurement%2520of%2520cardiac%2520function%2520using%2520pressure-volume%2520conductance%2520catheter%2520technique%2520in%2520mice%2520and%2520rats%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D1422%26epage%3D1434%26doi%3D10.1038%2Fnprot.2008.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b','cit9c','cit9d'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e','cit10f','cit10g','cit10h','cit10i','cit10j','cit10k','cit10l','cit10m','cit10n','cit10o','cit10p','cit10q','cit10r','cit10s','cit10t'],'ref11':['cit11'],'ref12':['cit12'],'ref13':[],'ref14':['cit14'],'ref15':[],'ref16':[],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">James A. Johnson, Soong-Hoon Kim, Ji Jiang, Monique Phillips, William A. Schumacher, Jeffrey S. Bostwick, Peter S. Gargalovic, Joelle M. Onorato, Chiuwa E. Luk, Claudia Generaux, Yan He, Xue-Qing Chen, Carrie Xu, Michael A. Galella, Tao Wang, David A. Gordon, Ruth R. Wexler, <span class="NLM_string-name hlFld-ContribAuthor">Heather J. Finlay</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3086-3099. <a href="https://doi.org/10.1021/acs.jmedchem.0c01878" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01878%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BHydroxypyridinone%252BAPJ%252BReceptor%252BAgonist%252Bas%252Ba%252BClinical%252BCandidate%26aulast%3DJohnson%26aufirst%3DJames%2BA.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29102020%26date%3D09032021%26volume%3D64%26issue%3D6%26spage%3D3086%26epage%3D3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Conrad  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of apelin receptor (APJR) modulators (2014-2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 251-261. <a href="https://doi.org/10.1080/13543776.2020.1731473" title="DOI URL">https://doi.org/10.1080/13543776.2020.1731473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1731473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1731473%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bapelin%252Breceptor%252B%252528APJR%252529%252Bmodulators%252B%2525282014-2019%252529%26aulast%3DFischer%26aufirst%3DConrad%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D251%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (Pyr<sup>1</sup>)apelin-13 and HTS hit.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Bis-Amides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-(trimethylsilyl)ethanol, NaH, toluene, 0–50 °C, 62%; (b) Tf<sub>2</sub>O, pyridine, DCM, 0 °C, 99%; (c) bis(pinacolato)diborane, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub>, KOAc, 1,4-dioxane, 65 °C, 96%; (d) PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene, H<sub>2</sub>O, 65 °C, 57%; (e) Zn, sat. NH<sub>4</sub>Cl solution, THF, rt, 97%; (f) 3-fluoro-4-methoxyaniline, HATU, DIEA, MeCN, rt, 81%; (g) TBAF, THF, rt, quant.; (h) RNH<sub>2</sub>, HATU, DIEA, DCM, rt; (i) TFA, DCM, rt, 68–95% for two steps.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Benzimidazole-Substituted BPAs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TBAF, THF, rt, quant.; (b) (<i>R</i>)-1-phenylbutan-1-amine, HATU, DIEA, DCM, rt, 75%; (c) Zn, sat. NH<sub>4</sub>Cl solution, THF, rt, 90%; (d) HATU, DIEA, DCM, rt, then AcOH, 85 °C, 68%–92%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Tri-Ester <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, xantphos, 1 M K<sub>3</sub>PO<sub>4</sub>, toluene, 70 °C, 65–74%.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Radioligand binding experiments; 1 μg of the human APJ-R-expressing HEK293 cell membrane was incubated with increasing concentration of <b>1</b> or <b>15a</b> and 0.1 nM [<sup>125</sup>I]-(Pyr<sup>1</sup>)apelin-13 in a final volume of 200 μL assay buffer containing 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 10 mM MgCl<sub>2</sub>, 2 mM ethylene glycol-bis(2-aminoethylether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid, and 0.1% bovine serum albumin, pH = 7.2. The membrane was separated from free compounds with a 0.3% poly ethyleneimine-soaked UniFilter-96 GF/B plate after incubation at room temperature for 1 h; inhibition binding reaction was carried out at room temperature for 3 h when 1 nM of [<sup>3</sup>H]-<b>15a</b> was used.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/medium/jm9b01513_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rat pressure-volume loop analysis of <b>1</b> and <b>15a</b>. Isoflurane-anesthetized male SD rats with a Millar <i>PV</i>-loop catheter in LV and a Millar pressure catheter in the abdominal aorta. After establishing a stable baseline, <b>1</b> [6 μg/kg/min (3.92 nmol/kg/min), <i>n</i> = 7] or <b>15a</b> (10, 100, 1000 μg/kg/min (0.0157, 0.157, 1.57 μmol/kg/min), <i>n</i> = 8/dose) or <i>N</i>,<i>N</i>-Dimethylacetamide vehicle (100 μL/kg/min, <i>n</i> = 10) was infused into the jugular vein for 15 min with continuous monitoring of hemodynamics. Hemodynamics were monitored for an additional 15 min after terminating infusion. Separate rats were prepared to measure exposures in response to the same 15 min infusions of <b>15a</b> (<i>n</i> = 3/dose); washout samples were obtained after stopping the 10 and 1000 μg/kg/min infusions; plasma concentration of <b>15a</b> (μM) after 15 min of infusion: 0.44 ± 0.18 (10 μg/kg/min); 4.4 ± 0.28 (100 μg/kg/min); 82 ± 4.2 (1000 μg/kg/min).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01513/20191127/images/large/jm9b01513_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01513&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 19 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yancy, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozkurt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drazner, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonarow, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraci, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januzzi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masoudi, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riegel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W. H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkoff, B. L.</span></span> <span> </span><span class="NLM_article-title">2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">e240</span>– <span class="NLM_lpage">e327</span>, <span class="refDoi"> DOI: 10.1161/cir.0b013e31829e8776</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2Fcir.0b013e31829e8776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=23741058" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2013&pages=e240-e327&author=C.+W.+Yancyauthor=M.+Jessupauthor=B.+Bozkurtauthor=J.+Butlerauthor=D.+E.+Caseyauthor=M.+H.+Draznerauthor=G.+C.+Fonarowauthor=S.+A.+Geraciauthor=T.+Horwichauthor=J.+L.+Januzziauthor=M.+R.+Johnsonauthor=E.+K.+Kasperauthor=W.+C.+Levyauthor=F.+A.+Masoudiauthor=P.+E.+McBrideauthor=J.+J.+V.+McMurrayauthor=J.+E.+Mitchellauthor=P.+N.+Petersonauthor=B.+Riegelauthor=F.+Samauthor=L.+W.+Stevensonauthor=W.+H.+W.+Tangauthor=E.+J.+Tsaiauthor=B.+L.+Wilkoff&title=2013+ACCF%2FAHA+Guideline+for+the+Management+of+Heart+Failure%3A+A+Report+of+the+American+College+of+Cardiology+Foundation%2FAmerican+Heart+Association+Task+Force+on+Practice+Guidelines&doi=10.1161%2Fcir.0b013e31829e8776"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1161%2Fcir.0b013e31829e8776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fcir.0b013e31829e8776%26sid%3Dliteratum%253Aachs%26aulast%3DYancy%26aufirst%3DC.%2BW.%26aulast%3DJessup%26aufirst%3DM.%26aulast%3DBozkurt%26aufirst%3DB.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DCasey%26aufirst%3DD.%2BE.%26aulast%3DDrazner%26aufirst%3DM.%2BH.%26aulast%3DFonarow%26aufirst%3DG.%2BC.%26aulast%3DGeraci%26aufirst%3DS.%2BA.%26aulast%3DHorwich%26aufirst%3DT.%26aulast%3DJanuzzi%26aufirst%3DJ.%2BL.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26aulast%3DKasper%26aufirst%3DE.%2BK.%26aulast%3DLevy%26aufirst%3DW.%2BC.%26aulast%3DMasoudi%26aufirst%3DF.%2BA.%26aulast%3DMcBride%26aufirst%3DP.%2BE.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%2BV.%26aulast%3DMitchell%26aufirst%3DJ.%2BE.%26aulast%3DPeterson%26aufirst%3DP.%2BN.%26aulast%3DRiegel%26aufirst%3DB.%26aulast%3DSam%26aufirst%3DF.%26aulast%3DStevenson%26aufirst%3DL.%2BW.%26aulast%3DTang%26aufirst%3DW.%2BH.%2BW.%26aulast%3DTsai%26aufirst%3DE.%2BJ.%26aulast%3DWilkoff%26aufirst%3DB.%2BL.%26atitle%3D2013%2520ACCF%252FAHA%2520Guideline%2520for%2520the%2520Management%2520of%2520Heart%2520Failure%253A%2520A%2520Report%2520of%2520the%2520American%2520College%2520of%2520Cardiology%2520Foundation%252FAmerican%2520Heart%2520Association%2520Task%2520Force%2520on%2520Practice%2520Guidelines%26jtitle%3DCirculation%26date%3D2013%26volume%3D128%26spage%3De240%26epage%3De327%26doi%3D10.1161%2Fcir.0b013e31829e8776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roger, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd-Jones, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravata, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailpern, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heit, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissela, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittner, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lackland, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisabeth, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makuc, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchar, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozaffarian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mussolino, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichol, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paynter, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotoodehnia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turan, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virani, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, M. B.</span></span> <span> </span><span class="NLM_article-title">Heart Disease and Stroke Statistics: 2012 Update</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">e2</span>– <span class="NLM_lpage">e220</span>, <span class="refDoi"> DOI: 10.1161/CIR.0b013e31823ac046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2FCIR.0b013e31823ac046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=22179539" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=e2-e220&author=V.+L.+Rogerauthor=A.+S.+Goauthor=D.+M.+Lloyd-Jonesauthor=E.+J.+Benjaminauthor=J.+D.+Berryauthor=W.+B.+Bordenauthor=D.+M.+Bravataauthor=S.+Daiauthor=E.+S.+Fordauthor=C.+S.+Foxauthor=H.+J.+Fullertonauthor=C.+Gillespieauthor=S.+M.+Hailpernauthor=J.+A.+Heitauthor=V.+J.+Howardauthor=B.+M.+Kisselaauthor=S.+J.+Kittnerauthor=D.+T.+Lacklandauthor=J.+H.+Lichtmanauthor=L.+D.+Lisabethauthor=D.+M.+Makucauthor=G.+M.+Marcusauthor=A.+Marelliauthor=D.+B.+Matcharauthor=C.+S.+Moyauthor=D.+Mozaffarianauthor=M.+E.+Mussolinoauthor=G.+Nicholauthor=N.+P.+Paynterauthor=E.+Z.+Solimanauthor=P.+D.+Sorlieauthor=N.+Sotoodehniaauthor=T.+N.+Turanauthor=S.+S.+Viraniauthor=N.+D.+Wongauthor=D.+Wooauthor=M.+B.+Turner&title=Heart+Disease+and+Stroke+Statistics%3A+2012+Update&doi=10.1161%2FCIR.0b013e31823ac046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1161%2FCIR.0b013e31823ac046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIR.0b013e31823ac046%26sid%3Dliteratum%253Aachs%26aulast%3DRoger%26aufirst%3DV.%2BL.%26aulast%3DGo%26aufirst%3DA.%2BS.%26aulast%3DLloyd-Jones%26aufirst%3DD.%2BM.%26aulast%3DBenjamin%26aufirst%3DE.%2BJ.%26aulast%3DBerry%26aufirst%3DJ.%2BD.%26aulast%3DBorden%26aufirst%3DW.%2BB.%26aulast%3DBravata%26aufirst%3DD.%2BM.%26aulast%3DDai%26aufirst%3DS.%26aulast%3DFord%26aufirst%3DE.%2BS.%26aulast%3DFox%26aufirst%3DC.%2BS.%26aulast%3DFullerton%26aufirst%3DH.%2BJ.%26aulast%3DGillespie%26aufirst%3DC.%26aulast%3DHailpern%26aufirst%3DS.%2BM.%26aulast%3DHeit%26aufirst%3DJ.%2BA.%26aulast%3DHoward%26aufirst%3DV.%2BJ.%26aulast%3DKissela%26aufirst%3DB.%2BM.%26aulast%3DKittner%26aufirst%3DS.%2BJ.%26aulast%3DLackland%26aufirst%3DD.%2BT.%26aulast%3DLichtman%26aufirst%3DJ.%2BH.%26aulast%3DLisabeth%26aufirst%3DL.%2BD.%26aulast%3DMakuc%26aufirst%3DD.%2BM.%26aulast%3DMarcus%26aufirst%3DG.%2BM.%26aulast%3DMarelli%26aufirst%3DA.%26aulast%3DMatchar%26aufirst%3DD.%2BB.%26aulast%3DMoy%26aufirst%3DC.%2BS.%26aulast%3DMozaffarian%26aufirst%3DD.%26aulast%3DMussolino%26aufirst%3DM.%2BE.%26aulast%3DNichol%26aufirst%3DG.%26aulast%3DPaynter%26aufirst%3DN.%2BP.%26aulast%3DSoliman%26aufirst%3DE.%2BZ.%26aulast%3DSorlie%26aufirst%3DP.%2BD.%26aulast%3DSotoodehnia%26aufirst%3DN.%26aulast%3DTuran%26aufirst%3DT.%2BN.%26aulast%3DVirani%26aufirst%3DS.%2BS.%26aulast%3DWong%26aufirst%3DN.%2BD.%26aulast%3DWoo%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DM.%2BB.%26atitle%3DHeart%2520Disease%2520and%2520Stroke%2520Statistics%253A%25202012%2520Update%26jtitle%3DCirculation%26date%3D2012%26volume%3D125%26spage%3De2%26epage%3De220%26doi%3D10.1161%2FCIR.0b013e31823ac046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Muiesan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agabiti
Rosei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertacchini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stassaldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvetti, M.</span></span> <span> </span><span class="NLM_article-title">Current Pharmacological Therapies in Heart Failure Patients</span>. <i>High Blood Pressure Cardiovasc. Prev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1007/s40292-017-0194-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1007%2Fs40292-017-0194-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=28349441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt1eltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=107-114&author=M.+L.+Muiesanauthor=A.+Painiauthor=C.+Agabiti%0ARoseiauthor=F.+Bertacchiniauthor=D.+Stassaldiauthor=M.+Salvetti&title=Current+Pharmacological+Therapies+in+Heart+Failure+Patients&doi=10.1007%2Fs40292-017-0194-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Current Pharmacological Therapies in Heart Failure Patients</span></div><div class="casAuthors">Muiesan, Maria Lorenza; Paini, Anna; Agabiti Rosei, Claudia; Bertacchini, Fabio; Stassaldi, Deborah; Salvetti, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">High Blood Pressure & Cardiovascular Prevention</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-114</span>CODEN:
                <span class="NLM_cas:coden">HBPCCX</span>;
        ISSN:<span class="NLM_cas:issn">1120-9879</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Heart failure (HF) is a major problem of public health.  More than 23 million patients worldwide are affected by heart failure.  Despite incidence and prevalence of heart failure may vary according to real world or randomized trials database, advancing age is a major determinant of heart failure.  Heart failure is also characterized by an elevated rate of morbidity and mortality and represents one of the leading causes of hospitalization.  A major consequence of heart failure is the frequent hospital admissions and related costs.  Guidelines have clearly indicated evidence-based treatments in patients with heart failure, and the adherence to these indications has translated in an improvement of patient's prognosis.  Nevertheless, the use of recommended treatments at the recommended dosages is still lower than expected.  In the last year in Europe new guidelines on the diagnosis and treatment of heart failure and in USA an update on pharmacol. treatment of heart failure were published, pointing the attention on the use of new available pharmacol. and non-pharmacol. treatments.  HF syndrome reflects the interaction between hemodynamic dysregulation (alterations in myocardial preload, afterload, and contractility and a neurohormonal disarray those results in the development of symptoms and in the progression of the disease.  Current treatment approaches target both hemodynamic alterations and the neurohumoral elements to slow disease progression as well as to improve symptoms and outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCAvxpveOE2bVg90H21EOLACvtfcHk0ljGcN5rtq_WGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt1eltbg%253D&md5=8483a453e80d1dca0d950cef05fe47eb</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1007%2Fs40292-017-0194-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40292-017-0194-3%26sid%3Dliteratum%253Aachs%26aulast%3DMuiesan%26aufirst%3DM.%2BL.%26aulast%3DPaini%26aufirst%3DA.%26aulast%3DAgabiti%2BRosei%26aufirst%3DC.%26aulast%3DBertacchini%26aufirst%3DF.%26aulast%3DStassaldi%26aufirst%3DD.%26aulast%3DSalvetti%26aufirst%3DM.%26atitle%3DCurrent%2520Pharmacological%2520Therapies%2520in%2520Heart%2520Failure%2520Patients%26jtitle%3DHigh%2520Blood%2520Pressure%2520Cardiovasc.%2520Prev.%26date%3D2017%26volume%3D24%26spage%3D107%26epage%3D114%26doi%3D10.1007%2Fs40292-017-0194-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jessup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brozena, S.</span></span> <span> </span><span class="NLM_article-title">Heart Failure</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2018</span>, <span class="refDoi"> DOI: 10.1056/nejmra021498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1056%2Fnejmra021498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=12748317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A280%3ADC%252BD3s3is12nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=2007-2018&author=M.+Jessupauthor=S.+Brozena&title=Heart+Failure&doi=10.1056%2Fnejmra021498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Heart failure</span></div><div class="casAuthors">Jessup Mariell; Brozena Susan</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2007-18</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvZ4lEH0HKskBuFdjgVNKSfW6udTcc2eZivL71_27sRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3is12nsg%253D%253D&md5=981c81c01f5c46d885bdcc3e53428586</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2Fnejmra021498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmra021498%26sid%3Dliteratum%253Aachs%26aulast%3DJessup%26aufirst%3DM.%26aulast%3DBrozena%26aufirst%3DS.%26atitle%3DHeart%2520Failure%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D2007%26epage%3D2018%26doi%3D10.1056%2Fnejmra021498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roger, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weston, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redfield, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellermann-Homan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yawn, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, S. J.</span></span> <span> </span><span class="NLM_article-title">Trends in Heart Failure Incidence and Survival in a Community-based Population</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1001/jama.292.3.344</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1001%2Fjama.292.3.344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=15265849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFaju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2004&pages=344-350&author=V.+L.+Rogerauthor=S.+A.+Westonauthor=M.+M.+Redfieldauthor=J.+P.+Hellermann-Homanauthor=J.+Killianauthor=B.+P.+Yawnauthor=S.+J.+Jacobsen&title=Trends+in+Heart+Failure+Incidence+and+Survival+in+a+Community-based+Population&doi=10.1001%2Fjama.292.3.344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in heart failure incidence and survival in a community-based population</span></div><div class="casAuthors">Roger, Veronique L.; Weston, Susan A.; Redfield, Margaret M.; Hellermann-Homan, Jens P.; Killian, Jill; Yawn, Barbara P.; Jacobsen, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-350</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Context: The epidemic of heart failure has yet to be fully investigated, and data on incidence, survival, and sex-specific temporal trends in community-based populations are limited.  Objective: To test the hypothesis that the incidence of heart failure has declined and survival after heart failure diagnosis has improved over time but that secular trends have diverged by sex.  Design, Setting, and Participants: Population-based cohort study using the resources of the Rochester Epidemiol. Project conducted in Olmsted County, Minnesota.  Patients were 4537 Olmsted County residents (57% women; mean [SD] age, 74 [14] years) with a diagnosis of heart failure between 1979 and 2000.  Framingham criteria and clin. criteria were used to validate the diagnosis.  Main Outcome Measures: Incidence of heart failure and survival after heart failure diagnosis.  Results: The incidence of heart failure was higher among men (378/100000 persons; 95% confidence interval [Cl], 361-395 for men; 289/100000 persons; 95% Cl, 277-300 for women) and did not change over time among men or women.  After a mean follow-up of 4.2 yr (range, 0-23.8 yr), 3347 deaths occurred, including 1930 among women and 1417 among men.  Survival after heart failure diagnosis was worse among men than women (relative risk, 1.33; 95% Cl, 1.24-1.43) but overall improved over time (5-yr age-adjusted survival, 43 % in 1979-1984 vs 52 % in 1996-2000, P<.001).  However, men and younger persons experienced larger survival gains, contrasting with less or no improvement for women and elderly persons.  Conclusion: In this community-based cohort, the incidence of heart failure has not declined during 2 decades, but survival after onset of heart failure has increased over-all, with less improvement among women and elderly persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO6I2PZwR6h7Vg90H21EOLACvtfcHk0liy-LB5l-yMbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFaju7k%253D&md5=44407f9bedb9db27ddb39013ad273226</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1001%2Fjama.292.3.344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.292.3.344%26sid%3Dliteratum%253Aachs%26aulast%3DRoger%26aufirst%3DV.%2BL.%26aulast%3DWeston%26aufirst%3DS.%2BA.%26aulast%3DRedfield%26aufirst%3DM.%2BM.%26aulast%3DHellermann-Homan%26aufirst%3DJ.%2BP.%26aulast%3DKillian%26aufirst%3DJ.%26aulast%3DYawn%26aufirst%3DB.%2BP.%26aulast%3DJacobsen%26aufirst%3DS.%2BJ.%26atitle%3DTrends%2520in%2520Heart%2520Failure%2520Incidence%2520and%2520Survival%2520in%2520a%2520Community-based%2520Population%26jtitle%3DJAMA%26date%3D2004%26volume%3D292%26spage%3D344%26epage%3D350%26doi%3D10.1001%2Fjama.292.3.344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petronis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span> <span> </span><span class="NLM_article-title">A Human Gene that Shows Identity with the Gene Encoding the Angiotensin Receptor is Located on Chromosome 11</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/0378-1119(93)90495-o</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2F0378-1119%2893%2990495-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=8294032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFGnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1993&pages=355-360&author=B.+F.+O%E2%80%99Dowdauthor=M.+Heiberauthor=A.+Chanauthor=H.+H.+Hengauthor=L.+C.+Tsuiauthor=J.+L.+Kennedyauthor=X.+Siauthor=A.+Petronisauthor=S.+R.+Georgeauthor=T.+Nguyen&title=A+Human+Gene+that+Shows+Identity+with+the+Gene+Encoding+the+Angiotensin+Receptor+is+Located+on+Chromosome+11&doi=10.1016%2F0378-1119%2893%2990495-o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11</span></div><div class="casAuthors">O'Dowd, Brian F.; Heiber, Michael; Chan, Audrey; Heng, Henry H. Q.; Tsui, Lap Chee; Kennedy, James L.; Shi, Xiaomei; Petronis, Arturas; George, Susan R.; Nguyen Tuan</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">355-60</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    </div><div class="casAbstract">The authors report the cloning of a gene, intron-less in its coding region, which the authors have named APJ.  This gene was cloned using the polymerase chain reaction (PCR), with a set of primers designed on the basis of the conservation that members of G protein-coupled receptors (GPCR) have in their transmembrane (TM) regions.  The putative receptor protein, APJ, shares closest identity to the angiotensin receptor (AT1) ranging from 40 to 50% in the hydrophobic TM regions of these receptors.  The transcripts for this gene were detected in many regions of the brain.  PCR anal. of somatic cell lines found APJ-related sequences to be only present on chromosome 11, and high-resoln. mapping by fluorescence in situ hybridization (FISH) sub-localized APJ on band q12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqp2kdIKETdbVg90H21EOLACvtfcHk0lhHxQvreKTj7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFGnsL0%253D&md5=4beb37696cbf0f919df6c1d22088e719</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0378-1119%2893%2990495-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-1119%252893%252990495-O%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DB.%2BF.%26aulast%3DHeiber%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DHeng%26aufirst%3DH.%2BH.%26aulast%3DTsui%26aufirst%3DL.%2BC.%26aulast%3DKennedy%26aufirst%3DJ.%2BL.%26aulast%3DSi%26aufirst%3DX.%26aulast%3DPetronis%26aufirst%3DA.%26aulast%3DGeorge%26aufirst%3DS.%2BR.%26aulast%3DNguyen%26aufirst%3DT.%26atitle%3DA%2520Human%2520Gene%2520that%2520Shows%2520Identity%2520with%2520the%2520Gene%2520Encoding%2520the%2520Angiotensin%2520Receptor%2520is%2520Located%2520on%2520Chromosome%252011%26jtitle%3DGene%26date%3D1993%26volume%3D136%26spage%3D355%26epage%3D360%26doi%3D10.1016%2F0378-1119%2893%2990495-o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tatemoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, M.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukusumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujino, M.</span></span> <span> </span><span class="NLM_article-title">Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>251</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1998.9489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1006%2Fbbrc.1998.9489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=9792798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADyaK1cXmvF2msbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1998&pages=471-476&author=K.+Tatemotoauthor=M.+Hosoyaauthor=Y.+Habataauthor=R.+Fujiiauthor=T.+Kakegawaauthor=M.-X.+Zouauthor=Y.+Kawamataauthor=S.+Fukusumiauthor=S.+Hinumaauthor=C.+Kitadaauthor=T.+Kurokawaauthor=H.+Ondaauthor=M.+Fujino&title=Isolation+and+Characterization+of+a+Novel+Endogenous+Peptide+Ligand+for+the+Human+APJ+Receptor&doi=10.1006%2Fbbrc.1998.9489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor</span></div><div class="casAuthors">Tatemoto, Kazuhiko; Hosoya, Masaki; Habata, Yugo; Fujii, Ryo; Kakegawa, Tadao; Zou, Min-Xu; Kawamata, Yuji; Fukusumi, Shoji; Hinuma, Shuji; Kitada, Chieko; Kurokawa, Tsutomu; Onda, Haruo; Fujino, Masahiko</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">In the search for an endogenous ligand of the orphan G protein-coupled receptor APJ, the presence of the ligand in various tissue exts. was examd. by measuring the increase in extracellular acidification rate of the cells expressing the APJ receptor as a specific signal induced by the interaction of the receptor and ligand.  By monitoring this activity, the authors isolated an APJ receptor ligand, designated apelin, from bovine stomach exts.  The structures of bovine and human apelin preproproteins were deduced from the sequences of the corresponding cDNAs.  The preproproteins consisted of 77 amino acid residues, and the apelin sequence was encoded in the C-terminal regions.  Synthetic peptides derived from the C-terminal amino acid sequence of bovine preproapelin were capable of specifically promoting the acidification rate in the cells expressing the APJ receptor in a range from 10-7 to 10-10 M, indicating that apelin is an endogenous ligand for the APJ receptor.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfZFYcVKcQs7Vg90H21EOLACvtfcHk0lj45l6tUe5m7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvF2msbY%253D&md5=54a069e5884731979abfdc1738ba6d44</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1998.9489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1998.9489%26sid%3Dliteratum%253Aachs%26aulast%3DTatemoto%26aufirst%3DK.%26aulast%3DHosoya%26aufirst%3DM.%26aulast%3DHabata%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DR.%26aulast%3DKakegawa%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DM.-X.%26aulast%3DKawamata%26aufirst%3DY.%26aulast%3DFukusumi%26aufirst%3DS.%26aulast%3DHinuma%26aufirst%3DS.%26aulast%3DKitada%26aufirst%3DC.%26aulast%3DKurokawa%26aufirst%3DT.%26aulast%3DOnda%26aufirst%3DH.%26aulast%3DFujino%26aufirst%3DM.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520a%2520Novel%2520Endogenous%2520Peptide%2520Ligand%2520for%2520the%2520Human%2520APJ%2520Receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1998%26volume%3D251%26spage%3D471%26epage%3D476%26doi%3D10.1006%2Fbbrc.1998.9489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kuba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, T.</span></span> <span> </span><span class="NLM_article-title">Apelin and Elabela/Toddler; Double Ligands for APJ/Apelin Receptor in Heart Development, Physiology, and Pathology</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2018.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.peptides.2018.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=29684595" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2018&pages=62-70&author=K.+Kubaauthor=T.+Satoauthor=Y.+Imaiauthor=T.+Yamaguchi&title=Apelin+and+Elabela%2FToddler%3B+Double+Ligands+for+APJ%2FApelin+Receptor+in+Heart+Development%2C+Physiology%2C+and+Pathology&doi=10.1016%2Fj.peptides.2018.04.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2018.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2018.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKuba%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26atitle%3DApelin%2520and%2520Elabela%252FToddler%253B%2520Double%2520Ligands%2520for%2520APJ%252FApelin%2520Receptor%2520in%2520Heart%2520Development%252C%2520Physiology%252C%2520and%2520Pathology%26jtitle%3DPeptides%26date%3D2018%26volume%3D111%26spage%3D62%26epage%3D70%26doi%3D10.1016%2Fj.peptides.2018.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Japp, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span> <span> </span><span class="NLM_article-title">The Apelin–APJ System in Heart Failure: Pathophysiologic Relevance and Therapeutic Potential</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1882</span>– <span class="NLM_lpage">1892</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2007.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bcp.2007.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=18272138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFOmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=1882-1892&author=A.+G.+Jappauthor=D.+E.+Newby&title=The+Apelin%E2%80%93APJ+System+in+Heart+Failure%3A+Pathophysiologic+Relevance+and+Therapeutic+Potential&doi=10.1016%2Fj.bcp.2007.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">The apelin-APJ system in heart failure</span></div><div class="casAuthors">Japp, Alan G.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1882-1892</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Apelin is the endogenous ligand for the previously orphaned G protein-coupled receptor, APJ.  This novel peptidic signalling pathway is widely represented in the heart and vasculature, and is emerging as an important regulator of cardiovascular homeostasis.  In preclin. models, apelin causes nitric oxide-dependent vasodilatation, reduces ventricular preload and afterload, and increases cardiac contractility in rats with normal and failing hearts.  Apelin-APJ signalling also attenuates ischemic myocardial injury and maintains cardiac performance in aging and chronic pressure overload.  Downregulation of apelin and APJ expression coincides with declining cardiac performance raising the possibility that diminished apelin-APJ activity may have pathophysiol. implications.  At present, data from human studies is limited but changes in apelin and APJ expression in patients with chronic heart failure parallel those seen in preclin. models.  Detailed clin. investigation is now required to establish the role of apelin in human cardiovascular physiol. and pathophysiol., and to det. the therapeutic potential of augmenting apelin signalling in patients with heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAka0TeezMa7Vg90H21EOLACvtfcHk0ljHrSfW3oZ1PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFOmsr4%253D&md5=63c1bf3e8feb31a6b78098b1b5336bf3</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DThe%2520Apelin%25E2%2580%2593APJ%2520System%2520in%2520Heart%2520Failure%253A%2520Pathophysiologic%2520Relevance%2520and%2520Therapeutic%2520Potential%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D1882%26epage%3D1892%26doi%3D10.1016%2Fj.bcp.2007.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Medhurst, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winborn, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrie, K. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervieu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolaky, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrity, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdock, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darker, J. G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological and Immunohistochemical Characterization of the APJ Receptor and its Endogenous Ligand Apelin</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1162</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.01587.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1046%2Fj.1471-4159.2003.01587.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=12603839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1ejtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=1162-1172&author=A.+D.+Medhurstauthor=C.+A.+Jenningsauthor=M.+J.+Robbinsauthor=R.+P.+Davisauthor=C.+Ellisauthor=K.+Y.+Winbornauthor=K.+W.+M.+Lawrieauthor=G.+Hervieuauthor=G.+Rileyauthor=J.+E.+Bolakyauthor=N.+C.+Herrityauthor=P.+Murdockauthor=J.+G.+Darker&title=Pharmacological+and+Immunohistochemical+Characterization+of+the+APJ+Receptor+and+its+Endogenous+Ligand+Apelin&doi=10.1046%2Fj.1471-4159.2003.01587.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin</span></div><div class="casAuthors">Medhurst, Andrew D.; Jennings, Carol A.; Robbins, Melanie J.; Davis, Robert P.; Ellis, Catherine; Winborn, Kim Y.; Lawrie, Kenneth W. M.; Hervieu, Guillaume; Riley, Graham; Bolaky, Jane E.; Herrity, Nicole C.; Murdock, Paul; Darker, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1162-1172</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Apelin peptides have recently been identified to be the endogenous ligands for the G protein-coupled receptor APJ.  However, little is known about the physiol. roles of this ligand-receptor pairing.  In the present study the authors investigated the pharmacol. of several apelin analogs at the human recombinant APJ receptor using radioligand binding and functional assays.  This has led to the identification of key residues in the apelin peptide required for functional potency and binding affinity through structure-activity studies.  In particular, the authors have identified that replacement of leucine in position 5, or arginine in position 2 and 4 of the C-terminal apelin peptide, apelin-13, resulted in significant changes in pharmacol.  The authors also investigated the detailed localization of pre-proapelin and APJ receptor mRNA in a wide range of human, rat and mouse tissues using quant. RT-PCR, and carried out a detailed immunohistochem. study of the distribution of the APJ receptor in rat brain and spinal cord.  Interestingly, the APJ receptor was not only co-localized in white matter with GFAP in the spinal cord, but was also clearly localized on neurons in the brain, suggesting that this receptor and its peptide may be involved in a wide range of biol. process yet to be detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99tyPHrKfxLVg90H21EOLACvtfcHk0likIRmKkZeCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1ejtb8%253D&md5=4a83eb10e5612872943c2a327659ab6d</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.01587.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.01587.x%26sid%3Dliteratum%253Aachs%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DJennings%26aufirst%3DC.%2BA.%26aulast%3DRobbins%26aufirst%3DM.%2BJ.%26aulast%3DDavis%26aufirst%3DR.%2BP.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DWinborn%26aufirst%3DK.%2BY.%26aulast%3DLawrie%26aufirst%3DK.%2BW.%2BM.%26aulast%3DHervieu%26aufirst%3DG.%26aulast%3DRiley%26aufirst%3DG.%26aulast%3DBolaky%26aufirst%3DJ.%2BE.%26aulast%3DHerrity%26aufirst%3DN.%2BC.%26aulast%3DMurdock%26aufirst%3DP.%26aulast%3DDarker%26aufirst%3DJ.%2BG.%26atitle%3DPharmacological%2520and%2520Immunohistochemical%2520Characterization%2520of%2520the%2520APJ%2520Receptor%2520and%2520its%2520Endogenous%2520Ligand%2520Apelin%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D84%26spage%3D1162%26epage%3D1172%26doi%3D10.1046%2Fj.1471-4159.2003.01587.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgs, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, J. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamyl Apelin-13 Identified as the Major Apelin Isoform in Human Plasma</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>442</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2013.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.ab.2013.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=23872001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=442&publication_year=2013&pages=1-9&author=E.+Y.+Zhenauthor=R.+E.+Higgsauthor=J.+A.+Gutierrez&title=Pyroglutamyl+Apelin-13+Identified+as+the+Major+Apelin+Isoform+in+Human+Plasma&doi=10.1016%2Fj.ab.2013.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma</span></div><div class="casAuthors">Zhen, Eugene Y.; Higgs, Richard E.; Gutierrez, Jesus A.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">442</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apelin is emerging as an important hormone regulator of cardiovascular homeostasis and an important biomarker for heart failure.  Apelin concns. have historically been measured by immunoassays; however, reported apelin concns. measured in healthy volunteers show a large disparity from a few picograms per mL (pg/mL) to several nanograms per mL (ng/mL).  Apelin exists in several isoforms ranging in size from 12 to 36 residues, and immunoassays generally cannot distinguish the specific forms present.  In this study, an optimized method for enriching apelin peptides with cation-exchange beads followed with mass spectrometry anal. is presented.  Apelin peptides are labile in plasma at physiol. conditions; however, by lowering the plasma pH to 4.5, the recovery of apelin peptides can be increased significantly.  Through optimizing the cation-exchange extn. process, the authors improved the lower limit of detection for most of the apelin peptides monitored to a few pg/mL.  Using the improved method, the authors detected pyroglutamyl apelin-13 [(pyr)apelin-13] as the major apelin isoform present in plasma from several healthy volunteers at concns. ranging from 7.7 to 23.3 pg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9q8cU6NvKV7Vg90H21EOLACvtfcHk0likIRmKkZeCzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntbzN&md5=32a7a24e4194c99ee6285be5408089dd</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2013.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2013.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DE.%2BY.%26aulast%3DHiggs%26aufirst%3DR.%2BE.%26aulast%3DGutierrez%26aufirst%3DJ.%2BA.%26atitle%3DPyroglutamyl%2520Apelin-13%2520Identified%2520as%2520the%2520Major%2520Apelin%2520Isoform%2520in%2520Human%2520Plasma%26jtitle%3DAnal.%2520Biochem.%26date%3D2013%26volume%3D442%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.ab.2013.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitkin, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, A. P.</span></span> <span> </span><span class="NLM_article-title">[Pyr<sup>1</sup>]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart: Vasoactive Mechanisms and Inotropic Action in Disease</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">598</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1161/hypertensionaha.109.134619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2FHYPERTENSIONAHA.109.134619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=19597036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsleksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=598-604&author=J.+J.+Maguireauthor=M.+J.+Kleinzauthor=S.+L.+Pitkinauthor=A.+P.+Davenport&title=%5BPyr1%5DApelin-13+Identified+as+the+Predominant+Apelin+Isoform+in+the+Human+Heart%3A+Vasoactive+Mechanisms+and+Inotropic+Action+in+Disease&doi=10.1161%2Fhypertensionaha.109.134619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">[Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart</span></div><div class="casAuthors">Maguire, Janet J.; Kleinz, Matthias J.; Pitkin, Sarah L.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">598-604</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Apelin receptors, present on vascular smooth muscle cells, endothelium, and cardiomyocytes, are activated by the family of apelin peptides to elicit cardiovascular effects in exptl. animals, but functional activity in humans has not been studied in detail.  The authors detected low levels of apelin immunoreactivity in plasma of volunteers consistent with an autocrine/paracrine action and detected apelin immunoreactivity in the supernatant from human cultured endothelial cells.  The authors found that [Pyr1]apelin-13 was the predominant isoform in cardiac tissue from patients with coronary artery disease.  The authors tested the hypothesis that apelins have vascular and cardiac actions in human tissues in vitro and compared responses to [Pyr1]apelin-13, apelin-13, and apelin-36.  In endothelium-intact mammary artery, all 3 of the apelins induced concn.-dependent vasodilatation with comparable potency (EC50: 0.6 to 1.6 nM; max. response: 40% to 50%).  Vasodilatation was abolished after endothelial removal or preincubation with indomethacin but was unaffected by preincubation with NG-nitro-l-arginine Me ester, indicating involvement of prostanoids but not NO in dilatation by apelins in this patient group.  Apelins were potent constrictors of endothelium-denuded saphenous vein (EC50: 0.6 to 1.6 nM; max. response: 17% to 26%) and mammary artery ([Pyr1]apelin-13; EC50: 0.2 nM; max. response: 29%).  In paced atrial strips, all 3 of the peptides increased the force of contraction with subnanomolar potencies (EC50: 40 to 125 pM).  For the first time, the authors demonstrate that the 3 principal forms of apelin have comparable potency and efficacy in human cardiovascular tissues.  Apelins are potent endothelium-dependent vasodilators acting via a prostanoid-dependent mechanism; however, removal of the endothelium revealed direct vasoconstrictor actions in both the artery and vein.  Furthermore, in human cardiac tissue, the apelin peptides are among the most potent endogenous pos. inotropic agents yet reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0rlY7c6SsibVg90H21EOLACvtfcHk0lgJZxR3wUlXWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsleksL4%253D&md5=bf568a68931b0815502522cc785df8ca</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.109.134619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.109.134619%26sid%3Dliteratum%253Aachs%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DKleinz%26aufirst%3DM.%2BJ.%26aulast%3DPitkin%26aufirst%3DS.%2BL.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3D%255BPyr1%255DApelin-13%2520Identified%2520as%2520the%2520Predominant%2520Apelin%2520Isoform%2520in%2520the%2520Human%2520Heart%253A%2520Vasoactive%2520Mechanisms%2520and%2520Inotropic%2520Action%2520in%2520Disease%26jtitle%3DHypertension%26date%3D2009%26volume%3D54%26spage%3D598%26epage%3D604%26doi%3D10.1161%2Fhypertensionaha.109.134619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Szokodi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Földes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voutilainen-Myllylä, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilves, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikkarainen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piuhola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rysä, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tóth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruskoaho, H.</span></span> <span> </span><span class="NLM_article-title">Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1161/01.res.0000033522.37861.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2F01.RES.0000033522.37861.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=12215493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2002&pages=434-440&author=I.+Szokodiauthor=P.+Taviauthor=G.+F%C3%B6ldesauthor=S.+Voutilainen-Myllyl%C3%A4author=M.+Ilvesauthor=H.+Tokolaauthor=S.+Pikkarainenauthor=J.+Piuholaauthor=J.+Rys%C3%A4author=M.+T%C3%B3thauthor=H.+Ruskoaho&title=Apelin%2C+the+Novel+Endogenous+Ligand+of+the+Orphan+Receptor+APJ%2C+Regulates+Cardiac+Contractility&doi=10.1161%2F01.res.0000033522.37861.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility</span></div><div class="casAuthors">Szokodi, Istvan; Tavi, Pasi; Foeldes, Gabor; Voutilainen-Myllylae, Sari; Ilves, Mika; Tokola, Heikki; Pikkarainen, Sampsa; Piuhola, Jarkko; Rysae, Jaana; Toth, Miklos; Ruskoaho, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The orphan receptor APJ and its recently identified endogenous ligand, apelin, exhibit high levels of mRNA expression in the heart.  However, the functional importance of apelin in the cardiovascular system is not known.  In isolated perfused rat hearts, infusion of apelin (0.01 to 10 nmol/L) induced a dose-dependent pos. inotropic effect (EC50: 33.1±1.5 pmol/L).  Moreover, preload-induced increase in dP/dtmax was significantly augmented (P<0.05) in the presence of apelin.  Inhibition of phospholipase C (PLC) with U-73122 and suppression of protein kinase C (PKC) with staurosporine and GF-109203X markedly attenuated the apelin-induced inotropic effect (P<0.001).  In addn., zoniporide, a selective inhibitor of Na+-H+ exchange (NHE) isoform-1, and KB-R7943, a potent inhibitor of the reverse mode Na+-Ca2+ exchange (NCX), significantly suppressed the response to apelin (P<0.001).  Perforated patch-clamp recordings showed that apelin did not modulate L-type Ca2+ current or voltage-activated K+ currents in isolated adult rat ventricular myocytes.  Apelin mRNA was markedly downregulated in cultured neonatal rat ventricular myocytes subjected to mech. stretch and in vivo in two models of chronic ventricular pressure overload.  The present study provides the first evidence for the physiol. significance of apelin in the heart.  Our results show that apelin is one of the most potent endogenous pos. inotropic substances yet identified and that the inotropic response to apelin may involve activation of PLC, PKC, and sarcolemmal NHE and NCX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAJihT3bR9_bVg90H21EOLACvtfcHk0lgJZxR3wUlXWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVKktL0%253D&md5=78b3fb521970692595debb7c819f0e3b</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000033522.37861.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000033522.37861.69%26sid%3Dliteratum%253Aachs%26aulast%3DSzokodi%26aufirst%3DI.%26aulast%3DTavi%26aufirst%3DP.%26aulast%3DF%25C3%25B6ldes%26aufirst%3DG.%26aulast%3DVoutilainen-Myllyl%25C3%25A4%26aufirst%3DS.%26aulast%3DIlves%26aufirst%3DM.%26aulast%3DTokola%26aufirst%3DH.%26aulast%3DPikkarainen%26aufirst%3DS.%26aulast%3DPiuhola%26aufirst%3DJ.%26aulast%3DRys%25C3%25A4%26aufirst%3DJ.%26aulast%3DT%25C3%25B3th%26aufirst%3DM.%26aulast%3DRuskoaho%26aufirst%3DH.%26atitle%3DApelin%252C%2520the%2520Novel%2520Endogenous%2520Ligand%2520of%2520the%2520Orphan%2520Receptor%2520APJ%252C%2520Regulates%2520Cardiac%2520Contractility%26jtitle%3DCirc.%2520Res.%26date%3D2002%26volume%3D91%26spage%3D434%26epage%3D440%26doi%3D10.1161%2F01.res.0000033522.37861.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finsterbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffarelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichhorn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greve, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quertermous, T.</span></span> <span> </span><span class="NLM_article-title">The Endogenous Peptide Apelin Potently Improves Cardiac Contractility and Reduces Cardiac Loading <i>in vivo</i></span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1016/j.cardiores.2004.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.cardiores.2004.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=15621035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFCqt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=73-82&author=E.+Ashleyauthor=J.+Powersauthor=M.+Chenauthor=R.+Kunduauthor=T.+Finsterbachauthor=A.+Caffarelliauthor=A.+Dengauthor=J.+Eichhornauthor=R.+Mahajanauthor=R.+Agrawalauthor=J.+Greveauthor=R.+Robbinsauthor=A.+J.+Pattersonauthor=D.+Bernsteinauthor=T.+Quertermous&title=The+Endogenous+Peptide+Apelin+Potently+Improves+Cardiac+Contractility+and+Reduces+Cardiac+Loading+in+vivo&doi=10.1016%2Fj.cardiores.2004.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo</span></div><div class="casAuthors">Ashley, Euan A.; Powers, Jennifer; Chen, Mary; Kundu, Ramendra; Finsterbach, Tom; Caffarelli, Anthony; Deng, Alicia; Eichhorn, Jens; Mahajan, Raina; Agrawal, Rani; Greve, Joan; Robbins, Robert; Patterson, Andrew J.; Bernstein, Daniel; Quertermous, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-82</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endogenous peptide apelin is differentially regulated in cardiovascular disease but the nature of its role in cardiac function remains unclear.  The authors investigated the functional relevance of this peptide using eCG and respiration gated magnetic resonance imaging, conductance catheter pressure-vol. hemodynamic measurements, and echocardiog. in vivo.  In addn., the authors carried out histol. and immunohistochem. to assess cardiac hypertrophy and to localize apelin and APJ in the adult and embryonic mouse heart.  The i.p. injection of apelin (300 μg/kg) resulted in a decrease in left ventricular end diastolic area (pre: 0.122; post: 0.104 cm2) and an increase in heart rate (pre: 537; post: 559 beats per min).  Hemodynamic measurements revealed a marked increase in ventricular elastance (pre: 3.7; post: 6.5 mm Hg/RVU) and preload recruitable stroke work (pre: 27.4; post: 51.8) with little change in diastolic parameters following acute infusion of apelin.  Chronic infusion (2 mg/kg/day) resulted in significant increases in the velocity of circumferential shortening (baseline: 5.36; 14 days: 6.85 circ/s) and cardiac output (baseline: 0.142; 14 days: 0.25 l/min) as detd. by 15 MHz echocardiog.  Post-mortem cor. heart wts. were not different between apelin and saline groups and histol. revealed no evidence of cellular hypertrophy in the apelin group.  Immunohistochem. studies revealed APJ staining of myocardial cells in all regions of the adult mouse heart.  Antibody staining, as well as quant. real time polymerase chain reaction identified expression of both APJ and apelin in embryonic myocardium as early as embryonic day 13.5.  Thus, apelin reduces left ventricular preload and afterload and increases contractile reserve without evidence of hypertrophy.  These results assoc. apelin with a pos. hemodynamic profile and suggest it as an attractive target for pharmacotherapy in the setting of heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkEP8xIMrQ2LVg90H21EOLACvtfcHk0liUmxTOgC-YiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFCqt7vM&md5=07088f2a5bc3ed114b26c2876bfd9a51</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.cardiores.2004.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardiores.2004.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%26aulast%3DPowers%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DKundu%26aufirst%3DR.%26aulast%3DFinsterbach%26aufirst%3DT.%26aulast%3DCaffarelli%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DA.%26aulast%3DEichhorn%26aufirst%3DJ.%26aulast%3DMahajan%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DR.%26aulast%3DGreve%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DA.%2BJ.%26aulast%3DBernstein%26aufirst%3DD.%26aulast%3DQuertermous%26aufirst%3DT.%26atitle%3DThe%2520Endogenous%2520Peptide%2520Apelin%2520Potently%2520Improves%2520Cardiac%2520Contractility%2520and%2520Reduces%2520Cardiac%2520Loading%2520in%2520vivo%26jtitle%3DCardiovasc.%2520Res.%26date%3D2005%26volume%3D65%26spage%3D73%26epage%3D82%26doi%3D10.1016%2Fj.cardiores.2004.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koguchi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishimitsu, T.</span></span> <span> </span><span class="NLM_article-title">Cardioprotective Effect of Apelin-13 on Cardiac Performance and Remodeling in End-stage Heart Failure</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1253/circj.cj-11-0689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1253%2Fcircj.cj-11-0689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2jt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2012&pages=137-144&author=W.+Koguchiauthor=N.+Kobayashiauthor=H.+Takeshimaauthor=M.+Ishikawaauthor=F.+Sugiyamaauthor=T.+Ishimitsu&title=Cardioprotective+Effect+of+Apelin-13+on+Cardiac+Performance+and+Remodeling+in+End-stage+Heart+Failure&doi=10.1253%2Fcircj.cj-11-0689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure</span></div><div class="casAuthors">Koguchi, Wataru; Kobayashi, Naohiko; Takeshima, Hiroshi; Ishikawa, Mayuko; Sugiyama, Fumihiro; Ishimitsu, Toshihiko</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">CJIOBY</span>;
        ISSN:<span class="NLM_cas:issn">1346-9843</span>.
    
            (<span class="NLM_cas:orgname">Japanese Circulation Society</span>)
        </div><div class="casAbstract">Background: Apelin and its cognate G protein-coupled receptor, APJ, constitute a signaling pathway with a pos. inotropic effect on cardiac function.  Recently, we and other investigators demonstrated that a redn. in myocardial apelin/APJ expression might play a crit. role in exptl. models of end-stage heart failure (HF).  Therefore, we evaluated whether exogenous apelin infusion restores apelin/APJ expression and improves cardiac function in the failing heart of Dahl salt-sensitive hypertensive (DS) rats.  Methods and Results: High salt-loaded DS rats were treated with vehicle and pyroglutamylated apelin-13 (Pyr-AP13; 200μg · kg-1 · day-1, IP) from the age of 11 to 18 wk.  Decreased end-systolic elastance and percent fractional shortening in failing rats was significantly ameliorated by Pyr-AP13.  Pyr-AP13 effectively inhibited vascular lesion formation and suppressed expression of inflammation factors such as tumor necrosis factor-α and interleukin-1β protein.  Downregulation of apelin and APJ expression, and phosphorylation of endothelial nitric oxide synthase at Ser1177 and Akt at Ser473 in failing rats was significantly increased by Pyr-AP13.  Upregulation of NAD(P)H oxidase p22phox, p47phox and gp91phox in DS rats was significantly suppressed by Pyr-AP13.  Conclusions: Exogenous apelin-13 may ameliorate cardiac dysfunction and remodeling and restore apelin/APJ expression in DS rats with end-stage HF.  Thus, apelin-13 may have significant therapeutic potential for end-stage HF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRZ6P_1OR7bVg90H21EOLACvtfcHk0liUmxTOgC-YiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2jt7w%253D&md5=ee9dc78fa905dc8d92d74afd39b4d883</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1253%2Fcircj.cj-11-0689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1253%252Fcircj.cj-11-0689%26sid%3Dliteratum%253Aachs%26aulast%3DKoguchi%26aufirst%3DW.%26aulast%3DKobayashi%26aufirst%3DN.%26aulast%3DTakeshima%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DSugiyama%26aufirst%3DF.%26aulast%3DIshimitsu%26aufirst%3DT.%26atitle%3DCardioprotective%2520Effect%2520of%2520Apelin-13%2520on%2520Cardiac%2520Performance%2520and%2520Remodeling%2520in%2520End-stage%2520Heart%2520Failure%26jtitle%3DCirculation%26date%3D2012%26volume%3D76%26spage%3D137%26epage%3D144%26doi%3D10.1253%2Fcircj.cj-11-0689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Japp, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruden, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amer, D. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudie, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Megson, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flapan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span> <span> </span><span class="NLM_article-title">Vascular Effects of Apelin <i>in vivo</i> in Man</span>. <i>J. Am. Coll. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1016/j.jacc.2008.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.jacc.2008.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=18772060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVyjsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=908-913&author=A.+G.+Jappauthor=N.+L.+Crudenauthor=D.+A.+B.+Amerauthor=V.+K.+Y.+Liauthor=E.+B.+Goudieauthor=N.+R.+Johnstonauthor=S.+Sharmaauthor=I.+Neilsonauthor=D.+J.+Webbauthor=I.+L.+Megsonauthor=A.+D.+Flapanauthor=D.+E.+Newby&title=Vascular+Effects+of+Apelin+in+vivo+in+Man&doi=10.1016%2Fj.jacc.2008.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Effects of Apelin In Vivo in Man</span></div><div class="casAuthors">Japp, Alan G.; Cruden, Nicholas L.; Amer, David A. B.; Li, Vivienne K. Y.; Goudie, Ewan B.; Johnston, Neil R.; Sharma, Sushma; Neilson, Ilene; Webb, David J.; Megson, Ian L.; Flapan, Andrew D.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">908-913</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This study was designed to establish the direct vascular effects of apelin in vivo in man.  Apelin is the endogenous ligand for the previously orphaned G-protein-coupled receptor, APJ.  This novel pathway is widely expressed in the cardiovascular system and is emerging as an important mediator of cardiovascular homeostasis.  In pre-clin. models, apelin causes venous and arterial vasodilation.  Vascular effects of apelin were assessed in 24 healthy volunteers.  Dorsal hand vein diam. was measured by the Aellig technique during local i.v. infusions (0.1 to 3 nmol/min) of apelin-36, (Pyr1)apelin-13, and sodium nitroprusside (0.6 nmol/min).  Forearm blood flow was measured by venous occlusion plethysmog. during intrabrachial infusions of apelin-36 and (Pyr1)apelin-13 (0.1 to 30 nmol/min) and subsequently in the presence or absence of a "nitric oxide clamp" (nitric oxide synthase inhibitor, L-N G-monomethylarginine [8 μmol/min], coinfused with nitric oxide donor, sodium nitroprusside [90 to 900 ng/min]), or a single oral dose of aspirin (600 mg) or matched placebo.  Although sodium nitroprusside caused venodilation (p < 0.0001), apelin-36 and (Pyr1)apelin-13 had no effect on dorsal hand vein diam. (p = 0.2).  Both apelin isoforms caused reproducible vasodilation in forearm resistance vessels (p < 0.0001).  (Pyr1)apelin-13-mediated vasodilation was attenuated by the nitric oxide clamp (p = 0.004) but unaffected by aspirin (p = 0.7).  Although having no apparent effect on venous tone, apelin causes nitric oxide-dependent arterial vasodilation in vivo in man.  The apelin-APJ system merits further clin. investigation to det. its role in cardiovascular homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFV91OuN1h07Vg90H21EOLACvtfcHk0lgZsukP9WqPCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVyjsbnE&md5=77645b8ab8034837a4f6c3f02868f4ab</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2008.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2008.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DAmer%26aufirst%3DD.%2BA.%2BB.%26aulast%3DLi%26aufirst%3DV.%2BK.%2BY.%26aulast%3DGoudie%26aufirst%3DE.%2BB.%26aulast%3DJohnston%26aufirst%3DN.%2BR.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DNeilson%26aufirst%3DI.%26aulast%3DWebb%26aufirst%3DD.%2BJ.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26aulast%3DFlapan%26aufirst%3DA.%2BD.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DVascular%2520Effects%2520of%2520Apelin%2520in%2520vivo%2520in%2520Man%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2008%26volume%3D52%26spage%3D908%26epage%3D913%26doi%3D10.1016%2Fj.jacc.2008.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Japp, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruden, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemeren, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denvir, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Megson, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flapan, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span> <span> </span><span class="NLM_article-title">Acute Cardiovascular Effects of Apelin in Humans Potential Role in Patients with Chronic Heart Failure</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">1818</span>– <span class="NLM_lpage">1827</span>, <span class="refDoi"> DOI: 10.1161/circulationaha.109.911339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2Fcirculationaha.109.911339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=20385929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2010&pages=1818-1827&author=A.+G.+Jappauthor=N.+L.+Crudenauthor=G.+Barnesauthor=N.+van+Gemerenauthor=J.+Mathewsauthor=J.+Adamsonauthor=N.+R.+Johnstonauthor=M.+A.+Denvirauthor=I.+L.+Megsonauthor=A.+D.+Flapanauthor=D.+E.+Newby&title=Acute+Cardiovascular+Effects+of+Apelin+in+Humans+Potential+Role+in+Patients+with+Chronic+Heart+Failure&doi=10.1161%2Fcirculationaha.109.911339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Acute Cardiovascular Effects of Apelin in Humans: Potential Role in Patients With Chronic Heart Failure</span></div><div class="casAuthors">Japp, A. G.; Cruden, N. L.; Barnes, G.; van Gemeren, N.; Mathews, J.; Adamson, J.; Johnston, N. R.; Denvir, M. A.; Megson, I. L.; Flapan, A. D.; Newby, D. E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1818-1827</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND: Apelin, the endogenous ligand for the novel G protein-coupled receptor APJ, has major cardiovascular effects in preclin. models.  The study objectives were to establish the effects of acute apelin administration on peripheral, cardiac, and systemic hemodynamic variables in healthy volunteers and patients with heart failure.  METHODS AND RESULTS: Eighteen patients with New York Heart Assocn. class II to III chronic heart failure, 6 patients undergoing diagnostic coronary angiog., and 26 healthy volunteers participated in a series of randomized, double-blind, placebo-controlled studies.  Measurements of forearm blood flow, coronary blood flow, left ventricular pressure, and cardiac output were made by venous occlusion plethysmog., Doppler flow wire and quant. coronary angiog., pressure wire, and thoracic bioimpedance, resp.  Intrabrachial infusions of (Pyr)apelin-13, acetylcholine, and sodium nitroprusside caused forearm vasodilatation in patients and control subjects (all P < 0.0001).  Vasodilatation to acetylcholine (P = 0.01) but not apelin (P = 0.3) or sodium nitroprusside (P = 0.9) was attenuated in patients with heart failure.  Intracoronary bolus of apelin-36 increased coronary blood flow and the max. rate of rise in left ventricular pressure and reduced peak and end-diastolic left ventricular pressures (all P < 0.05).  Systemic infusions of (Pyr)apelin-13 (30 to 300 nmol/min) increased cardiac index and lowered mean arterial pressure and peripheral vascular resistance in patients and healthy control subjects (all P<0.01) but increased heart rate only in control subjects (P < 0.01).  CONCLUSIONS: Acute apelin administration in humans causes peripheral and coronary vasodilatation and increases cardiac output.  APJ agonism represents a novel potential therapeutic target for patients with heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiqCbkcSGzQ7Vg90H21EOLACvtfcHk0lgZsukP9WqPCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVOls7k%253D&md5=35dd169c74c36b03d9c82c1215401467</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1161%2Fcirculationaha.109.911339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252Fcirculationaha.109.911339%26sid%3Dliteratum%253Aachs%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DBarnes%26aufirst%3DG.%26aulast%3Dvan%2BGemeren%26aufirst%3DN.%26aulast%3DMathews%26aufirst%3DJ.%26aulast%3DAdamson%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DN.%2BR.%26aulast%3DDenvir%26aufirst%3DM.%2BA.%26aulast%3DMegson%26aufirst%3DI.%2BL.%26aulast%3DFlapan%26aufirst%3DA.%2BD.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DAcute%2520Cardiovascular%2520Effects%2520of%2520Apelin%2520in%2520Humans%2520Potential%2520Role%2520in%2520Patients%2520with%2520Chronic%2520Heart%2520Failure%26jtitle%3DCirculation%26date%3D2010%26volume%3D121%26spage%3D1818%26epage%3D1827%26doi%3D10.1161%2Fcirculationaha.109.911339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veitch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruden, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Japp, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, D. E.</span></span> <span> </span><span class="NLM_article-title">Sustained Cardiovascular Actions of APJ Agonism During Renin-angiotensin System Activation and in Patients with Heart Failure</span>. <i>Circ.: Heart Failure</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1161/circheartfailure.111.000077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1161%2FCIRCHEARTFAILURE.111.000077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=23519586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSntbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=482-491&author=G.+D.+Barnesauthor=S.+Alamauthor=G.+Carterauthor=C.+M.+Pedersenauthor=K.+M.+Leeauthor=T.+J.+Hubbardauthor=S.+Veitchauthor=H.+Jeongauthor=A.+Whiteauthor=N.+L.+Crudenauthor=L.+Husonauthor=A.+G.+Jappauthor=D.+E.+Newby&title=Sustained+Cardiovascular+Actions+of+APJ+Agonism+During+Renin-angiotensin+System+Activation+and+in+Patients+with+Heart+Failure&doi=10.1161%2Fcircheartfailure.111.000077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained Cardiovascular Actions of APJ Agonism During Renin-Angiotensin System Activation and in Patients With Heart Failure</span></div><div class="casAuthors">Barnes, Gareth D.; Alam, Shirjel; Carter, Gordon; Pedersen, Christian M.; Lee, Kristina M.; Hubbard, Thomas J.; Veitch, Scott; Jeong, Herim; White, Audrey; Cruden, Nicholas L.; Huson, Les; Japp, Alan G.; Newby, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation: Heart Failure</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">482-491</span>CODEN:
                <span class="NLM_cas:coden">CHFICM</span>;
        ISSN:<span class="NLM_cas:issn">1941-3289</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">BACKGROUND-: To assess cardiovascular actions of APJ agonism during prolonged (Pyr)apelin-13 infusion and renin-angiotensin system activation.  METHODS AND RESULTS-: Forty-eight volunteers and 12 patients with chronic stable heart failure attended a series of randomized placebo-controlled studies.  Forearm blood flow, cardiac index, left ventricular dimensions, and mean arterial pressure were measured using bilateral venous occlusion plethysmog., bioimpedance cardiog., transthoracic echocardiog., and sphygmomanometry, resp., during brief local (0.3-3.0 nmol/min) and systemic (30-300 nmol/min) or prolonged systemic (30 nmol/min) (Pyr)apelin-13 infusions in the presence or absence of renin-angiotensin system activation with sodium depletion or angiotensin II coinfusion.  During sodium depletion and angiotensin II coinfusion, (Pyr)apelin-13-induced vasodilatation was preserved (P<0.02 for both).  Systemic i.v. (Pyr)apelin-13 infusion increased cardiac index, whereas reducing mean arterial pressure and peripheral vascular resistance index (P<0.001 for all) irresp. of sodium depletion or angiotensin II (0.5 ng/kg per min) coinfusion (P>0.05 for all).  Prolonged 6-h (Pyr)apelin-13 infusion caused a sustained increase in cardiac index with increased left ventricular ejection fraction in patients with chronic heart failure (ANOVA; P<0.001 for all).  CONCLUSIONS-: APJ agonism has sustained cardiovascular effects that are preserved in the presence of renin-angiotensin system activation or heart failure.  APJ agonism may hold major promise to complement current optimal medical therapy in patients with chronic heart failure.  Clin. TRIAL REGISTRATION-: URL: http://www.clinicaltrials.gov.  Unique identifiers: NCT00901719, NCT00901888, NCT01049646, NCT01179061.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWOAUpCsQtubVg90H21EOLACvtfcHk0liKd0_qSjIw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSntbvM&md5=7aa0219a8f5a363c3092b1b6a0631ed2</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1161%2FCIRCHEARTFAILURE.111.000077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCHEARTFAILURE.111.000077%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DG.%2BD.%26aulast%3DAlam%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DG.%26aulast%3DPedersen%26aufirst%3DC.%2BM.%26aulast%3DLee%26aufirst%3DK.%2BM.%26aulast%3DHubbard%26aufirst%3DT.%2BJ.%26aulast%3DVeitch%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DCruden%26aufirst%3DN.%2BL.%26aulast%3DHuson%26aufirst%3DL.%26aulast%3DJapp%26aufirst%3DA.%2BG.%26aulast%3DNewby%26aufirst%3DD.%2BE.%26atitle%3DSustained%2520Cardiovascular%2520Actions%2520of%2520APJ%2520Agonism%2520During%2520Renin-angiotensin%2520System%2520Activation%2520and%2520in%2520Patients%2520with%2520Heart%2520Failure%26jtitle%3DCirc.%253A%2520Heart%2520Failure%26date%3D2013%26volume%3D6%26spage%3D482%26epage%3D491%26doi%3D10.1161%2Fcircheartfailure.111.000077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudej, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akita, G. Y.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular Effects of a PEGylated Apelin</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2012.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.peptides.2012.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=22986020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GqurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=181-188&author=Z.+Q.+Jiaauthor=L.+Houauthor=A.+Legerauthor=I.+Wuauthor=A.+B.+Kudejauthor=J.+Stefanoauthor=C.+Jiangauthor=C.+Q.+Panauthor=G.+Y.+Akita&title=Cardiovascular+Effects+of+a+PEGylated+Apelin&doi=10.1016%2Fj.peptides.2012.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular effects of a PEGylated apelin</span></div><div class="casAuthors">Jia, Z. Q.; Hou, L.; Leger, A.; Wu, I.; Kudej, A. B.; Stefano, J.; Jiang, C.; Pan, C. Q.; Akita, G. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-188</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several studies have documented cardiovascular effects of apelin, including enhanced inotropy and vasodilation.  However, these cardiovascular effects are short lived due to the predicted short circulating half-life of the apelin peptide.  To address this limitation of apelin, we pursued N-terminal PEGylation of apelin and examd. the cardiovascular effects of the PEGylated apelin.  A 40 kDa PEG conjugated apelin-36 (PEG-apelin-36) was successfully produced with N-terminal conjugation, high purity (>98%) and min. redn. of APJ receptor binding affinity.  Using an adenylate cyclase inhibition assay, comparable in vitro bioactivity was obsd. between the PEG-apelin-36 and unmodified apelin-36.  In vivo evaluation of the PEG-apelin-36 was performed in normal rats and rats with myocardial infarction (MI).  Cardiac function was assessed via echocardiog. before, during a 20 min IV infusion and up to 100 min post peptide infusion.  Similar increases in cardiac ejection fraction (EF) were obsd. during the infusion of PEG-apelin-36 and apelin-36 in normal rats.  However, animals that received PEG-apelin-36 maintained significantly increased EF over the 100 min post infusion monitoring period compared to the animals that received unmodified apelin-36.  Interestingly, EF increases obsd. with PEG-apelin-36 and apelin-36 were greater in the MI rats.  PEG-apelin-36 had a prolonged circulating life compared to apelin-36 in rats.  There were no changes in aortic blood pressure when PEG-apelin-36 or apelin-36 was administered.  To our knowledge this is the first report of apelin PEGylation and documentation of its cardiovascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHeGbLwfiE0rVg90H21EOLACvtfcHk0liKd0_qSjIw5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GqurnI&md5=f46c15bd9764951ab36614c183304f0c</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2012.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2012.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.%2BQ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DLeger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DI.%26aulast%3DKudej%26aufirst%3DA.%2BB.%26aulast%3DStefano%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DC.%2BQ.%26aulast%3DAkita%26aufirst%3DG.%2BY.%26atitle%3DCardiovascular%2520Effects%2520of%2520a%2520PEGylated%2520Apelin%26jtitle%3DPeptides%26date%3D2012%26volume%3D38%26spage%3D181%26epage%3D188%26doi%3D10.1016%2Fj.peptides.2012.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Macaluso, N. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span> <span> </span><span class="NLM_article-title">Exploring the “RPRL” Motif of Apelin-13 through Molecular Simulation and Biological Evaluation of Cyclic Peptide Analogues</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1002%2Fcmdc.201000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=20486151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptl2jur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1247-1253&author=N.+J.+M.+Macalusoauthor=R.+C.+Glen&title=Exploring+the+%E2%80%9CRPRL%E2%80%9D+Motif+of+Apelin-13+through+Molecular+Simulation+and+Biological+Evaluation+of+Cyclic+Peptide+Analogues&doi=10.1002%2Fcmdc.201000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the RPRL' Motif of Apelin-13 through Molecular Simulation and Biological Evaluation of Cyclic Peptide Analogues</span></div><div class="casAuthors">Macaluso, N. J. Maximilian; Glen, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1247-1253</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Structural and binding-affinity studies on N-terminal fragments of apelin-13, either linear or cyclic, have not been performed.  Without exptl.-derived coordinates of apelin bound to the active APJ receptor, how can we know that a β-turn at the RPRL sequence is indeed important for ligand recognition in APJ receptor binding To address this question, we designed four novel cyclic peptide analogs of apelin-13 from the first nine residues of the natural sequence.  This result reveals the importance of conformation, namely the β-turn at the RPRL sequence, in apelin receptor ligand recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0cuIWzSe9SrVg90H21EOLACvtfcHk0lgy639LKt2xDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptl2jur4%253D&md5=a57328da2633e223b154dcb8461141ec</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000061%26sid%3Dliteratum%253Aachs%26aulast%3DMacaluso%26aufirst%3DN.%2BJ.%2BM.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DExploring%2520the%2520%25E2%2580%259CRPRL%25E2%2580%259D%2520Motif%2520of%2520Apelin-13%2520through%2520Molecular%2520Simulation%2520and%2520Biological%2520Evaluation%2520of%2520Cyclic%2520Peptide%2520Analogues%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1247%26epage%3D1253%26doi%3D10.1002%2Fcmdc.201000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Murza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besserer-Offroy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karadereye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, É.</span></span> <span> </span><span class="NLM_article-title">Elucidation of the Structure-activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma Stability</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1002%2Fcmdc.201100492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=22170700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=318-325&author=A.+Murzaauthor=A.+Parentauthor=E.+Besserer-Offroyauthor=H.+Tremblayauthor=F.+Karadereyeauthor=N.+Beaudetauthor=R.+Leducauthor=P.+Sarretauthor=%C3%89.+Marsault&title=Elucidation+of+the+Structure-activity+Relationships+of+Apelin%3A+Influence+of+Unnatural+Amino+Acids+on+Binding%2C+Signaling%2C+and+Plasma+Stability&doi=10.1002%2Fcmdc.201100492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of the Structure-Activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma Stability</span></div><div class="casAuthors">Murza, Alexandre; Parent, Alexandre; Besserer-Offroy, Elie; Tremblay, Hugo; Karadereye, Felix; Beaudet, Nicolas; Leduc, Richard; Sarret, Philippe; Marsault, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-325</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Apelin is the endogenous ligand of the APJ receptor, a member of the G-protein-coupled receptor family.  The apelin-APJ complex has been detected in many tissues and is emerging as a promising target for several pathophysiol. conditions.  There is currently little information on the structure-activity relationship (SAR) of the apelin hormone.  In an effort to better delineate SAR, we synthesized analogs of apelin-13 modified at selected positions with unnatural amino acids, with a particular emphasis on the C-terminal portion.  Analogs were then tested in binding and functional assays by evaluating Gi/o-mediated decreases in cAMP levels and by assessing β-arrestin2 recruitment to the APJ receptor.  The plasma stability of new compds. was also assessed.  Several analogs were found to possess increased binding and higher stability than the parent peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb17rjHTl2IrVg90H21EOLACvtfcHk0lgy639LKt2xDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sgur%252FL&md5=01202090f34b4a1933a0a3045cdf5763</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100492%26sid%3Dliteratum%253Aachs%26aulast%3DMurza%26aufirst%3DA.%26aulast%3DParent%26aufirst%3DA.%26aulast%3DBesserer-Offroy%26aufirst%3DE.%26aulast%3DTremblay%26aufirst%3DH.%26aulast%3DKaradereye%26aufirst%3DF.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DSarret%26aufirst%3DP.%26aulast%3DMarsault%26aufirst%3D%25C3%2589.%26atitle%3DElucidation%2520of%2520the%2520Structure-activity%2520Relationships%2520of%2520Apelin%253A%2520Influence%2520of%2520Unnatural%2520Amino%2520Acids%2520on%2520Binding%252C%2520Signaling%252C%2520and%2520Plasma%2520Stability%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D318%26epage%3D325%26doi%3D10.1002%2Fcmdc.201100492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhungana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span></span> <span> </span><span class="NLM_article-title">Identifying Structural Determinants of Potency for Analogs of Apelin-13: Integration of C-terminal Truncation with Structure-activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2992</span>– <span class="NLM_lpage">2997</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bmc.2014.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=24755525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2992-2997&author=Y.+Zhangauthor=R.+Maitraauthor=D.+L.+Harrisauthor=S.+Dhunganaauthor=R.+Snyderauthor=S.+P.+Runyon&title=Identifying+Structural+Determinants+of+Potency+for+Analogs+of+Apelin-13%3A+Integration+of+C-terminal+Truncation+with+Structure-activity&doi=10.1016%2Fj.bmc.2014.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure-activity</span></div><div class="casAuthors">Zhang, Yanyan; Maitra, Rangan; Harris, Danni L.; Dhungana, Suraj; Snyder, Rodney; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2992-2997</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apelin peptides function as endogenous ligands of the APJ receptor and have been implicated in a no. of important biol. processes.  While several apelinergic peptides have been reported, apelin-13 (Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe) remains the most commonly studied and reported ligand of APJ.  This study examines the effect of C-terminal peptide truncations and comprehensive structure-activity relationship (SAR) for a series of analogs based on apelin-13 to develop more potent and stable analogs.  C-terminal truncation studies identified apelin-13 (N-acetyl 2-11) amide as a potent agonist (EC50 = 4.4 nM).  Comprehensive SAR studies also detd. that Arg 2, Leu 5, Lys 8, Met 11, were key positions for detg. agonist potency, whereas the hydrophobic vol. of Lys-8 was a specific determinate of activity.  Plasma stability studies on the truncated 10-mer peptide (EC50 = 33 nM) indicated the primary sites of cleavage occurred between Nle 3 and Leu 4 and also between Ala 5 and Ala-6.  These new ligands represent the shortest known apelin peptides with good functional potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvVQ3Bxd0D_bVg90H21EOLACvtfcHk0ljVM1lv-XN8Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCmurg%253D&md5=6f04420714d191792dd27d43796d886d</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DD.%2BL.%26aulast%3DDhungana%26aufirst%3DS.%26aulast%3DSnyder%26aufirst%3DR.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DIdentifying%2520Structural%2520Determinants%2520of%2520Potency%2520for%2520Analogs%2520of%2520Apelin-13%253A%2520Integration%2520of%2520C-terminal%2520Truncation%2520with%2520Structure-activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2992%26epage%3D2997%26doi%3D10.1016%2Fj.bmc.2014.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Iturriox, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvear-Perez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mota, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabire, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Jouan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabane, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerbier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdeaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maigret, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galzi, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llorens-Cortes, C.</span></span> <span> </span><span class="NLM_article-title">Identification and Pharmacological Properties of E339-3D6, the First Nonpeptidic Apelin Receptor Agonist</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1506</span>– <span class="NLM_lpage">1516</span>, <span class="refDoi"> DOI: 10.1096/fj.09-140715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1096%2Ffj.09-140715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=20040517" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=1506-1516&author=X.+Iturrioxauthor=R.+Alvear-Perezauthor=N.+De+Motaauthor=C.+Franchetauthor=F.+Guillierauthor=V.+Lerouxauthor=H.+Dabireauthor=M.+Le+Jouanauthor=H.+Chabaneauthor=R.+Gerbierauthor=D.+Bonnetauthor=A.+Berdeauxauthor=B.+Maigretauthor=J.-L.+Galziauthor=M.+Hibertauthor=C.+Llorens-Cortes&title=Identification+and+Pharmacological+Properties+of+E339-3D6%2C+the+First+Nonpeptidic+Apelin+Receptor+Agonist&doi=10.1096%2Ffj.09-140715"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1096%2Ffj.09-140715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.09-140715%26sid%3Dliteratum%253Aachs%26aulast%3DIturriox%26aufirst%3DX.%26aulast%3DAlvear-Perez%26aufirst%3DR.%26aulast%3DDe%2BMota%26aufirst%3DN.%26aulast%3DFranchet%26aufirst%3DC.%26aulast%3DGuillier%26aufirst%3DF.%26aulast%3DLeroux%26aufirst%3DV.%26aulast%3DDabire%26aufirst%3DH.%26aulast%3DLe%2BJouan%26aufirst%3DM.%26aulast%3DChabane%26aufirst%3DH.%26aulast%3DGerbier%26aufirst%3DR.%26aulast%3DBonnet%26aufirst%3DD.%26aulast%3DBerdeaux%26aufirst%3DA.%26aulast%3DMaigret%26aufirst%3DB.%26aulast%3DGalzi%26aufirst%3DJ.-L.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DLlorens-Cortes%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520Pharmacological%2520Properties%2520of%2520E339-3D6%252C%2520the%2520First%2520Nonpeptidic%2520Apelin%2520Receptor%2520Agonist%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D1506%26epage%3D1516%26doi%3D10.1096%2Ffj.09-140715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, P.</span>; <span class="NLM_string-name">Maloney, P. R.</span>; <span class="NLM_string-name">Hedrick, M.</span>; <span class="NLM_string-name">Gosalia, P.</span>; <span class="NLM_string-name">Milewski, M.</span>; <span class="NLM_string-name">Li, L.</span>; <span class="NLM_string-name">Roth, G. R.</span>; <span class="NLM_string-name">Sergienko, E.</span>; <span class="NLM_string-name">Suyama, E.</span>; <span class="NLM_string-name">Sugarman, E.</span>; <span class="NLM_string-name">Nguyen, K.</span>; <span class="NLM_string-name">Mehta, A.</span>; <span class="NLM_string-name">Vasile, S.</span>; <span class="NLM_string-name">Su, Y.</span>; <span class="NLM_string-name">Shi, S.</span>; <span class="NLM_string-name">Stonich, D.</span>; <span class="NLM_string-name">Nguyen, H.</span>; <span class="NLM_string-name">Zeng, F.-Y.</span>; <span class="NLM_string-name">Novo, A. M.</span>; <span class="NLM_string-name">Vicchiarelli, M.</span>; <span class="NLM_string-name">Diwan, J.</span>; <span class="NLM_string-name">Chung, T. D. Y.</span>; <span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Smith, L. H.</span></span> <i>Functional Agonists of the Apelin (APJ) Receptor</i>. Sanford Burnham Center for Chemical Genomics Probe Report. <span class="NLM_year">2011</span>; <a href="http://www.ncbi.nlm.nih.gov/books/NBK98921/" class="extLink">http://www.ncbi.nlm.nih.gov/books/NBK98921/</a> (accessed Oct 28, <span class="NLM_year">2019</span>);</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+Khan&author=P.+R.+Maloney&author=M.+Hedrick&author=P.+Gosalia&author=M.+Milewski&author=L.+Li&author=G.+R.+Roth&author=E.+Sergienko&author=E.+Suyama&author=E.+Sugarman&author=K.+Nguyen&author=A.+Mehta&author=S.+Vasile&author=Y.+Su&author=S.+Shi&author=D.+Stonich&author=H.+Nguyen&author=F.-Y.+Zeng&author=A.+M.+Novo&author=M.+Vicchiarelli&author=J.+Diwan&author=T.+D.+Y.+Chung&author=A.+B.+Pinkerton&author=L.+H.+Smith&title=Functional+Agonists+of+the+Apelin+%28APJ%29+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DP.%26jtitle%3DFunctional%2520Agonists%2520of%2520the%2520Apelin%2520%2528APJ%2529%2520Receptor%26date%3D2011%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hachtel, S.</span>; <span class="NLM_string-name">Wohlfart, P.</span>; <span class="NLM_string-name">Weston, J.</span>; <span class="NLM_string-name">Mueller, M.</span>; <span class="NLM_string-name">Defossa, E.</span>; <span class="NLM_string-name">Mertsch, K.</span>; <span class="NLM_string-name">Weng, J.-H.</span>; <span class="NLM_string-name">Binnie, R. A.</span>; <span class="NLM_string-name">Abdul-Latif, F.</span>; <span class="NLM_string-name">Bock, W. J.</span>; <span class="NLM_string-name">Walser, A.</span></span> <span> </span><span class="NLM_article-title">Benzoimidazole-carboxylic Acid Amide Derivatives as APJ Receptor Modulators</span>. PCT Int. Appl. <span class="NLM_patent">WO2014044738A1</span>, <span class="NLM_year">2014</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Hachtel&author=P.+Wohlfart&author=J.+Weston&author=M.+Mueller&author=E.+Defossa&author=K.+Mertsch&author=J.-H.+Weng&author=R.+A.+Binnie&author=F.+Abdul-Latif&author=W.+J.+Bock&author=A.+Walser&title=Benzoimidazole-carboxylic+Acid+Amide+Derivatives+as+APJ+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHachtel%26aufirst%3DS.%26atitle%3DBenzoimidazole-carboxylic%2520Acid%2520Amide%2520Derivatives%2520as%2520APJ%2520Receptor%2520Modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Smith, L. H.</span></span> <span> </span><span class="NLM_article-title">Agonists of the Apelin Receptor and Methods of Use</span>. <span class="NLM_patent">WO2015184011A2</span>, <span class="NLM_year">2015</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+B.+Pinkerton&author=L.+H.+Smith&title=Agonists+of+the+Apelin+Receptor+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26atitle%3DAgonists%2520of%2520the%2520Apelin%2520Receptor%2520and%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span>; <span class="NLM_string-name">Maitra, R.</span>; <span class="NLM_string-name">Narayanan, S.</span>; <span class="NLM_string-name">Thomas, J. B.</span></span> <span> </span><span class="NLM_article-title">Preparation of Imidazolecarboxylic Acid Amino Acid and Peptide Amides as Apelin Receptor Agonists and Uses thereof</span>. <span class="NLM_patent">WO2015188073A1</span>, <span class="NLM_year">2015</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+P.+Runyon&author=R.+Maitra&author=S.+Narayanan&author=J.+B.+Thomas&title=Preparation+of+Imidazolecarboxylic+Acid+Amino+Acid+and+Peptide+Amides+as+Apelin+Receptor+Agonists+and+Uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DPreparation%2520of%2520Imidazolecarboxylic%2520Acid%2520Amino%2520Acid%2520and%2520Peptide%2520Amides%2520as%2520Apelin%2520Receptor%2520Agonists%2520and%2520Uses%2520thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortoff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasukuttan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Small Molecule Agonist Scaffold for the APJ Receptor</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3758</span>– <span class="NLM_lpage">3770</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bmc.2016.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=27369451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOntLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3758-3770&author=S.+Narayananauthor=R.+Maitraauthor=J.+R.+Deschampsauthor=K.+Bortoffauthor=J.+B.+Thomasauthor=Y.+Zhangauthor=K.+Warnerauthor=V.+Vasukuttanauthor=A.+Deckerauthor=S.+P.+Runyon&title=Discovery+of+a+Novel+Small+Molecule+Agonist+Scaffold+for+the+APJ+Receptor&doi=10.1016%2Fj.bmc.2016.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10fR"><div class="casContent"><span class="casTitleNuber">10f</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel small molecule agonist scaffold for the APJ receptor</span></div><div class="casAuthors">Narayanan, Sanju; Maitra, Rangan; Deschamps, Jeffery R.; Bortoff, Katherine; Thomas, James B.; Zhang, Yanyan; Warner, Keith; Vasukuttan, Vineetha; Decker, Ann; Runyon, Scott P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3758-3770</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The apelinergic system includes a series of endogenous peptides apelin, ELABELA/TODDLER and their 7-transmembrane G-protein coupled apelin receptor (APJ, AGTRL-1, APLNR).  The APJ receptor is an attractive therapeutic target because of its involvement in cardiovascular diseases and potentially other disorders including liver fibrosis, obesity, diabetes, and neuroprotection.  To date, pharmacol. characterization of the APJ receptor has been limited due to the lack of small mol. functional agonists or antagonists.  Through focused screening we identified a drug-like small mol. agonist hit 1 with a functional EC50 value of 21.5 ± 5 μM and binding affinity (Ki) of 5.2 ± 0.5 μM.  Initial structure-activity studies afforded compd. 22 having a 27-fold enhancement in potency and the first sub-micromolar full agonist with an EC50 value of 800 ± 0.1 nM and Ki of 1.3 ± 0.3 μM.  Preliminary SAR, synthetic methodol., and in vitro pharmacol. characterization indicate this scaffold will serve as a favorable starting point for further refinement of APJ potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol6Pre0xFpRbVg90H21EOLACvtfcHk0liie4zolfzGuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOntLnK&md5=5732daf586e08076db669b2e9aca1602</span></div><a href="/servlet/linkout?suffix=cit10f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DBortoff%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWarner%26aufirst%3DK.%26aulast%3DVasukuttan%26aufirst%3DV.%26aulast%3DDecker%26aufirst%3DA.%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Small%2520Molecule%2520Agonist%2520Scaffold%2520for%2520the%2520APJ%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3758%26epage%3D3770%26doi%3D10.1016%2Fj.bmc.2016.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Read, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuc, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, A. P.</span></span> <span> </span><span class="NLM_article-title">Cardiac Action of the First G protein Biased Small Molecule Apelin Agonist</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2016.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bcp.2016.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=27475715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1GhtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=63-72&author=C.+Readauthor=C.+M.+Fitzpatrickauthor=P.+Yangauthor=R.+E.+Kucauthor=J.+J.+Maguireauthor=R.+C.+Glenauthor=R.+E.+Fosterauthor=A.+P.+Davenport&title=Cardiac+Action+of+the+First+G+protein+Biased+Small+Molecule+Apelin+Agonist&doi=10.1016%2Fj.bcp.2016.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10gR"><div class="casContent"><span class="casTitleNuber">10g</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac action of the first G protein biased small molecule apelin agonist</span></div><div class="casAuthors">Read, Cai; Fitzpatrick, Christopher M.; Yang, Peiran; Kuc, Rhoda E.; Maguire, Janet J.; Glen, Robert C.; Foster, Richard E.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Apelin peptide analogs displaying bias towards G protein signalling pathways have beneficial cardiovascular actions compared with the native peptide in humans in vivo.  Our aim was to det. whether small mol. agonists could retain G protein bias.  We have identified a biased small mol., CMF-019 (I), and characterised it in vitro and in vivo.  In competition radioligand binding expts. in heart homogenates, CMF-019 bound to the human, rat and mouse apelin receptor with high affinity (pKi = 8.58 ± 0.04, 8.49 ± 0.04 and 8.71 ± 0.06 resp.).  In cell-based functional assays, whereas, CMF-019 showed similar potency for the Gαi pathway to the endogenous agonist [Pyr1]apelin-13 (pD2 = 10.00 ± 0.13 vs 9.34 ± 0.15), in β-arrestin and internalisation assays it was less potent (pD2 = 6.65 ± 0.15 vs 8.65 ± 0.10 and pD2 = 6.16 ± 0.21 vs 9.28 ± 0.10 resp.).  Anal. of these data demonstrated a bias of ∼400 for the Gαi over the β-arrestin pathway and ∼6000 over receptor internalisation.  CMF-019 was tested for in vivo activity using i.v. injections into anesthetized male Sprague-Dawley rats fitted with a pressure-vol. catheter in the left ventricle.  CMF-019 caused a significant increase in cardiac contractility of 606 ± 112 mmHg/s (p < 0.001) at 500 nmol.  CMF-019 is the first biased small mol. identified at the apelin receptor and increases cardiac contractility in vivo.  We have demonstrated that Gαi over β-arrestin/internalisation bias can be retained in a non-peptide analog and predict that such bias will have the therapeutic benefit following chronic use.  CMF-019 is suitable as a tool compd. and provides the basis for design of biased agonists with improved pharmacokinetics for treatment of cardiovascular conditions such as pulmonary arterial hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqmJ0WndHEdLVg90H21EOLACvtfcHk0liie4zolfzGuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1GhtbnJ&md5=0a2ba0ccb57382ceda2e0d27ff46c61e</span></div><a href="/servlet/linkout?suffix=cit10g&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2016.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2016.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DRead%26aufirst%3DC.%26aulast%3DFitzpatrick%26aufirst%3DC.%2BM.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DKuc%26aufirst%3DR.%2BE.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DFoster%26aufirst%3DR.%2BE.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DCardiac%2520Action%2520of%2520the%2520First%2520G%2520protein%2520Biased%2520Small%2520Molecule%2520Apelin%2520Agonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2016%26volume%3D116%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.bcp.2016.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span>; <span class="NLM_string-name">Kim, S.-H.</span>; <span class="NLM_string-name">Lawrence, R. M.</span>; <span class="NLM_string-name">Myers, M. C.</span>; <span class="NLM_string-name">Chao, H. J.</span>; <span class="NLM_string-name">Phillips, M.</span>; <span class="NLM_string-name">Jiang, J.</span></span> <span> </span><span class="NLM_article-title">Preparation of 4-Hydroxy-3-(heteroaryl)pyridine-2-one APJ Agonists for Use in the Treatment of Cardiovascular Disorders</span>. <span class="NLM_patent">WO2016196771A1</span>, <span class="NLM_year">2016</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+A.+Johnson&author=S.-H.+Kim&author=R.+M.+Lawrence&author=M.+C.+Myers&author=H.+J.+Chao&author=M.+Phillips&author=J.+Jiang&title=Preparation+of+4-Hydroxy-3-%28heteroaryl%29pyridine-2-one+APJ+Agonists+for+Use+in+the+Treatment+of+Cardiovascular+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DPreparation%2520of%25204-Hydroxy-3-%2528heteroaryl%2529pyridine-2-one%2520APJ%2520Agonists%2520for%2520Use%2520in%2520the%2520Treatment%2520of%2520Cardiovascular%2520Disorders%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Holder, J. R.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Miranda, L. P.</span>; <span class="NLM_string-name">Aral, J.</span>; <span class="NLM_string-name">Doherty, E. M.</span>; <span class="NLM_string-name">Nixey, T.</span></span> <span> </span><span class="NLM_article-title">APJ Receptor Agonists and Uses thereof</span>. U.S. Patent <span class="NLM_patent">20,160,067,347 A1</span>, <span class="NLM_year">2016</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+R.+Holder&author=G.+Swaminath&author=L.+P.+Miranda&author=J.+Aral&author=E.+M.+Doherty&author=T.+Nixey&title=APJ+Receptor+Agonists+and+Uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolder%26aufirst%3DJ.%2BR.%26atitle%3DAPJ%2520Receptor%2520Agonists%2520and%2520Uses%2520thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span>; <span class="NLM_string-name">Maitra, R.</span>; <span class="NLM_string-name">Narayanan, S.</span>; <span class="NLM_string-name">Thomas, J. B.</span>; <span class="NLM_string-name">Rehder, K. S.</span>; <span class="NLM_string-name">Olepu, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted Pyrazoles as Improved Apelin Receptor (APJ) Agonists and Uses thereof</span>. <span class="NLM_patent">WO2017100558A1</span>, <span class="NLM_year">2017</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+P.+Runyon&author=R.+Maitra&author=S.+Narayanan&author=J.+B.+Thomas&author=K.+S.+Rehder&author=S.+Olepu&title=Preparation+of+Substituted+Pyrazoles+as+Improved+Apelin+Receptor+%28APJ%29+Agonists+and+Uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DPreparation%2520of%2520Substituted%2520Pyrazoles%2520as%2520Improved%2520Apelin%2520Receptor%2520%2528APJ%2529%2520Agonists%2520and%2520Uses%2520thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Connors, R. V.</span>; <span class="NLM_string-name">Debenedetto, M. V.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Fu, Z.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Hedley, S. J.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Judd, T. C.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Olson, S. H.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Yeh, W.-C.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Triazole Compounds as Agonists of the APJ Receptor</span>. <span class="NLM_patent">WO2017192485A1</span>, <span class="NLM_year">2017</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=X.+Chen&author=Y.+Chen&author=A.+C.+Cheng&author=R.+V.+Connors&author=M.+V.+Debenedetto&author=P.+J.+Dransfield&author=Z.+Fu&author=J.+S.+Harvey&author=J.+A.+Heath&author=S.+J.+Hedley&author=J.+Houze&author=T.+C.+Judd&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=N.+Nishimura&author=S.+H.+Olson&author=V.+Pattaropong&author=G.+Swaminath&author=X.+Wang&author=W.-C.+Yeh&title=Heterocyclic+Triazole+Compounds+as+Agonists+of+the+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26atitle%3DHeterocyclic%2520Triazole%2520Compounds%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Connors, R. V.</span>; <span class="NLM_string-name">Deignan, J.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Fu, Z.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Horne, D. B.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Kaller, M. R.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">McGee, L. R.</span>; <span class="NLM_string-name">Medina, J. C.</span>; <span class="NLM_string-name">Mihalic, J. T.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Olson, S. H.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Yang, K.</span>; <span class="NLM_string-name">Yeh, W.-C.</span>; <span class="NLM_string-name">Debenedetto, M. V.</span>; <span class="NLM_string-name">Farrell, R. P.</span>; <span class="NLM_string-name">Hedley, S. J.</span>; <span class="NLM_string-name">Judd, T. C.</span>; <span class="NLM_string-name">Kayser, F.</span></span> <span> </span><span class="NLM_article-title">Triazoles as Agonists of the APJ Receptor and their Preparation</span>. <span class="NLM_patent">WO2016187308A1</span>, <span class="NLM_year">2016</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+Chen&author=X.+Chen&author=Y.+Chen&author=A.+C.+Cheng&author=R.+V.+Connors&author=J.+Deignan&author=P.+J.+Dransfield&author=X.+Du&author=Z.+Fu&author=J.+A.+Heath&author=D.+B.+Horne&author=J.+Houze&author=M.+R.+Kaller&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=L.+R.+McGee&author=J.+C.+Medina&author=J.+T.+Mihalic&author=N.+Nishimura&author=S.+H.+Olson&author=V.+Pattaropong&author=G.+Swaminath&author=X.+Wang&author=K.+Yang&author=W.-C.+Yeh&author=M.+V.+Debenedetto&author=R.+P.+Farrell&author=S.+J.+Hedley&author=T.+C.+Judd&author=F.+Kayser&title=Triazoles+as+Agonists+of+the+APJ+Receptor+and+their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26atitle%3DTriazoles%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%2520and%2520their%2520Preparation%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span>; <span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Connors, R. V.</span>; <span class="NLM_string-name">Deignan, J.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Fu, Z.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Heumann, L. V.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Kayser, F.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Medina, J. C.</span>; <span class="NLM_string-name">Mihalic, J. T.</span>; <span class="NLM_string-name">Olson, S. H.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Wanska, M.</span>; <span class="NLM_string-name">Yeh, W.-C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Furanyl Triazoles as Agonists of the APJ Receptor</span>. <span class="NLM_patent">WO2018097944A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Brown&author=N.+Chen&author=X.+Chen&author=Y.+Chen&author=A.+C.+Cheng&author=R.+V.+Connors&author=J.+Deignan&author=P.+J.+Dransfield&author=X.+Du&author=Z.+Fu&author=J.+S.+Harvey&author=J.+A.+Heath&author=L.+V.+Heumann&author=J.+Houze&author=F.+Kayser&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=J.+C.+Medina&author=J.+T.+Mihalic&author=S.+H.+Olson&author=V.+Pattaropong&author=G.+Swaminath&author=X.+Wang&author=M.+Wanska&author=W.-C.+Yeh&title=Preparation+of+Furanyl+Triazoles+as+Agonists+of+the+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Furanyl%2520Triazoles%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Chen, X.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Connors, R. V.</span>; <span class="NLM_string-name">Deignan, J.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Fu, Z.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Heumann, L. V.</span>; <span class="NLM_string-name">Horne, D. B.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Kaller, M. R.</span>; <span class="NLM_string-name">Kayser, F.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Medina, J. C.</span>; <span class="NLM_string-name">Mihalic, J. T.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Olson, S. H.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Wang, X.</span>; <span class="NLM_string-name">Wanska, M.</span>; <span class="NLM_string-name">Yang, K.</span>; <span class="NLM_string-name">Yeh, W.-C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Heteroaryl Triazoles as Agonists of the APJ Receptor</span>. <span class="NLM_patent">WO2018097945A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=N.+Chen&author=X.+Chen&author=Y.+Chen&author=A.+C.+Cheng&author=R.+V.+Connors&author=J.+Deignan&author=P.+J.+Dransfield&author=X.+Du&author=Z.+Fu&author=J.+S.+Harvey&author=J.+A.+Heath&author=L.+V.+Heumann&author=D.+B.+Horne&author=J.+Houze&author=M.+R.+Kaller&author=F.+Kayser&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=J.+C.+Medina&author=J.+T.+Mihalic&author=N.+Nishimura&author=S.+H.+Olson&author=V.+Pattaropong&author=G.+Swaminath&author=X.+Wang&author=M.+Wanska&author=K.+Yang&author=W.-C.+Yeh&title=Preparation+of+Heteroaryl+Triazoles+as+Agonists+of+the+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26atitle%3DPreparation%2520of%2520Heteroaryl%2520Triazoles%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Debenedetto, M. V.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Yeh, W.-C.</span>; <span class="NLM_string-name">Kreiman, C.</span></span> <span> </span><span class="NLM_article-title">Preparation of Triazole Phenyl Compounds as Agonists of APJ Receptor</span>. <span class="NLM_patent">WO2018093579A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=N.+Chen&author=Y.+Chen&author=M.+V.+Debenedetto&author=P.+J.+Dransfield&author=J.+S.+Harvey&author=J.+A.+Heath&author=J.+Houze&author=A.+Y.+Khakoo&author=S.-J.+Lai&author=Z.+Ma&author=N.+Nishimura&author=V.+Pattaropong&author=G.+Swaminath&author=W.-C.+Yeh&author=C.+Kreiman&title=Preparation+of+Triazole+Phenyl+Compounds+as+Agonists+of+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26atitle%3DPreparation%2520of%2520Triazole%2520Phenyl%2520Compounds%2520as%2520Agonists%2520of%2520APJ%2520Receptor%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Debenedetto, M. V.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Kreiman, C.</span>; <span class="NLM_string-name">Moebius, D. C.</span>; <span class="NLM_string-name">Sharma, A.</span></span> <span> </span><span class="NLM_article-title">Preparation of Triazole Pyridyl Compounds as Agonists of the APJ Receptor</span>. <span class="NLM_patent">WO2018093580A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Y.+Chen&author=A.+C.+Cheng&author=M.+V.+Debenedetto&author=P.+J.+Dransfield&author=J.+S.+Harvey&author=J.+Houze&author=A.+Y.+Khakoo&author=S.-J.+Lai&author=Z.+Ma&author=V.+Pattaropong&author=G.+Swaminath&author=C.+Kreiman&author=D.+C.+Moebius&author=A.+Sharma&title=Preparation+of+Triazole+Pyridyl+Compounds+as+Agonists+of+the+APJ+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520Triazole%2520Pyridyl%2520Compounds%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">DeBenedetto, M. V.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Yeh, W.-C.</span>; <span class="NLM_string-name">Ramsden, P. D.</span>; <span class="NLM_string-name">Sharma, A.</span></span> <span> </span><span class="NLM_article-title">Alkyl Substituted Triazole Compounds as Agonists of the APJ Receptor and their Preparation</span>. <span class="NLM_patent">WO2018093576A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Y.+Chen&author=M.+V.+DeBenedetto&author=P.+J.+Dransfield&author=J.+S.+Harvey&author=J.+Houze&author=A.+Y.+Khakoo&author=S.-J.+Lai&author=Z.+Ma&author=N.+Nishimura&author=V.+Pattaropong&author=G.+Swaminath&author=W.-C.+Yeh&author=P.+D.+Ramsden&author=A.+Sharma&title=Alkyl+Substituted+Triazole+Compounds+as+Agonists+of+the+APJ+Receptor+and+their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DAlkyl%2520Substituted%2520Triazole%2520Compounds%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%2520and%2520their%2520Preparation%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Dransfield, P. J.</span>; <span class="NLM_string-name">Harvey, J. S.</span>; <span class="NLM_string-name">Heath, J. A.</span>; <span class="NLM_string-name">Houze, J.</span>; <span class="NLM_string-name">Khakoo, A. Y.</span>; <span class="NLM_string-name">Kopecky, D. J.</span>; <span class="NLM_string-name">Lai, S.-J.</span>; <span class="NLM_string-name">Ma, Z.</span>; <span class="NLM_string-name">Nishimura, N.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Swaminath, G.</span>; <span class="NLM_string-name">Yeh, W.-C.</span>; <span class="NLM_string-name">Ramsden, P. D.</span></span> <span> </span><span class="NLM_article-title">Cycloalkyl Substituted Triazole Compounds as Agonists of the APJ Receptor and Their Preparation</span>. <span class="NLM_patent">WO2018093577A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Y.+Chen&author=P.+J.+Dransfield&author=J.+S.+Harvey&author=J.+A.+Heath&author=J.+Houze&author=A.+Y.+Khakoo&author=D.+J.+Kopecky&author=S.-J.+Lai&author=Z.+Ma&author=N.+Nishimura&author=V.+Pattaropong&author=G.+Swaminath&author=W.-C.+Yeh&author=P.+D.+Ramsden&title=Cycloalkyl+Substituted+Triazole+Compounds+as+Agonists+of+the+APJ+Receptor+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10r&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DCycloalkyl%2520Substituted%2520Triazole%2520Compounds%2520as%2520Agonists%2520of%2520the%2520APJ%2520Receptor%2520and%2520Their%2520Preparation%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Runyon, S. P.</span>; <span class="NLM_string-name">Maitra, R.</span>; <span class="NLM_string-name">Narayanan, S.</span>; <span class="NLM_string-name">Rehder, K. S.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Apelin Receptor (APJ) Agonists and Uses thereof</span>. <span class="NLM_patent">WO2018071526A1</span>, <span class="NLM_year">2018</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+P.+Runyon&author=R.+Maitra&author=S.+Narayanan&author=K.+S.+Rehder&title=Heterocyclic+Apelin+Receptor+%28APJ%29+Agonists+and+Uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26atitle%3DHeterocyclic%2520Apelin%2520Receptor%2520%2528APJ%2529%2520Agonists%2520and%2520Uses%2520thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10t"><span><span class="NLM_label">(t) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trifonov, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palczewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshin, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruzman, A.</span></span> <span> </span><span class="NLM_article-title">An Expedient Synthesis of CMF-019: (S)-5-Methyl-3-{1-(pentan-3-yl)-2- (thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic Acid, a Potent Apelin Receptor (APJ) Agonist</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.2174/1573406414666180412154952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10t&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.2174%2F1573406414666180412154952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10t&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=29651942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10t&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOrtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=688-694&author=L.+Trifonovauthor=M.+Afriauthor=K.+Palczewskiauthor=E.+E.+Korshinauthor=A.+Gruzman&title=An+Expedient+Synthesis+of+CMF-019%3A+%28S%29-5-Methyl-3-%7B1-%28pentan-3-yl%29-2-+%28thiophen-2-ylmethyl%29-1H-benzo%5Bd%5Dimidazole-5-carboxamido%7Dhexanoic+Acid%2C+a+Potent+Apelin+Receptor+%28APJ%29+Agonist&doi=10.2174%2F1573406414666180412154952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10tR"><div class="casContent"><span class="casTitleNuber">10t</span><div class="casTitle"><span class="NLM_cas:atitle">An Expedient Synthesis of CMF-019: (S)-5-Methyl-3-{1-(pentan-3-yl)-2-(thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic Acid, a Potent Apelin Receptor (APJ) Agonist</span></div><div class="casAuthors">Trifonov, Lena; Afri, Michal; Palczewski, Krzysztof; Korshin, Edward E.; Gruzman, Arie</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">688-694</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Here, a detailed prepn. of (S)-5-methyl-3-{1-(pentan-3-yl)-2-(thiophen-2-ylmethyl)-1H-benzo[d]imidazole-5-carboxamido}hexanoic acid (CMF-019) (I) through a modified and improved synthetic pathway was described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoomZkzMgjze7Vg90H21EOLACvtfcHk0lhAJmo0QJU9fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOrtLbO&md5=3cb74ff0832e87edd877a443c5805bf8</span></div><a href="/servlet/linkout?suffix=cit10t&amp;dbid=16384&amp;doi=10.2174%2F1573406414666180412154952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573406414666180412154952%26sid%3Dliteratum%253Aachs%26aulast%3DTrifonov%26aufirst%3DL.%26aulast%3DAfri%26aufirst%3DM.%26aulast%3DPalczewski%26aufirst%3DK.%26aulast%3DKorshin%26aufirst%3DE.%2BE.%26aulast%3DGruzman%26aufirst%3DA.%26atitle%3DAn%2520Expedient%2520Synthesis%2520of%2520CMF-019%253A%2520%2528S%2529-5-Methyl-3-%257B1-%2528pentan-3-yl%2529-2-%2520%2528thiophen-2-ylmethyl%2529-1H-benzo%255Bd%255Dimidazole-5-carboxamido%257Dhexanoic%2520Acid%252C%2520a%2520Potent%2520Apelin%2520Receptor%2520%2528APJ%2529%2520Agonist%26jtitle%3DMed.%2520Chem.%26date%3D2018%26volume%3D14%26spage%3D688%26epage%3D694%26doi%3D10.2174%2F1573406414666180412154952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Card, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapik, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, B.</span></span> <span> </span><span class="NLM_article-title">HTRF: A Technology Tailored for Drug Discovery—A Review of Theoretical Aspects and Recent Applications</span>. <i>Curr. Chem. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.2174/1875397300903010022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.2174%2F1875397300903010022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=20161833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=22-32&author=F.+Degorceauthor=A.+Cardauthor=S.+Sohauthor=E.+Trinquetauthor=G.+P.+Knapikauthor=B.+Xie&title=HTRF%3A+A+Technology+Tailored+for+Drug+Discovery%E2%80%94A+Review+of+Theoretical+Aspects+and+Recent+Applications&doi=10.2174%2F1875397300903010022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications</span></div><div class="casAuthors">Degorce, Francois; Card, Amy; Soh, Sharon; Trinquet, Eric; Knapik, Glenn P.; Xie, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HTRF (Homogeneous Time Resolved Fluorescence) is the most frequently used generic assay technol. to measure analytes in a homogenous format, which is the ideal platform used for drug target studies in high-throughput screening (HTS).  This technol. combines fluorescence resonance energy transfer technol. (FRET) with time-resolved measurement (TR).  In TR-FRET assays, a signal is generated through fluorescent resonance energy transfer between a donor and an acceptor mol. when in close proximity to each other.  Buffer and media interference is dramatically reduced by dual-wavelength detection, and the final signal is proportional to the extent of product formation.  The HTRF assay is usually sensitive and robust that can be miniaturized into the 384 and 1536-well plate formats.  This assay technol. has been applied to many antibody-based assays including GPCR signaling (cAMP and IP-One), kinases, cytokines and biomarkers, bioprocess (antibody and protein prodn.), as well as the assays for protein-protein, protein-peptide, and protein-DNA/RNA interactions.  Since its introduction to the drug-screening world over ten years ago, researchers have used HTRF to expedite the study of GPCRs, kinases, new biomarkers, protein-protein interactions, and other targets of interest.  HTRF has also been utilized as an alternative method for bioprocess monitoring.  The first-generation HTRF technol., which uses Europium cryptate as a fluorescence donor to monitor reactions between biomols., was extended in 2008 through the introduction of a second-generation donor, Terbium cryptate (Tb), enhancing screening performance.  Terbium cryptate possesses different photophys. properties compared to Europium, including increased quantum yield and a higher molar extinction coeff.  In addn. to being compatible with the same acceptor fluorophors used with Europium, it can serve as a donor fluorophore to green-emitting fluors because it has multiple emission peaks including one at 490 nm.  Moreover, all Terbium HTRF assays can be read on the same HTRF-compatible instruments as Europium HTRF assays.  Overall, HTRF is a highly sensitive, robust technol. for the detection of mol. interactions in vitro and is widely used for primary and secondary screening phases of drug development.  This review addresses the general principles of HTRF and its current applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKDP8Vd8k247Vg90H21EOLACvtfcHk0lg9hZG3WdjWDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D&md5=9590149ceeed17ce424522ef85aa32f9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1875397300903010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397300903010022%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DF.%26aulast%3DCard%26aufirst%3DA.%26aulast%3DSoh%26aufirst%3DS.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DKnapik%26aufirst%3DG.%2BP.%26aulast%3DXie%26aufirst%3DB.%26atitle%3DHTRF%253A%2520A%2520Technology%2520Tailored%2520for%2520Drug%2520Discovery%25E2%2580%2594A%2520Review%2520of%2520Theoretical%2520Aspects%2520and%2520Recent%2520Applications%26jtitle%3DCurr.%2520Chem.%2520Genomics%26date%3D2009%26volume%3D3%26spage%3D22%26epage%3D32%26doi%3D10.2174%2F1875397300903010022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bondensgaard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ankersen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thøgersen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulff, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bywater, R. P.</span></span> <span> </span><span class="NLM_article-title">Recognition of Privileged Structures by G-Protein Coupled Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">888</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1021/jm0309452</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0309452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFyjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=888-899&author=K.+Bondensgaardauthor=M.+Ankersenauthor=H.+Th%C3%B8gersenauthor=B.+S.+Hansenauthor=B.+S.+Wulffauthor=R.+P.+Bywater&title=Recognition+of+Privileged+Structures+by+G-Protein+Coupled+Receptors&doi=10.1021%2Fjm0309452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recognition of Privileged Structures by G-Protein Coupled Receptors</span></div><div class="casAuthors">Bondensgaard, Kent; Ankersen, Michael; Thogersen, Henning; Hansen, Birgit S.; Wulff, Birgitte S.; Bywater, Robert P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">888-899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Privileged structures are ligand substructures that are widely used to generate high-affinity ligands for more than one type of receptor.  To explain this, we surmised that there must be some common feature in the target proteins.  For a set of class A GPCRs, we found a good correlation between conservation patterns of residues in the ligand binding pocket and the privileged structure fragments in class A GPCR ligands.  A major part of interior surface of the common ligand binding pocket of class A receptors, identified in many GPCRs, is lined with variable residues that are responsible for selectivity in ligand recognition, while other regions, typically located deeper into the binding pocket, are more conserved and retain a predominantly hydrophobic and arom. character.  The latter is reflected in the chem. nature of most GPCR privileged structures and is proposed to be the common feature that is recognized by the privileged structures.  Further, we find that this subpocket is conserved even in distant orthologs within the class A family.  Three pairs of ligands recognizing widely different receptor types were docked into receptor models of their target receptors utilizing available structure- activity relationships and mutagenesis data.  For each pair of ligands, the ligand-receptor complexes reveal that the nature of the privileged structure binding pocket is conserved between the two complexes, in support of our hypothesis.  Only part of the privileged structures can be accommodated within the conserved subpocket.  Some contacts are established between the privileged structure and the nonconserved parts of the binding pocket.  This implies that any one particular privileged structure can target only a subset of receptors, those complementary to the full privileged structure.  Our hypothesis leads to a valuable novelty in that ligand libraries can be designed without any foreknowledge of the structure of the endogenous ligand, which in turn means that even orphan receptors can in principle now be addressed as potential drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodmGlCbtYqNLVg90H21EOLACvtfcHk0lj8sHXzv0x6NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFyjsg%253D%253D&md5=9640167e22644d2a79e2577bb2542ab8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm0309452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309452%26sid%3Dliteratum%253Aachs%26aulast%3DBondensgaard%26aufirst%3DK.%26aulast%3DAnkersen%26aufirst%3DM.%26aulast%3DTh%25C3%25B8gersen%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DB.%2BS.%26aulast%3DWulff%26aufirst%3DB.%2BS.%26aulast%3DBywater%26aufirst%3DR.%2BP.%26atitle%3DRecognition%2520of%2520Privileged%2520Structures%2520by%2520G-Protein%2520Coupled%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D888%26epage%3D899%26doi%3D10.1021%2Fjm0309452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Compared to the activation by (Pyr<sup>1</sup>)apelin-13 (<b>1</b>) which was set at 100%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niimi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigenaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai-Moritani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, S.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Activity of Selective and Orally Available TF/FVIIa Complex Inhibitors Containing Non-amidine P1 Ligands</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.09.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1016%2Fj.bmc.2006.09.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=17064913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=160-173&author=M.+Miuraauthor=N.+Sekiauthor=T.+Koikeauthor=T.+Ishiharaauthor=T.+Niimiauthor=F.+Hirayamaauthor=T.+Shigenagaauthor=Y.+Sakai-Moritaniauthor=A.+Tagawaauthor=T.+Kawasakiauthor=S.+Sakamotoauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamoto&title=Design%2C+Synthesis+and+Biological+Activity+of+Selective+and+Orally+Available+TF%2FFVIIa+Complex+Inhibitors+Containing+Non-amidine+P1+Ligands&doi=10.1016%2Fj.bmc.2006.09.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands</span></div><div class="casAuthors">Miura, Masanori; Seki, Norio; Koike, Takanori; Ishihara, Tsukasa; Niimi, Tatsuya; Hirayama, Fukushi; Shigenaga, Takeshi; Sakai-Moritani, Yumiko; Tagawa, Ayako; Kawasaki, Tomihisa; Sakamoto, Shuichi; Okada, Minoru; Ohta, Mitsuaki; Tsukamoto, Shin-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">160-173</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We found the novel selective and orally available non-amidine TF/FVIIa complex inhibitor 21e (I), 4-({[(1S)-(aminocarbonyl)-3-methylbutyl]amino}carbonyl)-2'-({[4- (aminomethyl)phenyl]amino}carbonyl)-4'-(methylamino)biphenyl-2-carboxylic acid.  The derivs. were synthesized by conversions of the iso-Bu moiety and the introduction of alkylamino groups to 4'-position of the central Ph ring of compds. 2a and 2b reported previously.  Some compds. show increased in vitro anti-TF/FVIIa and PT prolongation activities.  Among them, compd. 21e reached and sustained micromolar plasma concn. levels of up to 2 h after oral administration in mice.  Moreover, compd. 21e did not prolong the bleeding time even at the highest dose level in cynomolgus monkeys, while PT was prolonged 3.7-fold increases at this dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeyYBTGFY_DbVg90H21EOLACvtfcHk0liQIYD4h3L3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CmtrbM&md5=5349b8f0727b66611a9fb43f04aa0365</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.09.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.09.071%26sid%3Dliteratum%253Aachs%26aulast%3DMiura%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DKoike%26aufirst%3DT.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DNiimi%26aufirst%3DT.%26aulast%3DHirayama%26aufirst%3DF.%26aulast%3DShigenaga%26aufirst%3DT.%26aulast%3DSakai-Moritani%26aufirst%3DY.%26aulast%3DTagawa%26aufirst%3DA.%26aulast%3DKawasaki%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Activity%2520of%2520Selective%2520and%2520Orally%2520Available%2520TF%252FFVIIa%2520Complex%2520Inhibitors%2520Containing%2520Non-amidine%2520P1%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D160%26epage%3D173%26doi%3D10.1016%2Fj.bmc.2006.09.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_001.pdf" class="ext-link">Supporting Information</a> for detail.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Unpublished results.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span> <span> </span><span class="NLM_article-title">Atropisomerism, Biphenyls, and Fluorine: A Comparison of Rotational Barriers and Twist Angles</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1002/cbic.200300906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1002%2Fcbic.200300906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=15122636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFeqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=644-649&author=F.+Leroux&title=Atropisomerism%2C+Biphenyls%2C+and+Fluorine%3A+A+Comparison+of+Rotational+Barriers+and+Twist+Angles&doi=10.1002%2Fcbic.200300906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomerism, biphenyls, and fluorine: A comparison of rotational barriers and twist angles</span></div><div class="casAuthors">Leroux, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">644-649</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLmDoMA_ANbVg90H21EOLACvtfcHk0liQIYD4h3L3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFeqtLY%253D&md5=5112533a436c00b58807fb23f8c169d3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200300906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200300906%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux%26aufirst%3DF.%26atitle%3DAtropisomerism%252C%2520Biphenyls%252C%2520and%2520Fluorine%253A%2520A%2520Comparison%2520of%2520Rotational%2520Barriers%2520and%2520Twist%2520Angles%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D644%26epage%3D649%26doi%3D10.1002%2Fcbic.200300906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span> <span> </span><span class="NLM_article-title">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7005</span>– <span class="NLM_lpage">7022</span>, <span class="refDoi"> DOI: 10.1021/jm200584g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200584g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7005-7022&author=S.+R.+LaPlanteauthor=L.+D.+Faderauthor=K.+R.+Fandrickauthor=D.+R.+Fandrickauthor=O.+Huckeauthor=R.+Kemperauthor=S.+P.+F.+Millerauthor=P.+J.+Edwards&title=Assessing+Atropisomer+Axial+Chirality+in+Drug+Discovery+and+Development&doi=10.1021%2Fjm200584g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span></div><div class="casAuthors">LaPlante, Steven R.; Fader, Lee D.; Fandrick, Keith R.; Fandrick, Daniel R.; Hucke, Oliver; Kemper, Ray; Miller, Stephen P. F.; Edwards, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7005-7022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ8uS-SDx68bVg90H21EOLACvtfcHk0liQIYD4h3L3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN&md5=6b44135b3871d2460fba4b3246b899e3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm200584g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200584g%26sid%3Dliteratum%253Aachs%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DFandrick%26aufirst%3DK.%2BR.%26aulast%3DFandrick%26aufirst%3DD.%2BR.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DKemper%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DS.%2BP.%2BF.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26atitle%3DAssessing%2520Atropisomer%2520Axial%2520Chirality%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7005%26epage%3D7022%26doi%3D10.1021%2Fjm200584g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bátkai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span> <span> </span><span class="NLM_article-title">Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1422</span>– <span class="NLM_lpage">1434</span>, <span class="refDoi"> DOI: 10.1038/nprot.2008.138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=10.1038%2Fnprot.2008.138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=18772869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1422-1434&author=P.+Pacherauthor=T.+Nagayamaauthor=P.+Mukhopadhyayauthor=S.+B%C3%A1tkaiauthor=D.+A.+Kass&title=Measurement+of+cardiac+function+using+pressure-volume+conductance+catheter+technique+in+mice+and+rats&doi=10.1038%2Fnprot.2008.138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats</span></div><div class="casAuthors">Pacher, Pal; Nagayama, Takahiro; Mukhopadhyay, Partha; Batkai, Sandor; Kass, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1422-1434</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ventricular pressure-vol. relationships have become well established as the most rigorous and comprehensive ways to assess intact heart function.  Thanks to advances in miniature sensor technol., this approach has been successfully translated to small rodents, allowing for detailed characterization of cardiovascular function in genetically engineered mice, testing effects of pharmacotherapies and studying disease conditions.  This method is unique for providing measures of left ventricular (LV) performance that are more specific to the heart and less affected by vascular loading conditions.  Here we present descriptions and movies for procedures employing this method (anesthesia, intubation and surgical techniques, calibrations).  We also provide examples of hemodynamics measurements obtained from normal mice/rats, and from animals with cardiac hypertrophy/heart failure, and describe values for various useful load-dependent and load-independent indexes of LV function obtained using different types of anesthesia.  The completion of the protocol takes 1-4 h (depending on the exptl. design/end points).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcTELjk9tJALVg90H21EOLACvtfcHk0lh8xTewCotlRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsL7M&md5=c45c214702bd92ba67e38bfaa564ad54</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.138%26sid%3Dliteratum%253Aachs%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DMeasurement%2520of%2520cardiac%2520function%2520using%2520pressure-volume%2520conductance%2520catheter%2520technique%2520in%2520mice%2520and%2520rats%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D1422%26epage%3D1434%26doi%3D10.1038%2Fnprot.2008.138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01513">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61110"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01513">10.1021/acs.jmedchem.9b01513</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplementary synthetic schemes, experimental protocols, synthesis of <b>12a–h</b>, synthesis of <b>15a</b> via intermediate <b>14</b>, assay condition, summary of <i>PV</i>-loop study, biotransformation study on the analogue of <b>9b</b>, details on HTP screening, and NMR spectra and HPLC traces (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_001.pdf">PDF</a>).</p></li><li><p class="inline">Molecular formula strings for the final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_001.pdf">jm9b01513_si_001.pdf (2.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01513/suppl_file/jm9b01513_si_002.csv">jm9b01513_si_002.csv (2.52 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01513&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01513%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01513" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997de308363d24","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
